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ABSTRACT 
Valproic acid (VPA) is extensively used for the treatment of epilepsy. This 
drug also functions as an inhibitor of histone deacetylase enzymes and causes 
the expression of growth arrest genes. It has been reported that mild to 
moderate cognitive impairments occur in adult patients taking VP A. This 
investigation aimed to examine the relationship between cognition and changes 
in cell proliferation within the rat hippocampus, a brain region where continued 
formation of new neurons is associated with learning and memory. Also, the 
antiproliferative function of VP A was investigated in rat and mouse 
hippocampal neural stem cells (NSCs) and cancer cell lines in vitro. 
The cognitive and antiproliferative effects of VP A were determined in adult 
Hooded Lister rats treated with VP A (300mg/kg) by intraperitoneal injection 
twice daily for 10 days. Cognition was assessed by the Novel Object Location 
(NOL) and contextual fear conditioning tests. Cell proliferation within the 
subgranular zone (SGZ) of the dentate gyrus was determined by 
immunostaining for Ki67. Additionally, levels of the brain-derived 
neurotrophic factor (BDNF), doublecortin (DCX) and the receptor Notchl 
expression were measured by Western blotting. The results showed that 
animals treated with VPA had a hippocampal specific cognitive impairment as 
shown by NOL, test but not contextual fear conditioning. This was linked to a 
significant reduction in cell proliferation within the SGZ. Moreover, VPA 
treatment statistically significantly decreased levels of BDNF and Notch I , but 
not DCX within the hippocampus. 
The antiproliferative effect ofVPA treatment (0.3 and 1 mM) for 24 hours was 
investigated in hippocampal neural stem cells (NSCs) in vitro. The numbers of 
neurosphere and cell proliferation assessed in VPA-treated rat and mouse 
hippocampal NSCs showed significantly decreased in a concentration-
dependent manner. Levels of Notch 1 , Sox2, nestin and c-Myc gene expression 
were quantified using qPCR. This revealed that 1 mM VPA reduced expression 
iii 
of Notch 1 , Sox2 and nestin but not c-Myc. However, there were no changes in 
levels of these gene expressions in 0.3 mM VPA. 
The influence of VP A on cancer cell proliferation was examined in human 
Epnl, Medl and SHSY5Y cell lines by treating with 1,2 and 3 mM VPA for 
72 hours. The data of cell proliferation showed that VP A produced a 
significant reduction of tumour cell growth in a dose-dependent manner in all 
three cell lines. VPA (1, 2 and 3 mM) induced levels of Notchl expression in 
SHSY5Y cell lines. Additionally, the number of dividing cells of Epnl and 
Medl treated with 2.5 mM VPA was significantly decreased compared to 
untreated cells using Ki67 immunostaining. However, Notchl expression was 
not detected in either Epnl or Medl cell lines. 
These results indicate that VP A treatment induced cognitive deficits in rats and 
that this was associated with a reduction in hippocampal NSCs both in vivo and 
in vitro. In addition, VPA reduced BDNF and Notchl expression in the 
hippocampus. Moreover, VPA induced a decrease of levels of Notch 1 , Sox2 
and nestin gene expression in hippocampal NSCs. The present study also 
reveals that antiproliferative effect of VPA was associated with an increase of 
Notchl expression in SHSY5Y. However, this action ofVPA appeared to have 
no link with Notch 1 expression in Epnl and Medl cell lines. 
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Chapter 1 
Literature review 
1. Introduction 
It has been suggested that many chemicals and therapeutic drugs may have 
cognitive side-effects. These may be longstanding and debilitating for patients 
on these medications. For instance, chemotherapeutic drugs can cause memory 
loss and other cognitive problems (Schagen et al., 2006, Tannock et al., 2004). 
More recently, it has been suggested that the commonly used antiepileptic 
drug, valproic acid (VPA), may have both cognitive effects and direct adverse 
effects on the adult hippocampus (Aldenkamp, 2001, Gualtieri and Johnson, 
2006). This project investigated the nature and cause of these effects. 
1.1 Valproic acid 
The synthesis of valproic acid (VP A) was first reported by Burton in 1882 as a 
clear, colourless, eight-branched chain fatty acid which derived its name from 
chemical name of 2-propylvaleric acid (Fig. 1.1) (Blaheta and CinatI, 2002, 
Henry, 2003). VPA is an oily liquid at room and body temperature, has high 
solubility in organic solvents but low solubility in water (Henry, 2003). In 
1962, Carraz and colleagues investigated whether antiepileptic drugs were 
highly soluble in VPA instead of water or the usual organic solvents. It was 
discovered that VP A on its own was a potent anticonvulsant. This led to the 
therapeutic potential of VP A as an anticonvulsant, with the first epilepsy trials 
for VP A in humans reported the following year. VP A was approved for the 
treatment of epilepsy in France in 1967 and by the USA in 1978 (Blaheta and 
Cinatl, 2002, Henry, 2003, Lagace et al., 2004). 
2 
COOII 
Fig 1.1 Chemical structure ofVPA (Adapted from Blaheta and Cinalt 2002). 
1.1.1 Properties of VPA 
VPA admjnistered orally is absorbed rapidly and effectively (96% to 100%) 
across intestinal mucosal membranes without any effects of first-pass 
metabolism in humans (Lagace et al ., 2004). After oral admjnistration, VPA 
serum concentration maxirruzes approximately 1-3 hours. In humans, VP A has 
a half-life of between 13 and 18 hours. However the half-life is dramatically 
rufferent between species, for instance, 0.6 hours in rhesus monkeys, 0.8 hours 
in mjce, 2.5 hours in rats and 9 hours in cats. The lipid soluble portion of VPA 
is rustributed rrunimally into tissues by passive ruffusion across membranes 
because VPA is hjghly ionized into a carboxylate moiety, valproate. VPA (70-
94%) is bound to plasma proteins, albumn, but a low proportion of VPA is 
bound to albumin in elderly patients and pregnant women. The concentration 
of VPA reaches its peak within rrunutes in the cerebrospinal fluid (CSF) of 
rodents and monkeys after intravenous or intraperitoneal injection (Lagace et 
al. , 2004). Sturues in humans show a concentration of VPA in brain tissue and 
CSF less than 30% of the total serum concentration. The brain VP A 
concentration depends on the unbound plasma fractions (Henry, 2003). 
However, VP A can reduce epileptic symptoms within less than 20 mjnutes, 
since VPA reaches the brain rapidly. In the central nervous system (CNS), the 
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choroid plexus and the blood-brain barrier regulate the uptake and elimination 
of VP A. The elimination of VP A takes place mostly through the blood-brain 
barrier. The rate of VPA elimination in eNS is higher than the rate of uptake; 
therefore patients require high doses ofVPA to accomplish effective treatment 
(Lagace et al., 2004). VPA is largely metabolized in the liver, consequently 
only a very small amount is found in urine (Henry, 2003, Lagace et aI., 2004). 
1.1.2 ModeojlPA action 
1.1.2.1 IPA effects on epilepsy 
Epilepsy is a disorder of the central nervous system characterized by recurrent 
seizures unprovoked by an acute systemic or neurogenic insult. A seizure is the 
sequence of a sudden imbalance between the excitatory and inhibitory inputs to 
a hyperexcitable network. It has been reported that pathological stimulation of 
seizures enhances neurogenesis and migration of type-3 progenitor cells in the 
hippocampal dentate gyrus in rodent models (Jessberger et al., 2005). There are 
several different types of epilepsy including temporal lobe epilepsy (TLE) 
which is the most frequent cause of partial seizures (Rho et al., 2004, Shin and 
McNamara, 1994). Experimental studies have led to two theories regarding the 
cellular network changes which cause the hippocampus (the most common 
sites of origin of partial seizures) to become hyperexcitable. The first theory 
suggests that a selective loss of intemeurons decreases the normal inhibition of 
the dentate granule cells, an important group of principal neurons. Therefore, 
GABA-mediated inhibition of dentate granule cells is decreased. The second 
proposes that synaptic reorganization follows injury and creates recurrent 
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excitatory connections, via axonal sprouting, between neighbouring dentate 
granule cells. This investigation proposes an increase in hyperexcitation 
causing seizure (Shin and McNamara, 1994, Rho et al., 2004). Anticonvulsants 
can function to inhibit seizure by increasing synaptic GABA, by prolonging the 
open time of the chloride channel or by enhancing binding of GABA to 
GABA receptor, thus increasing the frequency of chloride channel openings 
(Treiman, 2001). 
Researchers have discovered that one of the anti-epileptic therapeutic 
mechanisms of VPA is to increase levels of the inhibitory neurotransmitter y-
aminobutyric acid (GABA). As a consequence, acute uptake ofVPA increases 
GABA in the brains of rodents and in the plasma and CSF of humans. There 
are also studies showing that GABA signalling potentiated to prevent seizures 
(Lagace et al., 2004). In contrast, GABA antagonists which reduce GABAergic 
inhibition in the cerebral cortex cause seizures. VP A increases GABA by 
inhibition of GABA transaminase (GAB A-T) which degrades GABA to 
succinic semialdehyde (SSA). Furthermore, VPA may stimulate glutamic acid 
decarboxylase (GAD) to transform glutamic acid to GABA (Lagace et al., 
2004). Action of VPA also depresses aspartate release within brain. Moreover, 
one of the primary actions of VP A have been postulated to block Na ~ ~ -channels 
and Ca+-channels (Kwan et al., 2001). 
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1.1.2.2 VPA effects on cell proliferation and differentiation 
As described above, VPA has been recognized as a long-term anti-epileptic 
drug. More recently, it has been shown to be associated with inhibition of 
histone deacetylase (HDAC) enzymes. However, VPA inhibition ofHDACs in 
human has not been found yet (Blaheta and Cinatl, 2002, Kostrouchova et al., 
2007, Lagace et al., 2004). The important function of HDAC enzymes is 
removal of acetyl groups from an B-N-acetyl lysine amino acid on histone 
proteins. Deacetylation adds a positive electric charge to the lysine amino acid, 
which increases the affinity between histones and DNA. This results in the 
inhibition of transcription which requires a separation of the DNA strands and 
loosening in the DNAlhistone attachment (Blaheta and Cinatl, 2002). A 
separate family of enzymes, the histone acetyl transferases (HAT), adds acetyl 
groups to the histone proteins, loosen the binding of DNA to histone proteins 
and so promote transcription. Both in vitro and in vivo, transcriptional 
regulation is a crucial event in determining cell function, including, growth 
arrest, differentiation, and apoptosis. Interestingly, VP A directly inhibits 
HDACs 1-5 and 7, causing hyperacetylation and so weakening the association 
of histones with DNA. Consequently, gene transcription is enhanced. 
Surprisingly, this enhanced transcriptional activity, specifically up regulates the 
expression of genes associated with cell differentiation, cell eycle arrest and 
apoptosis (Blaheta and Cinatl, 2002, Kostrouchova et al., 2007, Lagace et al., 
2004). For example, studies have confirmed that VPA causes an increase in the 
expression of p21, a eyelin-dependent kinase inhibitor, which induces cell 
eyele arrest in both normal and cancer cells. In line with this, the site of VP A 
antiproliferative effects within the cell cycle is postulated to be in the mid GI 
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phase. VP A is also capable of inducing neuronal differentiation and 
suppressing glial differentiation by up-regulating neurogenic transcription 
factors including Neuro D in neural progenitor cells (Li et al., 2005, Martin and 
Regan, 1991, Kostrouchova et al., 2007, Hsieh et al., 2004). In neural stem 
cells, accordingly, VPA promotes neural production but attenuates glial 
formation (Laeng et al., 2004). In vitro, VPA reduces the number of neural 
cells migrating during epithelial-mesenchymal transitions, decreases their 
proliferation, and increases cell-cell adhesion. This causes a slowing of motility 
of neural cells and a change in neural cell morphology, making them more 
rounded (Fuller et al., 2002). 
VP A has been demonstrated as a potential novel therapeutic agent, due to its 
HDAC inhibitor effects, on transcriptional regulation in cancer cells (Gottlicher 
et al., 2001). Transcription, which is the primary target of HDAC inhibitors 
such as VP A, plays an crucial role in determining cell fate in response to 
treatment (Chen et al., 2006). Strikingly, VPA decreases cell proliferation of 
small cell lung cancer, human thyroid cancer and endometrial tumour cells by 
inducing cell cycle arrest and stimulating apoptosis (Platta et al., 2008, Shen et 
al., 2005, Blaheta et al., 2005). Similarly in neuroendocrine cancers, VPA 
induces cell cycle arrest, causing an inhibition of cell growth of carcinoid cells 
(Greenblatt et al., 2007). Therefore, VPA has been investigated as a new 
therapeutic approach for the treatment of cancers of the nervous system. This 
novel clinical use ofVPA may cause milder side effects in comparison with the 
normal regimen of chemotherapy with or without radiotherapy. 
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1.1.2.3 VPA effects on brain development 
As the use of VP A as an effective treatment for epilepsy became more wide 
spread it became apparent that VP A, if taken during pregnancy, could act as a 
teratogen. Specifically, it became associated with an increased incidence of 
neural tube defects. This ability to induce neural tube effects is found in both 
human and mouse embryos but the mechanism remains unknown (Kultima et 
al., 2004). The number of gross malformations induced by VPA is low «1 %); 
however recently, more subtle long-term cognitive and behavioural effects of 
VPA exposure in utero have been found. A study of exposure to VPA of 
children in utero showed a higher incidence of minor morphological 
abnormalities but some children had major cognitive and behavioural problems 
including autism syndrome (Viinikainen et al., 2006). During brain 
development, moreover, prenatal VP A treatment leads to alterations of the 
development of the hippocampal formation by interrupting lamination and cell 
migration (Manent et al., 2007). It is likely that these development effects ofVPA 
are associated with its ability to inhibit cell proliferation and migration. 
1.1.2.4 VPA effects on the adult brain including cognition 
1.1.2.4.1 Hu1lUl1l studies 
Epilepsy develops in 1-1.5 % of the population and VPA is widely used as a 
long-term epileptic therapy (> 104 individuals in the UK) (Wallace et al., 1998) 
and this has led to an investigation into its cognitive effects in adults. Several 
studies have reported that patients treated with VP A develop mild to moderate 
cognitive deficits (A1denkamp, 2001, Easterford et al., 2004, Gualtieri and 
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Johnson, 2006, Jamora et al., 2007, Hommet et al., 2007). VPA caused 
impairment of memory function, psychomotor function and mental speed 
(Hommet et al., 2007). A study of 50 patients taking VPA has demonstrated 
that 6% of the patients develop Parkinsonism and cognitive impairment 
(Easterford et al., 2004). Six patients suffered from insidious cognitive 
impairment and Parkinsonism while being with treated VPA (Masmoudi et al., 
2006). More recently, a side effect such as Parkinsonism appeared in six 
(5.04%) of 119 patients who had been on long-term high doses of VPA 
(Jamora et al., 2007). In contrast the previously mentioned studies at least one 
study has found that administration of VP A monotherapy in patients does not 
show cognitive and neurological symptoms (Gillham et al., 1990). In epileptic 
patients, withdrawal of VPA has been found to alleviate these cognitive 
deficits; however, it takes at least several months, after discontinuing drug 
treatment, to resolve these adverse effects (Goldberg and Burdick, 2001, 
Hessen et al., 2006, Masmoudi et al., 2006, Hommet et al., 2007). Although, 
VP A has been generally considered to have a good safety profile for several 
years, the drug-induced cognitive dysfunction and Parkinsonism must be 
considered in all patients treated with VP A. Recently, VP A is increasingly 
being used as a mood stabiliser in bipolar disorder which will increase the 
number of patients taking this drug (Rao et al., 2007). 
Assessment of the cognitive effects of VPA is complicated by the fact that 
epilepsy, the prime reason for prescribing VP A, also causes cognitive 
impairments and changes to hippocampal function (Jessberger et al., 2007). 
For this reason an animal model of the behavioural effects of VP A independent 
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of pre existing conditions would be useful in understanding the effects of this 
drug. 
1.1.2.4.2 Animal studies 
Few studies have looked at cognitive effects of VP A in animals. One group has 
reported that animals receiving a single dose of 250 mg/kg VPA showed 
cognitive impairment in terms of long-term memory deficits using a passive 
avoidance test (Balakrishnan and Pandhi, 1997, Pandhi and Balakrishnan, 
1999). 
A more recent study treated adult rats with 300 mg/kg VP A injected i.p. twice 
daily for 14 days (Hsieh et al., 2004). This regime produced a significant 
decrease (-50%) in the numbers of BrdU positive cells in neurogenic region of 
the hippocampus in comparison to control animals. The same study treated 
neural progenitor cells from the adult hippocampus in vitro. Exposure to 1 mM 
VP A for 24 hours substantially decreased the number of BrdU positive cells 
from 50% to 20% compared to controls (Hsieh et al., 2004). Furthermore, VP A 
treatment increased apoptosis of the hippocampal progenitor cells as evaluated 
by staining propidium iodide. This result was dose-dependent with treatment 
with 0.3 and 1 mM VPA for 2 days producing approximately 2% and 7% 
apoptotic cells respectively. However, the amount of cell death in the lower 
dose was only slightly higher than untreated cells. These results show that VPA 
has similar effects on proliferation and cell death in adult neural progenitor 
cells as has been described for cancer cells. 
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Hsieh et al also postulated that VP A has the potential to affect chromatin 
modification which is important in determining stem cell fate between self-
renewal and differentiation (Hsieh et al., 2004). Strikingly, the mechanism of 
VP A action leads to increases in the level of a neural transcription factor 
(NRSFIREST) which activates gene expression to induce neuronal 
differentiation (Hsieh et al., 2004, Jessberger et al., 2007). 
An animal study has reported that the serum concentrations of rats, after 
administration subcutaneously with 400 mg/kg ofVPA for 1, 3, 6 and 9 hours, 
were approximately 2.5, 1.2, 0.4 and 0.3 mmollL, respectively. Moreover, the 
serum concentration almost dropped to zero within 24 hours (Ubeda et al., 
2002). 
In addition, metabolites of VPA have been found to accumulate in the 
hippocampus (Masmoudi et al., 2000) suggesting that this brain region may be 
particularly affected by this drug. The results of this investigation suggest that 
VP A may be having a direct effect on hippocampal neurogenesis and this 
might be the mechanism for the cognitive deteriorations found in human 
studies. However, behavioural testing was not done in this investigation and it 
remains to be determined to what extent changes in neuronal stem cells 
proliferation and differentiation correlate with behavioural changes after VP A 
treatment. 
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1.2 Anatomy of hippocampus 
The hippocampal formation comprises the hippocampus, the presubiculum, the 
subiculum, and the dentate gyrus (Kempermaan, 2006, FitzGerald et aI., 2007). 
The hippocampus is located at the floor of the inferior horn of the lateral 
ventricle and its external surface is continuous through the subiculum with the 
parahippocampal gyrus. In coronal section, the appearance of the hippocampus 
is an s-shape. The gross anatomy of the human hippocampal formation and 
fornix is similar to a sea horse; from which it derives its name - hippocampus. 
The anterior extremity of hippocampus forms the pes hippocampi which 
resemble a paw (Wikinson, 1998). Part of the hippocampus is also called 
Amrnon's horn or cornu ammonis (CA) and is subdivided into four CA fields: 
CA1, CA2, CA3 and CA4 (Kempermaan, 2006, FitzGerald et al., 2007, 
Anderson et al., 2007). CA3 and CA2 fields (region inferior) are a larger area 
compared to CA1, also called region superior. CA3 and CA2 pyramidal cell 
bodies are large and quite variable but CA2 is not innervated by mossy fibers. 
CAl pyramidal cells are more substantially homogeneous and smaller than 
CA3 cells. CA4 is defined as the deep layer of dentate gyrus (polymorphic 
layer) (Anderson et al., 2007). The thin white matter on the ventricular surface 
of hippocampus is known as the alveus in which these fibres run medially to 
form the fimbria of fornix. After the hippocampus terminates beneath the 
splenium of corpus collosum, the fimbria continues as the crus of fornix, 
forming commissural and associational connections with the limbic and 
cortical systems (Con, 2003). 
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The hippocampus is recognized as a trilaminar cortex. The external layer, 
called molecular layer, continues with the molecular layers of the dentate gyrus 
and neocortex. The pyramidal layer, the middle layer, consists of large 
pyramidal shape neurons which are the principal cells of hippocampus. The 
internal layer, called the polymorphic layer, is beneath the alveus. The dentate 
gyrus also has three layers (molecular layer, granule cell layer and plexiform 
layer) and covers the distal tip of the CA region. Granule cells are the principal 
cells of the middle layer of the dentate gyrus which is consequently named a 
granule cell layer. The hilus of the dentate gyrus is continuous with the 
polymorphic layer of area CA3 (FitzGerald et al., 2007, Kieman, 1998). 
The perforant pathway which projects from the entorhinal cortex contains the 
largest afferent fibres of the hippocampus. These afferent fibres terminate on 
the dendrites of the granule cells of the dentate gyrus in the molecular layer 
which surrounds the external surface of the dentate gyrus. The axons from the 
dentate gyrus granule cells are known as mossy fibres, project to the pyramidal 
cells in the CA3 field (Figure 1.2). These CA3 pyramidal cells project axons 
into the fimbria; they give off Schaffer collaterals which run to CAl where the 
third synapse in this circuit is found. CA I pyramidal cells project axons to 
synapse on the subiculum. The subiculum then returns a projection to the 
entorhinal cortex. The subiculum is the other source of efferent fibres, via the 
alveus, to end in the fimbria. The largest efferent pathway of hippocampus is 
the fornix which originates from the fimbria. In addition, the efferent pathway 
from the hippocampus is also a proj ection via the entorhinal cortex to the 
association areas of the neocortex, the diencephalon, and brain stem 
(Kempermaan, 2006, FitzGerald et al ., 2007, Kieman, 1998). 
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Figure 1.2 Diagram shows hippocampal circuits. CAI and CA3 of the 
hippocampus are shaded purple. Subgranular zone (SGZ; shaded green) of the 
dentate gyrus (shaded purple) can generate new neurons throughout life. This 
pathway is essential for acquisition of memory and has three steps, called tri-
synaptic circuit. Afferent fibers from the sensory association cortex project to 
the dentate gyrus via the enthorinal cortex which is called the perforant 
pathway. Then, mossy fibers are given off from granule cells to pyramidal cells 
in the CA3 . After that, CA3 pyramidal cells project axons, which are known as 
Schaffer coJlaterals, to synapse with CA} pyramidal cells. CA} pyramidal cells 
return a projection to the entorhinal cortex via the subiculum. Abbreviation: 
CAI , cornu ammonis I; A3 , cornu ammonis 3 (Adapted from McCaffery et 
al ., 2006). 
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1.3 Development of hippocampal dentate gyrus and subgranular zone 
Hippocampal development originates from the ventricular zone (YZ) in the 
dorsal forebrain. The YZ is derived from the neuroepithelial cells lining the 
primordial ventricles which give rise to a proliferative matrix just beneath the 
YZ called subventricular zone (SYZ). The proliferation of cells in the SYZ 
exceeds that in the YZ and after birth the YZ does not function as a 
germinative layer. However, the SYZ in the lateral walls of the lateral ventricle 
continue to generate new neurons throughout postnatal life (Kempermaan, 
2006). 
The precursor cells, which will form the dentate gyrus, migrate from the 
primary germinative matrix in the SYZ to form a second germinative matrix. 
From this matrix cells migrate to form the outer shell of the dentate gyrus. The 
secondary germinative matrix gives rise to a tertiary germinative matrix around 
E22. During the early postnatal period, the secondary matrix has nearly 
finished developing and is replaced by the tertiary matrix. This is most active 
during postnatal day 3 to postnatal day 10. The tertiary germinative matrix 
forms the hilus or plexiform layer of the dentate gyrus in the adult. The tertiary 
germinative matrix generates the inner layer of the granule cell layer. The 
newly generated granule cells migrate from this inner layer to the outer shell of 
the dentate gyrus. Consequently, the youngest granule cells are located 
internally and the oldest granule cells are located externally. The tertiary 
germinative matrix becomes increasingly confined to the subgranular zone 
(SGZ), from which the new neurons of adult hippocampal neurogenesis are 
continuously generated. This postnatal phenomenon (hippocampal adult 
neurogenesis) has recently generated significant interest (Kempermaan, 2006). 
15 
1.4 Memory and hippocampus 
1.4.1 Memory 
From prospective investigations, memory is formed and retrieved in three 
mains stages: encoding, storage and retrieval, respectively. Encoding or 
registration is receiving, processing and combining of received information. 
Storage is a creation of a permanent record of the encoded information. 
Retrieval or recall is calling back the stored information in response to some 
cue for use in a process or activity (Anderson et al., 2007). Memory can be 
divided into two types; short term and long term memory. Short term memory 
also known as working memory, has a strictly limited capacity and new 
information is temporarily stored for a certain period of time. Short-term 
memory allows recall for a period of seconds to a minute without rehearsal, but 
is not retained indefinitely (Fig. 1.3). By contrast, long-term memory has a 
much larger capacity and is capable of storing information for potentially 
unlimited duration (sometimes a whole life span) (Bear et al., 2007, FitzGerald 
et al., 2007). In human and non-human animals, working memory has an 
important role in intellectual function (Smith et al., 1996). The frontal cortex 
(particularly the dorsolateral prefrontal cortex) and the parietal lobe are 
essential for transient patterns of neuronal activity involved in short-term 
memory. While long-term memories are sustained by more stable and 
permanent changes in neural connections widely spread throughout the brain. 
Short-term memory is consolidated and transferred into long-term memory by 
the hippocampus (Kempermaan, 2006). 
16 
+ 
repefition 
r e t r ~ e v a l l
I Stimulus I 
l 
Sensory organ 
1 perception 
Sensory memory 
1 attention 
,I Short-term memory 1---__+, forgetting 
I Encoding consolidation 
Long-term memory 
(days, months, years) 
Figure 1.3 Short-term memory. Short-term memory is a system which is 
required to temporarily store and manage new information. Short-term memory 
is involved in the selection, initiation, and termination of information-
processing functions such as encoding, storing, and retrieving data. Several 
recalls/rehearsals of short-term memory are needed for long-term memory to 
last long for a year (Modified from http://www.aboutmind.comlmemory-brain-
neurons-l.shtml ). 
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Figure 1.4 Long-term memory is divided into declarative and procedural 
memories. There are two types of declarative memory: semantic (i.e. words, 
ideas, concepts) and episodic (i.e. biographical events) memory. Procedural 
memory is composed of skills, priming and conditioning (Modified from 
Milner et al., 1998). 
Long-term memory is divided into declarative and procedural memories (Fig. 
1.4). Declarative memory, which is also called explicit memory, involves the 
knowledge and recall of facts and events that can be consciously recollected. 
There are two major sub-types of declarative memory; semantic and episodic 
memory. Semantic memory is the memory of meanings, understanding and 
knowledge. Episodic memory, on the other hand, involves in information 
specific to a particular context, such as a time and place (FitzGerald et al., 
2007). The formation of new episodic memories requires the medial temporal 
lobe, a structure that includes the hippocampus. In addition, the hippocampus is 
believed to be involved in spatialleaming and declarative leaming. In contrast 
to declarative memory, procedural or implicit memory is primarily described as 
the memory for learning skills of performed motor tasks (i.e. riding a bicycle) 
and mental activities (i.e. using common vocabulary and grammatical rules of 
language), which does not depend on the conscious recall of information. This 
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memory is stored gradually by practice and repetition (FitzGerald et al., 2007, 
Kieman, 1998). Procedural memory involved in motor learning depends on the 
cerebellum and basal ganglia (Lynch, 2004). 
1.4.2 Long-term potentiation, long-term depression and memory 
Long-term potentiation (L TP) is a process in which synapses are strengthened. 
After intense stimulation of the presynaptic neuron, the amplitude of the post-
synaptic neuron's response increases. Nerve impulses trigger release of 
glutamate, from the pre-synaptic cell. Glutamate is the most abundant 
excitatory neurotransmitter in the mammalian nervous system. Glutamate 
receptors in the opposing post-synaptic cell, such as the NMDA receptor, bind 
glutamate and then these receptors are activated. In the postsynaptic neuron, 
this stimulus causes sufficient depolarization to evacuate the magnesium ions 
that are blocking the NMDA receptor, thus allowing large numbers of calcium 
ions to enter the dendrite (Lynch, 2004, Anderson et al., 2007, Bear et al., 
2007). This rise in calcium activates protein kinase C and Ca2+ Icamodulin-
dependent protein kinase IT (CaMK IT). Either protein kinase C or CaMK IT 
phosphorylate the AMPA receptors to remain open longer. Additionally, new 
AMP A receptors are delivered and inserted into the postsynaptic membrane. 
As a result, the postsynaptic neurons become further depolarized, thus 
contributing to LTP (Bear et al., 2007, Anderson et al., 2007). 
In contrast to LTP, long-term depression (LID) may be regarded as a 
complementary mechanism to LTP. In the hippocampus, LTD plays an 
important role to bring synapses that have been potentiated back to an ordinary 
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level in order to have synapses available for new information. L TD develops 
when a presynaptic neuron is active without the postsynaptic neuron's being 
subjected to strong depolarization, as it is with L TP. This lack of association 
between the two neurons raises the concentration of calcium in the 
postsynaptic neuron, but much less than in LTP (Duman et al., 2001b, Duman 
et al., 2001 a). Consequently, phosphatases are activated instead of CaMK 11 
being activated. This enzyme dephosphorylates the AMP A receptors by 
removing certain phosphate groups from them. This depolarization of the 
AMPA receptor reduces the amplitude of the postsynaptic potential to the 
normal level and decrease the number of AMP A receptors during LTD. The 
mechanism of LTD is opposite to LTP showing that AMPA receptors are 
removed from the postsynaptic membrane to a reserve in LTP while these 
receptors are inserted in to the membrane in LTD (Bear et al., 2007, Anderson 
et al., 2007). 
Changes in neuronal synapses are capable of being used to form the basis of 
learning and memory, and these changes are believed to be brought about by 
LTP and LTD. Several lines of studies show that LTP and LTD are correlated 
to memory. For instance, activation of NMDA receptors needed for synaptic 
plasticity in both LTP and LTD is involved in learning (Bear et al., 2007). 
Researchers have found that rats receiving an NMDA-receptor antagonist 
injected into the hippocampus spend a longer time finding the location of the 
hidden platform in the Morris water maze test, than normal rats (Lynch, 2004, 
Bear et al., 2007). This finding reveals that NMDA receptors are necessary for 
memory. In parallel with the role of the NMDA receptor in hippocampal LTP, 
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it has been found that CaMK II knockout mice shows deficits in hippocampal 
LTP as well as memory (Bear et al., 2007). In short, NMDA receptors are 
essential for hippocampal LTP and LID as well as learning and memory. 
1.4.3 The hippocampus and spatial menwry 
Assessment of preference between a new and a familiar object or picture can 
be used to investigate recognition memory using the visual paired comparison 
task. In both human and animal studies, localised damage to the hippocampus 
impairs memory (Con, 2003). For example, Clark and his colleagues (2000) 
have demonstrated that direct hippocampal damage in rats produced 
recognition memory impairment. In cognitive psychology and neuroscience, 
spatial memory is a form of working memory, which is used to define position 
within the environment. In non-humans, spatial memory is responsible for 
describing the environment, including distances and directions such as learning 
the location of food at the end of the maze (Abrahams et al., 1997). In humans, 
similarly, spatial memory is needed for navigating around a familiar city. It is 
still controversial how spatial memories are formed and then stored in a spatial 
map both in human and animals. Prior to spatial memories being formed; 
sensory information (particularly vision and propioceptive) of environments is 
gathered and processed in CAl. Several studies have demonstrated that the 
hippocampus is strongly involved in spatial memory and spatial information 
(spatial mapping) is particularly processed in the right hippocampus of the 
brain (Abrahams et aI., 1997, Nunn et al., 1999). Accordingly, the 
hippocampus is also considerably implicated in spatial memory (Morris water 
maze) and recognition memory, but spatial memory requires more of the 
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hippocampus than recognition memory (Broadbent et al., 2004). Moreover, 
investigation of hippocampal lesions in rodents and primates has produced 
impairments of spatial memory. Human, patients who have had the right 
hippocampus removed, show deficits in object location memory (Nunn et al., 
1999, Broadbent et al., 2004). Similarly, spatial memory deficits have been 
demonstrated in patients who have right hippocampal injury or resection 
(Abrahams et al., 1997). 
The hippocampus is not a storage area of memory, but functions as the gateway 
to memory. It prepares and transfers information (i.e. short-term memory) 
before long-term memory is stored permanently in neocortical areas 
(Kempermaan, 2006). The hippocampus converts information into explicit and 
implicit memory (FitzGerald et al., 2007, Kieman, 1998). John O'Keefe and 
his colleagues have demonstrated that many neurons in the hippocampus 
selectively exhibit a high rate of firing when an animal is in a specific location 
in an environment corresponding to the cell's place field. These neurons, which 
are distinct from other neurons with spatial firing properties, are called place 
cells (Anderson et al., 2007, Bear et al., 2007). These place cells in the 
hippocampus are specifically active in this spatial navigation with humans as 
well as with rats. Interestingly, alteration of the spatial environment 
demonstrates that place cells are responsive to new location more than old 
location (Bear et al., 2007). Further evidence from transgenic studies show that 
the plasticity inherent in long-term place field stability depends on NMDA 
receptors. For example, mutant mice with blocked NMDA receptors take 
longer time than control mice to find a hidden platform in the Morris water 
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maze (Anderson et al., 2007). Additional studies have reported that NMDA 
receptors are required in consolidation of spatial memory and AMP A receptors 
in involved in the retrieval of this memory (Liang et al., 1994). 
1.5 Neural stem cells 
The term stem cell describes undifferentiated cells that have unlimited 
proliferative capacity, long-term self-renewal and pluripotency. Stem cells may 
be pluripotent - in which case they can give to all cell types (e.g. embryonic 
stem cells) or can be multi potent and be able to give rise to a limited number of 
cell types but not all body tissues (Rao, 2006). Self-renewal is considered to be 
the most important definition of sternness and is defined as the ability to go 
through numerous cycle of cell division while maintaining the undifferentiated 
state and not becoming senescent (Kempermaan, 2006). Self-renewal is also 
important to sustain stem cell developmental potency and proliferative capacity 
(Rao, 2006). Embryonic stem cells are true stem cells in that they are 
pluripotent and show unlimited capacity for self-renewal. In contrast, adult 
stem cells would be better described as progenitor cells because their 
capabilities for self-renewal are not unlimited and their degree of potency can 
be multi potent, bipotent or unipotent (Kempermaan, 2006). The most primitive 
cells, cell produced by the first few division of the fertilized egg, are totipotent 
that can produce all organisms and tissues. The potency can be limited within 
stem cell lineage; therefore, stem cells may be pluripotent or multipotent 
(generating various cell types, but not entire system), oligopotent (capability of 
differentiating into a few cell types) or unipotent (producing only one cell type) 
(Rao, 2006). 
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Embryonic stem (ES) cells are derived from the inner cell mass of the 
blastocyst. In cell culture, ES cells are capable to produce functioning neurons 
and glial cells. Adult stem cells which also known as somatic stem cells 
generate another cell like itself and also divide and create a cell more 
differentiated than itself (Kempermaan, 2006). Stem-like cells have been 
discovered in the embryonic CNS and PNS. The neural stem cells are derived 
from neuroectoderm and are multi potent (Kempermaan, 2006). In adult rodent, 
primate and human, interestingly, neural stem cells (NSCs) can be most easily 
isolated from two known neurogenic regions; the sub ventricular zone (SVZ) 
of the lateral walls of the lateral ventricle and SGZ of the dentate gyrus (which 
produces granule cells in the hippocampus) (Potten et al., 2006). Recently, 
stem cells have been shown to be a more widespread feature of the adult 
nervous system than previously considered as they have been found in the non-
neurogenic areas such as the spinal cord and neocortex (Potten et al., 2006). 
During embryonic development, symmetric division of stem cells within the 
neuroepithelium forming the neural tube can produce either two identical stem 
cells or by asymmetrical division create one stem cell and one transit-
amplifying or transit amplifying progenitor cell (Fig. 1.5) (Kemperrnaan, 2006, 
Potten et al., 2006). Transit amplifying progenitor cells are rapidly dividing 
progenitors which lack the self-renewing ability of their stem cells but which 
are the majority of dividing progenitor in the tissue (Diaz-Flores et al., 2006). 
In adult tissues, only multi potent progenitor cells rather than pluripotent or 
totipotent cells are found. As in embryonic tissues these can divide 
symmetrically to generate two identical daughters which are similar to the 
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mother cell or divide asymmetrically to produce two daughter cells in which 
one is different from the mother cell while the other retains the characteristics 
of the mother cell (Kempermaan, 2006, Potten et al ., 2006). Additionally, 
terminally symmetric division of progenitor cells can also generate two 
identical cells that are both different from the mother cell and then these 
progeny differentiate into neurons (Kempermaan, 2006) . 
Symmetric divisions 
Expansion 
0_0 
Neuroepithelial cell 0 
Expansion of stem cells 
Progenitor cells 
Expansion of progenitor cells 
Asymmetric divisions 
Expansion 
Neuroepithelial cell 
Asymmetric Symmetri ::; 
neurogenic division neurogenic 0- ::s:;:-
Progenitor cells Progenitor cells 
Figure 1. 5 Symmetric and asymmetric divisions of stem and progenitor cells. 
The principal fundamental of stem cells is self-renewal . Accordingly, division 
of every stem cell has to produce at least one new stem cell. Asymmetric 
division generates one new stem cell progeny and one progenitor cell. Stem 
cell properties are limited in progenitor cells, especially self-renewal . 
Expansion of progenitor cells can produce two differentiating progenies 
(Adapted from Karnpermann, 2006). 
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1.5.1 Neural stem cell self-renewal 
Currently, two main neurogenic regions, SGZ and SVZ have been identified 
which continue to produce neurones and glia throughout life. In addition some 
non-neurogenic regions, i.e. the spinal cord, have been found to contain adult 
NSCs which appear to be quiescent in normal tissue. NSCs in the mammalian 
CNS have been extensively used to investigate a model of the molecular 
mechanisms that control cell-fate specification (Hsieh and Gage, 2004). The 
undifferentiated NSCs maintain the potential to proliferate and self-renew, 
moreover, NSCs are capable of differentiating into the three main types of the 
CNS cell. Self-perpetuation or self-renewal is the most important intrinsic 
capacity of stem cells (Shi et al., 2008, Galli et al., 2003). Stem cells self-
renewal and differentiation are regulated by transcription factor, chromatin 
remodelling and epigenetic factors (Shi et al., 2008). Histone deacetylation 
(HDAC) plays an important role in the regulation of gene activation by 
increasing affinity between histone proteins and DNA, packaging the DNA 
into condensed chromatin regions, called nuc1eosomes. This activity blocks 
access to the promoter regions of genes and facilitate transcriptional repression 
(Hsieh and Gage, 2004). Histone acetylation is the addition of acetyl groups in 
histone proteins; consequently, the interaction between the positively charged 
histone tails and the negatively charged phosphate backbone of DNA is 
decreased, causing relaxation of the nuc1eosomes. This relaxation enables RNA 
polymerase and transcription factors to access transcriptional regions, thus 
resulting in transcriptional expression (Hsieh and Gage, 2004). Treatment of 
adult NSCs with HDAC inhibitors, i.e. mood stabilizers and anti-epileptics, 
26 
induced neuronal differentiation by activating REST-regulated neuronal-
specific genes (Shi et al., 2008). 
1. 5.2 Stem cell niche 
The immediate environment of stem cells, called the stem cell niche, has been 
postulated to be essential for controlling the behaviour of stem cells. This local 
environment influences the stem cell fate as stem cells are given signals from 
the niche to determine proliferation and differentiation into different types of 
progeny. During development of the mammalian brain, neural stem cells are 
generated and reside in the ventricular zone (VZ) and the SVZ, whereas there 
are two specific areas, the SVZ and the hippocampus of the dentate gyrus, 
which continue to generate stem cells in the adult brain. These regions have 
been found to contain many extracellular molecules and growth factors, i.e., 
EGF and FGFs. It is interesting that the region-specific niche molecules can 
control the ability of cell differentiation in a particular region. Stem cells 
isolated from non-neurogenic regions such as spinal cord are capable of 
making only glial after transplantation back into spinal cord although they can 
produce neurons and glial in culture. However, these spinal cord stem cells can 
generate neurons as well as glial in a neurogenic region such as SVZ. This 
indicates that the ability of stem cell proliferation and differentiation are 
influenced by environmental molecules within different adult eNS niches 
(Rao, 2006). The stem niche will be described in section 1.9.1. 
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1.5.3 Neural stem cells in the adult hippocampus 
Proliferating cells have been shown in the SGZ of the dentate gyrus since 
1960s (Altman, 1962); however, neurogenesis is still controversial (Abrous et 
al., 2005). On the basis of in vivo studies, two different precursor cell types 
have been found in the SGZ. Type-l cells express glial fibrillary acidic protein 
(GFAP) and nestin and are equivalent to type B cells (the putative stem cells). 
Whereas type-2 cells are derived from type B cells and express nestin but not 
GF AP. These cells act as transient precursors and make new granule neurons 
(Abrous et al., 2005, Kempermaan, 2006). The type-l cells are analogous to 
radial glia-like morphology and show astrocytic properties. In mice, 
approximately 50% of the GF AP-positive cells with radial glia morphology 
account for nestin-expressing cells (Kempermaan, 2006). Type-l cells can be 
detected constantly with the proliferation marker bromodeoxyuridine (BrdU) 
for a long period of time. Type-l cells produce type-2 and type-3 cells which 
are also called fast proliferating intermediate precursor cells. Type-2 cells are 
divided into subtypes. Type-2a cells are positive for nestin and negative for 
doublecortin neuronal marker (DCX) whereas type-2b cells are DCX positive 
(Kronenberg et al., 2003, Ehninger and Kempermann, 2008). Type-3 cells, 
show only little proliferative activity, are DCX-positive cells, but do not 
express nestin. Cells in type-3 stage migrate into the granule cell layer. Type-
2b and type-3 cells, which show DCX expression, are equivalent to D cells or 
astrocyte-like precursor cells (Kempermaan, 2006, Ehninger and Kempermann, 
2008). According to the classical morphology of stem cell biology, it can be 
concluded that type-I, type-2 and type-3 cells correspond to the stem cells, 
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transiently amplifying progenitor cells and the (migrating) neuroblasts, 
respectively (Kempermaan, 2006). 
The stem cells in the SGZ are comparable to the astrocyte-like cells (B cells) 
that generate the transiently amplifying progenitor cells (0 cells) which in turn 
give rise to migrating neuroblasts or neuronal progenitor cells (G cells) 
(Doetsch, 2003). In rodent, precursor cells can be isolated from the 
hippocampus by proliferating effect of FGF-2. These FGF-2 responsive 
precursor cells can be subcultured, frozen, thawed and cultured for over a 
period of time (Ray et al., 1993). 
1.5.4 Neural stem cells in vitro 
Neural stem cells can be isolated in cell culture to investigate the vital function 
such as the developmental potential and maintaining cell homeostasis. Neural 
stem cells can be grown either as free-floating neurospheres or as monolayer 
cultures under appropriate condition and in the presence of mitogens (Table 
1.1). Growth factors and serum-free condition are used similarly in both 
methods (Kempermaan, 2006). These methods are beneficial models to 
investigate the action of epigenetic mechanisms (Hsieh and Gage, 2004). In 
monolayer culture, the putative stem cells are cultured in the presence of 
mitogens on coated surfaces as adherent cultures, whereas in neurosphere 
procedure, the putative stem cells are grown as cell suspension and form 
floating cluster of cells without adhering to the substrate. Lately, the 
neurosphere method has been exploited widely to rapidly produce a greater 
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number of dividing cells and it provides an easier method to prepare of single-
cell suspensions (Kempermaan, 2006). 
Table 1.1 Neural precursor cell cultures from the adult brain 
Neurospheres Monolayers 
Synonym Aggregate cultures Adherent cultures 
Cell culture on nonadherent Grown on surface with 
surface as floating cells adhesive substrates such as 
laminin, fibronectin 
Growth factors 
Mouse EGF and/or FGF-2 
Rat EGFor FGF-2 FGF-2 
Human EGF and/or FGF2 and/or LIF EGF, FGF -2, LIF 
EGF, epidermal growth factor; FGF, fibroblast growth factor; LIF, leukocyte 
inhibitory factor (Modified from Kempermann, 2006). 
The neurosphere culture is a selective technique in a heterogeneous primary 
culture. The undifferentiated NSCs are effectively selected and induced to an 
active proliferating state, as differentiating/differentiated cells rapidly die 
(Galli et al., 2003). Spherical clusters in cell suspension, called neurospheres, 
are generated from proliferating NSCs to form floating clusters of cells that 
adhere to each other (Galli et al., 2003, Kempermaan, 2006). Neurospheres can 
be generated from the astrocyte-like B cells (Rao, 2006). In neurosphere 
formation, two new identical NSCs are produced by symmetrical neurogenic 
division of NSCs, however, not all of the NSC progeny in neurospheres are 
identical to stem cells (Galli et al., 2003). The majority of proliferating cells are 
located on the outside of the three-dimensional neurospheres, in contrast, the 
differentiating cells are found within the spheres (Kempermaan, 2006). 
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Figure 1. 6 Schematic outline of NSC expansion in culture. Initially, a single 
NSC forms a clonal cluster of cells called neurosphere which contains a 
mixture of numerous NSCs, differentiating progenitors and differentiated 
neurons and glia. A neurosphere is dissociated and plated as single cells under 
serum-free conditions and in the sustained presence of mitogens such as EGF 
and/or FGF2. After neurospheres are dissociated, some of the cells die because 
of the stringent culture conditions; however, the surviving NSCs continue to 
proliferate and form more secondary neurospheres. NSCs in secondary 
neuIOspheres are capable of differentiating into neurons, astrocytes and 
oligodendrocytes by removing the mitogens (Modified from Galli et al ., 2003 ; 
Kempermann, 2006). 
31 
Actually, 10-50% of the cells in neurospheres still conserve stem cell 
characteristics whereas the remainders are cells that undergo spontaneous 
differentiation. Thus a neurosphere contains NSCs, differentiating progenitors 
and differentiated neurons and glia (Fig. 1.6). Neurosphere size and time in 
culture are the most important factors required to obtain a large number of 
NSCs. This method can be serially repeated for over a year through multiple 
passages to increase exponentially, the number of NSCs and establish 
continuous NSC cell lines (Galli et al., 2003). 
1.5.5 Neural stem cell markers 
1.5.6.1 Notch1 
The receptor Notchl is a member of transmembrane proteins (Wang et al., 
2004). Notchl is involved in stem cell proliferation and also maintains neural 
precursor and stem cell proliferation (Breunig et al., 2007, Wang et al., 2004, 
Hitoshi et al., 2002). Moreover, Notchl regulates NSC self-renewal and stem 
cell population in vivo and in vitro (Hitoshi et al., 2002, Potten et al., 2006). 
The receptor notch I will be described in section 1.10.1. 
1.5.6.2 Sox2 
Sox2, which is a member of Sry related box family of transcription factor. 
Sox2 genes are defined as containing approximately 90% sequence homology 
of the male sex determining gene Sry. In common with Soxl, Sox2 and Sox3 
which are a member of SoxB 1 subfamily, it is needed to inducing pluripotent 
stem cells and maintaining self-renewal of undifferentiated embryonic stem 
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cells (Masui et al., 2007, Zhao and Daley, 2008, Kempermaan, 2006, Miyagi et 
al., 2006, Collignon et al., 1996, Avilion et al., 2003). Sox2 is expressed in 
embryonic stem cells in the inner cell mass of the blastocyst and exists in many 
multi potent cell lineages (Ferri et al., 2004). Besides embryonic stem cells, 
Sox2 is required for neural stem cell proliferation and maintenance of sternness 
in adult neurogenesis (Episkopou, 2005). Conversely, Sox2 heterozygous mice 
show a decrease of precursor cell proliferation in neurogenic regions. 
Furthermore, Sox2 expression is present in adult mouse neurospheres derived 
from neurogenic regions, for instance olfactory bulb and SGZ of the 
hippocampal dentate gyrus. This indicates that Sox2 is produced in adult NSCs 
(Brazel et al., 2005). Sox2 can be detected in neurospheres derived from either 
the embryonic CNS or the adult CNS (Ellis et al., 2004, Brazel et al., 2005). 
Moreover, Sox2-positive cells are capable of forming neurospheres and 
differentiating into neurons, astrocytes and oligodendrocytes in culture. 
Nevertheless, expression of Sox2 in adult mouse neural stem cells is greater 
than in embryonic stem cells (Kim et al., 2008). Taken together, these findings 
implicate Sox2 as a neural stem cell marker to investigate cells that have a 
potential of self-renewal and multi potent differentiation (Ellis et al., 2004). 
1.5.6.3 Nestin 
Nestin is an intermediate filament protein that has been known as a protein 
marker for neural stem/progenitor cells (Gilyarov, 2008). Expression of nestin 
appears in many types of cells during development, especially in dividing cells 
of the central nervous system, peripheral nervous system and other tissues 
(Korzhevskii et al., 2008, Gilyarov, 2008). During the differentiation period, 
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nestin expression becomes gradually decreased and tissue-specific intermediate 
filament proteins start to be expressed. While nestin is therefore transiently 
expressed and is not found in fully differentiated cells its expression is more 
complex than being simply a marker of undifferentiated cells. To date, nestin 
has been detected in the two germinative zones of the brain: the SVZ of the 
lateral ventricle and the DG of the hippocampus (Gilyarov, 2008). There are 
two types ofnestin-immunopositive cells in the SGZ of the dentate gyrus: early 
precursor and late precursor. The late precursor has been described as an 
immature neuron marker (Gilyarov, 2008). 
1.5.6.4 c-Myc 
c-Myc (also called Myc) IS a member of the Myc family (so called 
protooncogene) including n-Myc and l-Myc. The crucial role of c-Myc is to 
induce cell proliferation by down-regulating p21, in stem cell self-renewal, 
angiogenesis and cell growth; however, c-Myc also inhibits terminal 
differentiation and apoptosis (Murphy et al., 2005, Nagao et al., 2008). In 
addition, c-Myc is expressed in neural progenitor cells and its expression 
promotes self-renewal in neurospheres of neural progenitor cells (Kerosuo et 
al., 2008). It has been found that inactivation of c-Myc in mice impairs granule 
cell precursor proliferation and attenuates self-renewal (Nagao et al., 2008). 
Interestingly, levels of c-Myc expression in adult mouse neural stem cells are 
higher than in embryonic stem cells (Kim et al., 2008). 
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1.6 Neurogenesis 
The generation of neural cells in most mammalian brain regions occurs in the 
prenatal period. However, in 1962 Joseph Altman wrote an article entitled "Are 
new neurons formed in the brains of adult mammals". In 1963 the Anatomical 
Record, published the first image of newly generated granule cells identified in 
the dentate gyrus of the hippocampus (Kempermaan, 2006). This led Joseph 
Altman in 1965 to postulate postnatal hippocampal neurogenesis. The first 
report on neurogenesis in the adult olfactory bulb was published by Kaplan and 
Hinds in 1977 (Kempermaan, 2006). Results based on labelling dividing cells 
with radioactive thymidine demonstrating that newly born cells had a neuronal 
morphology. However many people remained unconvinced by this evidence. 
More recent work using BrdU labelling of dividing cells, retroviral lineage 
tracing and immunological identification of new neurons has now confirmed 
the correctness of Altman's observations in all mammalian species, including 
man, which have been investigated (Kempermaan, 2006). 
At present it has been shown that there are only two main neurogenic regions 
within the adult mammalian brain; (i) the lateral walls of lateral ventricle which 
contribute cells to the rostral migratory stream and olfactory bulb and (ii) the 
subgranular zone of the dentate gyrus in hippocampus. In these regions neural 
stem cells continue to divide and generate new neurons and glia throughout life 
(Lledo et al., 2006, Mackowiak et al., 2004). A particularly striking 
demonstration of neurogenesis within the dentate gyrus has been shown using 
GFP encoding replication deficient retroviruses, see Fig 1.7 (Zhao et al., 2006). 
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Figure 1.7 Taken from Zhao et al . 2006, shows mice put down at a series of 
time intervals (3 days to 14 months) after stereotaxic injection of GFP coding 
retrovirus. Only dividing cells are infected by the retrovirus which shows 
infected cells initially in the SGZ adjacent to the dentate gyrus (3days after 
injection) followed by migration into the dentate gyrus and extension of 
dendrites into the molecular layer of the hippocampus in animals put down at 
progressively later ages. 
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Neurogenesis in the olfactory bulb has been observed in adult rodents and non-
human primates. Neural progenitor cells in the SVZ of lateral ventricles 
produce new intemeurons destined for the adult olfactory bulb. The SVZ is 
defined as a narrow area of one to two cells wide below the ependyma. The 
developing new neurons migrate from SVZ to the olfactory bulb via a 
particular chain migration called the "rostral migratory stream" (RMS) or 
"rostral migratory path" (RMP) (Kempermaan, 2006, Mackowiak et al., 2004). 
Recently the RMS has been demonstrated in humans (Curtis et al., 2007). 
From observations in rodents, non-human primates and humans, the neuronal 
progenitor cells also divide in SGZ of dentate gyrus (Mackowiak et al., 2004). 
By definition, the SGZ is described as a layer three cell nuclei wide, adjacent to 
the basal cell band of the granular cell layer and a two nucleus-wide zone into 
the hilus (Kempermaan, 2006). The generated neuronal progenitor cells migrate 
from the SGZ into the granule cell layer of the dentate gyrus and then 
differentiate into neurons and glial cells (Mackowiak et al., 2004). 
1.6.1 Postnatal hippocampal neurogenesis 
During embryonic development, neural stem cells migrate from the walls of the 
ventricle (SVZ) to the developed hippocampus to form a secondary neurogenic 
area During early postnatal development, the proliferation of these cells 
decreases rapidly from six hours to five days of age (Altrnan and Das, 1965). 
Then it builds up gradually to reach a peak at about 15 days tertiary 
neurogenesis and then substantially declines after this age although this decline 
is accompanied by an increase in size of hippocampus. The decrease of this 
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germinal pool, involving the number of undifferentiated cells is accompanied 
by an increase in the number of differentiated granule cells. In addition, the 
internal arm of granular layer and Ammon's horn are not completely developed 
at this age and showed only a diffuse cell mass of undifferentiated cells 
(Altman and Das, 1965). The development of the dentate gyrus takes place 
during gestation and substantially continues into the postnatal period until 
adulthood. Approximately 80% of granule cells in rats are produced after birth 
and neuronal production reaches a peak during the first postnatal weeks. In the 
guinea pig, in contrast, 80% of the granule cells of the dentate gyrus are 
generated before birth and 20% are developed postnatally, particularly during 
the first two weeks. This developmental pattern is similar to human and non-
human primates (Guidi et aI., 2005). 
1.6.2 Adult hippocampal neul'Ogenesis 
Eriksson et al., (1998) showed the genesis and survival of new granule cell 
neurons in the dentate gyrus of the adult human brain. This indicates that some 
regions of the human brain are potentially self-renewable throughout life. 
However, neurogenesis declines gradually during adulthood and senescence 
which is associated with a reduction of granule cell progenitor proliferation 
(Kuhn et al., 1996). In addition to the human findings, the production of new 
hippocampal neurons has also been found in the dentate gyrus of two species 
of adult macaque monkeys (Gould et al., 1999). The approximate rate of 
generation of new granule neurons is 9,000 cells per day in the adult rat 
hippocampus with over 70% of new cells differentiating into neurons 
(Cameron and McKay, 2001, Zhao et al., 2006). The number of the newly 
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generated granule cells every month is about 6% of the granule cell population 
(Cameron and McKay, 2001). The large number of the new neuronal cells 
generated in dentate gyrus, suggests that they have an essential role in the 
function of hippocampus. From these studies, therefore, adult neurogenesls 
may be an important phenomenon in hippocampal function . 
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Figure 1.8 Diagram illustrates neurogenesls In the dentate gyrus of the 
hippocampus from neuronal stem cells in the SGZ. In adult generation of new 
granular neurons in the dentate gyrus of hippocampus proceed five 
developmental stages: proliferation, fate specification, migration, axon/dendrite 
targeting, and synaptic integration, respectively. DG, dentate gyrus; ML, 
molecular cell layer; GL, granular cell layer (Adapted from Ming and Song, 
2005). 
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Neurogenesis is composed of three processes; cell proliferation, migration, and 
differentiation see Fig. 1.8 (Ming and Song, 2005). Neural stem cells in the 
SGZ of the hippocampal dentate gyrus give rise to transit amplifying cells 
which differentiate into immature neurons. Subsequently, these cells migrate 
into the granule cell layer and then mature into new granular neurons. These 
neurons receive inputs from the entorhinal cortex and extend projections into 
CA3. A variety of markers can be used to follow the progress of neurogenesis. 
Nestin marks early progenitors or stem cells, doublecortin marks immature 
neurons whereas NeuN marks mature neurons. 
1.7 Neurogenesis and hippocampal/unction 
There remains some question about whether the new granule cells born during 
adulthood become functional, although it has been proved that these cells are 
born and survive in the dentate gyrus of the adult hippocampus. A study in rats 
demonstrated that the adult new neurons extend axons into CA3 area and make 
morphological synapses with adjacent neurons and dendrites (Markakis and 
Gage, 1999). Similarly, the newly adult-generated granule cells in rats give off 
axonal projections into mossy fibre pathways. After mitosis, the immature 
granule cells also promptly send mossy fibres into CA3 field between days 4-
10 (Hastings and Gould, 1999). Furthermore, it has also been found that mature 
new granule neurons display gene expression patterns, supporting the idea that 
these cells participate in functional hippocampal networks induced by learning 
experiences (Ramirez-Amaya et al., 2006). Another intriguing possibility is 
that the newly generated granule cells develop associations with existing 
hippocampal circuits and replace earlier generated cells which are removed by 
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apoptosis. In this way, postnatal cells may replace cells produced prenatally 
(Dayer et al., 2003). 
As described above, the adult hippocampus has been recognized to have 
numerous cognitive functions, including learning, spatial memory, and long-
term recognition memory (Suzuki and Clayton, 2000, Brown and Aggleton, 
2001). Several lines of evidence suggest that the rate of adult neuronal 
proliferation in the subgranular zone of the dentate gyrus is both altered by 
emotional, pharmacological and behavioural factors and that the production of 
new neurones is related to learning and memory. Intriguingly, enhancement of 
the production of new neurons improves long-term recognition memory while 
antimitotic agents that diminish hippocampal neurogenesis, result in impaired 
long-term memory (Bruel-Jungerman et al., 2005, Duman et al., 200lb, Gould 
et al., 1999). 
1.8 Modulation ojhippocampaJ neurogenesis 
The stem cell/progenitor activity and fate of the hippocampal SGZ are 
regulated by cellular and molecular interactions. Adult neurogenesis is a 
representative of extremely dynamic processes in the mature CNS that 
responds to numerous intrinsic and extrinsic influences (Table 1.2). Cell 
generation and cell death have to be balanced since elimination of surplus cells 
is one of the key mechanisms in controlling adult neurogenesis. New generated 
granule cells are preferentially integrated in spatial learning circuits in the 
dentate gyrus (Kee et al., 2007). Early phase of learning does not alter 
neurogenesis but increases the cell survival of adult born cells, which may be 
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involved in the encoding of memory. Learning itself requires death of the 
neurons born during the early phase of learning to suppressing old unnecessary 
neurons and/or the immature neurons that are too old or have not established 
learning-related synaptic connections. This cell death phenomenon may 
involve in memory trace consolidation. However, there is an increase in the 
number of cells generated contingently with the late phase training. This 
phenomenon indicates that learning-induced neurogenesis is not associated 
with learning performance but may be involved in a resetting process for a new 
memory (Abrous et al., 2005). 
1.8.1 Vascular niche 
The generation of new granule neurons in the dentate gyrus of the 
hippocampus is regulated by numerous local factors. This has led to the idea of 
a stem cell niche within the SGZ where adjacent cells, local growth factor 
production and the extracellular matrix can influence stem cell proliferation. 
The vascular system within the SGZ may provide a vascular stem cell niche 
which may be one of the most influential factors in either up or down 
regulating cell proliferation. It is a functional unit, consisting of the precursor 
cells, astrocytes, endothelial cells, microglia or macrophages, extracellular 
matrix, and close contact with the basal membrane (Fig. 1.9). The vascular 
niche is implicated in stem and progenitor cell generation, maintenance, repair, 
and also promotes neuronal differentiation. It is a place where precursor cells 
interact with the environment. In this unit, cell-to-cell interaction takes place 
and the precursor cells are capable of receiving local regulatory cues (Scadden, 
2006, Kempermaan, 2006). Palmer et al. (2000) have revealed that precursor 
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cell proliferation in adult SGZ is paralleled with the vasculature. Adult 
hippocampal neurogenesis develops within an angiogenic niche where 
mesenchymal-derived cells in combination with circulating factors influence 
the continued development of the adult central nervous system. 
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Figure 1.9 Vascular niche is also called stem cell niche which is defined as the 
environment that stem cells reside and interacts with ependymal cells, blood 
vessels, astrocytes and neuronal progenitor cells (Adapted from 
http ://www.scitopics.com/Neurogenesis_in_the_adult_brain_the_subependyma 
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Indeed, it now appears that microvascular endothelial cells support neuronal 
expansion and survival in the CNS by secreting soluble neurotrophin including 
brain-derived neurotrophic factor (BDNF) whereas neural stem cells can 
produce angiogenic factors (Leventhal et al., 1999). Endothelial cells function 
as a source of soluble factors that induce self-renewal, suppress differentiation 
of neural stem cells, and also enhance their neuron production. Thus 
endothelial cells were characterized as a powerful component of the neural 
stem cell niche (Shen et al., 2004). Aside from these few studies, growth 
factors which are secreted by blood vessels have been determined to participate 
with neural generation. Vascular endothelial growth factor (VEGF) is a protein 
secreted under hypoxic condition that binds to receptor tyrosine kinases on 
endothelial cells to promote angiogenesis. It has also been shown to be 
associated with the stimulation of neurogenesis (Jin et al., 2002). Hippocampal 
expression of VEGF causes an increase of neurogenesis and cognitive 
improvement which associate with both enriched environment and running. 
Furthermore, environmental enrichment and increased hippocampal activity are 
associated with endothelial cell production, and clusters of dividing cells occur 
around new blood vessels (Cao et al., 2004). 
1.8.2BDNF 
The neurotrophin, BDNF, is a polypeptide growth factor that has been shown 
to have not only an influential role in regulating the proliferation and survival 
of neurons but also in prohibiting inordinate neuronal cell death (Linnarsson et 
al., 2000). BDNF also plays essential roles in controlling the survival and the 
formation of synaptic plasticity (Cheng et al., 2003). The BDNF protein is 
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generated by granule cells in the hippocampal dentate gyrus (Conner et al., 
1997, Wetmore et al., 1990). Levels of the BDNF generally correlate with the 
levels of cell proliferation in the SGZ (Kempermaan, 2006). BDNF expression 
has been shown to be associated with the process of learning and adult 
neurogenesis. Additionally, BDNF is considered to be involved in mediating 
the effects of antidepressants (Nibuya et al., 1995, Shirayama et al., 2002). An 
enhancement of BDNF expression promotes an induction of granule precursor 
cell proliferation in the rat hippocampus (Katoh-Semba et al., 2002). Infusion 
of BDNF into the hippocampal dentate gyrus increases granule cell 
proliferation in normal adult rat (Scharfman et al., 2005). Conversely, adult 
hippocampal neurogenesis is decreased in heterozygous BDNF knockout mice 
in comparison with wild-type mice. The reduction of neurogenesis is correlated 
with a decrease in the size of the dentate gyrus (Rossi et al., 2006, Lee et al., 
2002). BDNF has been found to be involved in producing long term 
potentiation (L TP) which is required for memory consolidation (Bekinschtein 
et al., 2008, Korte et al., 1995, Lu et al., 2008, Minichiello et al., 1999). BDNF 
expression is upregulated in enhanced learning and memory in an enriched 
environment (Rossi et al., 2006, Cheng et al., 2003). In the process of 
neurogenesis within the SGZ, BDNF is required for the survival, migration and 
maturation of newly formed neurons and promotes their dendritic growth and 
branching. Reducing BDNF levels or BDNF signalling in the brain is 
associated with impaired spatial memory (Minichiello et al., 1999, Mustafa et 
al., 2008). 
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1.8.3 Genetic/actors 
Genetics have been shown to impact on the rate of hippocampal neurogenesis. 
For instance, different strains of adult mice housed under the same 
environment, show striking differences in baseline levels of cell proliferation, 
survival and differentiation (Kempermann et al., 1997). In addition, the 
genetically determined baseline level of the adult neurogenesis is associated 
with acquisition of spatial memory in the water maze which is a hippocampal-
dependent task (Kempermann and Gage, 2002). 
1.8.4 Enriched environment and learning 
Neuronal activity and environmental factors control adult neurogenesis in both 
a positive and negative manner. Animals living in an enriched environment 
have shown an increase in hippocampal neurogenesis in comparison to naIve 
animals, suggesting that enrichment enhances new neuronal cell generation. 
Environmental enrichment is produced by social interaction and physical 
aspects of the environment such as sets of tunnels and objects including toys to 
stimulate exploratory behaviour (Bruel-Jungerman et al., 2005). It has been 
demonstrated that hippocampal-dependent learning tasks such as eyeblink 
conditioning and spatial water-maze training induce adult hippocampal 
neurogenesis (Gould et al., 1999). Whereas, running and enriched environment 
stimulate cell survival in the dentate gyrus compared with water-maze learning, 
swimming and standard housed groups. Furthermore, voluntary activity using 
running wheel enhances the generation of newborn hippocampal neurons (van 
Praag et al., 1999b). Physical activity and running, can also improve learning 
(water maze performance) and increase adult generated neurons in the 
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hippocampus (van Praag et al., 1999a). A rat would not usually choose 
swimming activity; therefore, it may cause psychological stress which may 
neutralize neurogenic stimuli. There is a report showing that environmental 
enrichment increases hippocampal neurogenesis. Enriched and irradiated 
animals show no difference in the visible platform training. However in hidden 
platform training, environmental enrichment improves spatialleaming whereas 
irradiation does not reduce this effect of enrichment. This result indicates that 
increased hippocampal neurogenesis is not always associated with changes of 
environmental enrichment (Meshi et al., 2006). 
1.8.5 Physiological and pathological states 
Several studies of adult neurogenesis under pathological conditions have 
shown that epilepsy enhances progenitor cell proliferation in dentate gyrus 
(Ming and Song, 2005, Parent, 2007). In contrast decreased neurogenesis of 
granule cells in adult hippocampus appears in animals experiencing stress and 
depression (Duman et al., 2001a, Grote and Hannan, 2007). Stress promotes an 
induction of circulating corticosteroids which play a regulatory role in adult 
hippocampal neurogenesis (Grote and Hannan, 2007). Stress Increases 
glucocorticoids in blood circulation, causing down-regulation of adult 
neurogenesis. In adult rat hippocampus, administration of glucocorticoids 
reduces generation of granule precursor cells (Grote and Hannan, 2007). 
Moreover, a reduction of hippocampal volume appears in patients exposed to 
prolonged stress and elevated g1ucocorticoids. This effect has been investigated 
by quantifying cell number in the post-mortem hippocampi of mood disorder 
patients (Duman et al., 200 la). Attenuation of mitotic activity of neuronal 
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progenitor cells in the dentate gyrus is also related to senescence in adult rats 
(Kuhn et al., 1996). A study of old mice, living in an enriched environment has 
shown an increase neurogenesis in the dentate gyrus (Kempermann et al., 
1998). 
1.8.6 Growth/actors, neurotransmitters, antidepressants 
Changes in neurotransmitter signalling have been shown to regulate 
hippocampal granule cell proliferation in adult brain, e.g. a decrease of 
hippocampal neurogenesis is correlated with reduction of serotonin (5-HT). In 
contrast, increasing serotonin synthesis induces granule cell proliferation in 
adult hippocampus. Furthermore, proliferation of progenitor cells in the adult 
hippocampus is up-regulated by administration of as-HT lA agonist and 
blocked by pre-treatment with a 5-HT lA antagonist (Duman et al., 2001b, 
Durnan et al., 200Ia). Activation of N-Metyl-D-Aspartate (NMDA) receptors, 
a gl utamate receptor subtype, sustains a usual rate of adult hippocampal 
neurogenesis. Administration of NMDA receptor antagonist increases 
generation of granule cells in adult hippocampus but this is reduced by 
systemic administration ofNMDA (Duman et al., 200Ia). 
Moreover, neuronal generation in adult brains is influenced by antidepressants. 
Antidepressants up-regulate the phosphorylation of the cAMP-CREB (cAMP 
response element binding protein) which in turn increases the level of BDNF 
expression that leads to induction of adult hippocampal neurogenesis (Duman 
et al., 2001 b). Besides up-regulation of CREB and BDNF, antidepressants also 
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increase the level of 5-HT which is involved in alterations of neurogenesis in 
adult hippocampus (Santarelli et al., 2003). 
Growth factors are extracellular signalling molecules i.e. epidermal growth 
factor (EGF) and fibroblast growth factor (FGF) increase cell growth and 
maintenance. EGF and FGF also retain the capability of stem cells to generate 
neurons and glia (Caldwell et al., 2001). In culture, the combination of EGF 
and FGF have the ability to induce the long-term growth of the embryonic, 
neonatal and adult neurospheres taken from human and rodent central nervous 
system, (Caldwell et al., 2001, Kempermaan, 2006). However, it has been 
demonstrated that EGF has a stronger potential than FGF to enhance adult 
neurogenesis by increasing numbers of BrdU cells (Kempermaan, 2006). 
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Table 1.2 Regulators ofneurogenesis in the adult dentate gyrus (Adapted from Rao, 2006) 
EtTeds Context I 
Genetic Changes in proliferation Unknown loci ! 
Number of new neurons Unknown loci 
Environmental enrichment Increased number of new neurons in the Population cage, food treats, toys, running wheel 
hippocampus 
Absence of effect in SVZ and olfactory bulb 
Physical exercise Increases in proliferation and number of new Running wheel 
neurons in the hippocampus 
Learning Increased in number of new neurons Water maze, eye-blink conditioning 
Stress and other hormones Increased proliferation Adrenalectomy, estrogen, 
Reduced proliferation Glucocorticoids, predator/psychosocial stress 
Neurotransmitters Increased proliferation NMDA antagonists, serotonin, epinephrine, 
norepinephrine and dopamine signalling 
Reduced proliferation NMDA agonists, serotonin receptor antagonists, 
depletion of 5-hydroxytryptamine, antidepressants 
Growth factors/mitogens Increased proliferation and number of neurons FGF-2, EGF, VEGF 
1. 9 Markers of cell proliferation in neurogenesis 
1.9.1 5-bromo-2-deoxyuridine (BrdU) 
In all mammalian species including humans, neurogenesis in the adult dentate 
gyrus has been demonstrated. The rate of cell proliferation is altered by 
numerous factors. Until now 5-bromo-2-deoxyuridine (BrdU) has been the 
most commonly used mitotic marker in such studies. However, it has been 
demonstrated that high doses of BrdU 60-600 mg/kg, i.p. possibly cause 
mutations in cells and consequently severe abnormalities of the developing 
tissue, especially in the eNS (Taupin, 2007). Diffusion of BrdU is uncertain 
among various tissues of the body following intraperitoneal injection. In the 
brain, for instance, diffusion of BrdU could be difficult since it may be reduced 
by the blood brain barrier and other metabolic factors, particularly in older 
animals. It has been reported that the BrdU injection before or after a learning 
experiment is likely to be a stressful procedure which stress is recognized to be 
able to inhibit neurogenesis and the BrdU incorporation into the dividing cells 
(Kee et al., 2002). 
1.9.2 Endogenous nulI'kers in neurogenesis 
Ki67, a nuclear protein, is an alternative method of detecting cell proliferation. 
Ki67 is present in all dividing cells throughout the mitotic cycle but is absent 
from resting cells (Go) (Gerdes et al., 1984). It is an effective marker for 
determining the so-called growth fraction of a given cell population. Like 
BrdU, Ki67 is detectable with immunohistochemistry. Unlike BrdU, Ki67 is an 
endogenous marker and so is also a non-invasive marker in living cells. Ki67 is 
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a reliable marker of mitosis because its expression is strictly correlated with 
cell proliferation and to active phases of the cell cycle and its half-life is very 
short, even though the role of Ki67 is not known. Furthermore, studies have 
shown that Ki67 is present in all neuronal tissue of mammalians from rodents 
to humans (Kee et al., 2002, Scholzen and Gerdes, 2000). A study of 
neurogenesis in the hippocampal dentate gyrus has compared BrdU and Ki67. 
This has clearly proved that Ki67 has most of the benefits of BrdU and none of 
costs (Kee et al., 2002). Thus it is an excellent indicator for a comparative 
study of neuronal proliferation among different species or among different 
brain regions. However, it is not suitable for an experiment that involves 
tracing of cells over long periods (Kee et al., 2002). 
In addition to Ki67, doublecortin (DCX) has been postulated as an alternative 
indicator for adult neurogenesis since DCX expression is associated with 
neurogenic processes (Couillard-Despres et al., 2005, Brown et al., 2003). 
DCX, a microtubule binding protein, is transiently expressed in 
differentiating/migrating and immature neurons within the adult mammalian 
brain, the SGZ of the dentate gyrus and olfactory bulb (Couillard-Despres et 
al., 2005, Abrahams et al., 1997). In newly formed cells of adult hippocampal 
dentate gyrus, expression of DCX can be detected for nearly 30 days (Brown et 
al., 2003). In the adult dentate gyrus, DCX expression in newly generated 
granule cells is detected during migration, early differentiation and the 
maturation period (Rao and Shetty, 2004). Once new born neurons have 
completely matured, they will stop expressing DCX protein (Couillard-Despres 
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et al., 2005). As these reasons, both Ki67 and DCX were utilised as 
neurogenesis markers in the experimental study. 
1.10 Notch signalling 
The Notch signalling pathway has been shown to mediate cell-cell 
communication between adjacent cells. Notch is a family of four cell surface 
receptors activated by ligands on adjacent cells (Yoon and Gaiano, 2005). 
Notch receptors are single pass transmembrane proteins (-320KDa) composed 
of a -200KDa functional extracellular (NECD) and a -120KDa 
transmembrane (TM) domains (Conboy et al., 2007). The full length Notch 
receptor (NFL) presents at the cell surface as a heterodimer and the TM 
domain is cleaved by presenilins complex to yield a -IIOKDa Notch 
intracellular domain (NICD) (Conboy et al., 2007). The NECD contains 
multiple epidermal growth factor (EGF) repeats, which regulate ligand binding 
and three Linl2 repeats. Whereas the INCD containes a RAM sequence, 
ankyrin repeats, a tranactivation domain (TAD) and PEST sequence is 
involved in signal transduction (Fig. 1.10) (Allenspach et al., 2002, Fiuza and 
Arias, 2007). 
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E G F ~ i k . . repeats Lin12 ... epeals RAM Ankylin repeals TAD PEST 
Extracellular domain Intracellular domain 
Figure 1.10 Structure of Notch which 1S composed of extracellular and 
intracellular domains. The extracellular domain is composed by up to 36 EDF-
like repeats and Lin12 repeats . In the intracellular domain, Notch consists of a 
region called RAM, Ankylin repeats, TAD and PEST. 
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Figure 1.11 Notch signalling pathway. Notch binding on one cell to ligand on 
another cell elicits two steps of proteolytic cleavages. Firstly, Notch is cleaved 
at the S2 site by ADAM protease and then creates a substrate for S3 cleavage 
by y-secretase. This process causes release of Notch intracellular domain that 
translocates into the nucleus and associates with the DNA-binding CSL 
transcription factor while co-repressors are released (Adapted from Osbome 
and Minter, 2007). 
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The Notch receptor is synthesized in the endoplasmic reticulum (ER) as a 
single precursor protein (pre-Notch). Then, the pre-Notch is fucosylated by 0-
fucosyltransferasel (O-Fut) to facilitate the pre-Notch transportation from ER 
to the Golgi apparatus. This process is also crucial for the production of a 
functional receptor (Bray, 2006, Fiuza and Arias, 2007). Within the Golgi 
apparatus, a furine-like protease cleaves the pre-Notch at the SI-cleavage site 
to produce a non-covalent heterodimer receptor comprised of the extracellular 
and intracellular domains (Fiuza and Arias, 2007, Osbome and Minter, 2007). 
The heterodimer undergoes glycosylation by adding an N-acetylglucosamine 
(GlcNAc) sugar by an N-acetylglucosarninyltransferase called Fringe proteins, 
including radical, manic and lunatic. The heterodimer is then translocated to 
the plasma membrane where it becomes available to interact with Notch 
ligands on adjacent ligand-expressing cells. The interaction induces proteolytic 
cleavage of Notch receptor at a conserved Valine l711 (site 2, S2) by a 
disintegrin and metalloproteinase (ADAM) protease tumour necrosis factor-a 
converting enzyme (TACE), or Kuzbanian (Kuz) , removing the bulk of the 
extracellular domain (Fiuza and Arias, 2007, Osbome and Minter, 2007). The 
transmembrane domain is then cleaved by the presenilins complex (y-
secretase) at site 3 (S3) between Glycine1743 and Valine1744, releasing the NICD 
from the transmembrane domain (Fiuza and Arias, 2007, Osbome and Minter, 
2007). NICD then translocates into the nucleus and binds to the transcription 
factor CSL (CBFI-RBP-Jk). This interaction leads to transcriptional activation 
by displacement of corepressors (CoR) and simultaneous recruitment of 
coactivators (CoA), including mastermind-like proteins (MAML 1) (Fig. 1.11) 
(Allenspach et al., 2002, Fiuza and Arias, 2007, Osbome and Minter, 2007). 
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1.10.1 Notch1 in neurogenesis, progenitor or stem cells 
Notch signalling is used by neurons in the hippocampus of the adult mouse 
brain (Wang et al., 2004). In addition, Notch1 expression has been found in the 
adult hwnan hippocampus (Nagarsheth et al., 2006, Berezovska et al., 1998). It 
has been known that Notch signalling is triggered by its ligands expressed on 
neighbouring cells in the SGZ and dentate gyrus (Breunig et al., 2007, Stump 
et al., 2002). This activation leads to the cleavage of the transmembrane 
domain of the Notch receptor and then the release of the intracellular domain 
ICD which translocates into the nucleus and associates with the transcription 
factor RBP-J. This complex activates Hesl which Notch1 ICD functions 
effectively to up regulate Hes1 promoter activity (Kageyama and Ohtsuka, 
1999) and subsequently regulates maintenance of neural stem phenotype and 
progenitor cell proliferation (Kageyama and Ohtsuka, 1999, Kageyama et al., 
2005). 
Recent evidence has suggested that impairment of the Notch signalling 
pathway by reducing Notch1 expression might decrease neurogenesis and 
progenitor survival (Oishi et al., 2004). Expression of Notch1 is correlated to 
the regions where neurogenesis takes place. Furthermore, activation of Notch 1 
expression occurs when neurogenesis is activated (Hatakeyama and Kageyama, 
2006). During neural development and in the germinal zones of the adult brain, 
Notch 1 functions to regulate neurogenesis and cell fate determination by 
preventing neural differentiation and maintaining neural precursor and the stem 
cell proliferation (Breunig et al., 2007, Wang et al., 2004, Hitoshi et al., 2002). 
Additionally, it has been found that Notchl regulates NSC self-renewal (potten 
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et al., 2006). However, Notch 1 is not only involved in alterations of 
neurogenesis and survival but also plays a crucial role for the regulation of 
neural stem cell population in vivo and in vitro (Hitoshi et al., 2002). 
Besides its known function in neurogenesis, Notch 1 also controls the formation 
of dendritic morphology in the postnatal hippocampal dentate gyrus (Breunig 
et al., 2007, Wang et al., 2004, Hitoshi et al., 2002). In post mitotic neurons, 
Notchl is important for the later stages of granule cell maturation and dendritic 
branching (Redmond et al., 2000, Breunig et al., 2007). A recent study has 
reported that heterozygous knock out adult mice demonstrate impairments of 
spatial leaming and memory (Costa et al., 2003). In addition, transgenic mice 
with reduced expression of Notch I show reduced LTP which can be rescued by 
addition of Notch signalling components (Wang et al., 2004). The Notch 
signalling pathway has been proposed to maintain the integration of synapses 
transiently produced during memory consolidation in adult rats (Conboy et al., 
2007). 
1.10.2 Notch1 in cancer 
Notch I has multi functional roles in regulating cellular differentiation, 
development, proliferation and survival in the animal kingdom. Notch I in 
human cancer cells can function as either a tumour suppressor or an oncogene 
(Fig. 1.12) (Kunnimalaiyaan and Chen, 2007, Allenspach et al., 2002). Firstly, 
the oncogenic function of Notch I was investigated in human T -cell neoplasia. 
Subsequently, upregulation of Notch 1 has been demonstrated in several types 
of cancer, for instance pancreatic cancer, colon cancer, non-small cell lung 
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cancer, cervical cancer, renal cell carcinoma and several lymphomas. In these 
types of cancer, Notch 1 exhibits a powerful oncogenic function by inhibiting 
differentiation and apoptosis (Kunnimalaiyaan and Chen, 2007). In contrast, 
Notch 1 signalling expression is very low or absent in prostate cancer, and in 
neuroendocrine tumours (NETs) such as small-cell lung cancer (SCLC), 
pancreatic carcinoid and medullary thyroid cancer (MTC). Expression of 
Notchl in these cancers results in reduction of cell growth (Sriuranpong et al., 
2001, Allenspach et al., 2002, Kunnimalaiyaan and Chen, 2007). Taken 
together, inactivation of the Notchl oncogene leads to growth inhibition and 
induction of apoptosis whereas activation of Notch 1 tumour suppressor results 
in growth suppression (Kunnimalaiyaan and Chen, 2007). These studies led to 
investigating a potential role of Notchl in affecting cellular differentiation, 
proliferation and/or survival in cancers. Thus, understanding of Notch 
signalling in regulating normal development and malignant transformation may 
be essential for novel cancer therapeutics. 
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MTC, medullary thyroid cancer; NETs, neuroendocrine tumours; SCLC, small-
cell lung cancers (Adapted from Kunnimalaiyaan and Chen, 2007). 
1.11 Behavioural tests in this study 
1.11.1 Novel object location (NOL) task 
Studies in human, patients were tested their ability in detecting movement of 
objects or dots (Smith et al., 1996). Patients with right hippocampal damaged 
showed deficits in their spatial memory for the location of the objects (Nunn et 
al., 1999). Similarly, in rodents, NOL has been used as a standard behavioural 
test to investigate spatial memory. A novel-preference paradigm is used in the 
NOL test to measure the memory for spatial locations within a familiar area. In 
this test, two identical objects are presented in the choice (test) trial, which one 
object is moved to a novel location (Dix and Aggleton, 1999, Ennaceur et al., 
1997). Rodents naturally prefer to approach and explore an object in a novel 
location, a response which was not required training or reward. They normally 
also prefer to explore an object in a novel location more than an object in a 
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familiar location (Dere et al., 2007), indicating that rodents remember the 
features of an object and also the spatial location in which it was encountered. 
Rodents naturally approach and inspect objects by directing their noses to sniff 
the object and manipulating the object by their forepaws. The NOL test uses 
the natural tendency of rats to spontaneously explore an object placed in new 
position without primary reinforcement (i.e. food or electric shock delivery), 
spatial learning, the learning of rule and the learning of response-reward 
association which needed in other behavioural tests (Dix and Aggleton, 1999, 
Ennaceur et al., 2005). Therefore, it does not need lengthy pretraining and does 
not induce arousal and stress caused by using negative reinforcement as 
compared with the water maze and the inhibitory and active avoidance of fear 
conditioning (Ennaceur and Delacour, 1988). Several studies have reported that 
impairment in the performance of the NOL test occurs in rats who have been 
given a lesion in the hippocampus, indicating that the hippocampus, per se, is 
critically important for this task (Dere et al., 2007). Moreover, DG lesioned 
animals showed lack of reexploration the objects in novel locations, suggesting 
that the DG plays an important role to acquisition of the novel information 
(Lee et al., 2005). Since spatial information or spatial mapping is processed in 
the hippocampus, NOL should be an excellent behavioural model to quantify 
and utilized to study spatial memory in rodents. 
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1.11.2 Contextual/ear conditioning 
It has been known that the hippocampus has an important role in learning and 
memory. Declarative, relational, and spatial memory are hippocampal-
dependent while others (e.g. procedure and implicit) are hippocampal-
independent. Recently, contextual fear conditioning has been recognized as a 
popular behavioural model for learning and memory that is dependent on the 
hippocampus (Fanselow, 2000, Mei et al., 2005). Contextual fear conditioning 
is displayed by a rat after exploring a novel environment (a shock chamber) in 
which it has received an aversive electric footshock which is approximately 
0.5-2 s, 0.3-1.5 mA and one to four shocks (Fanselow, 2000). Lesions of the 
hippocampus blocked freezing to contextual fear associated with shock 
(Fanselow, 2000, Fendt and Fanselow, 1999). Similarly, disruption of 
hippocampal neurogenesis with X-irradiation caused impairment of contextual 
fear conditioning (Saxe et al., 2006). 
Fear is a powerful emotional experience and also a defensive behaviour that 
protect animals and humans from potentially dangerous environmental threats. 
Contextual fear conditioning experiments use an electric shock as an 
unconditioned stimulus (US) which is similar to Pavlov's meat powder. The 
contextual cue (the shock chamber) functions as a conditioned stimulus (CS) 
which predicts the happening of the shock and evokes a state of fear (e.g. 
freezing, called the conditional response (CR». The contextual cue plays an 
important role like the bell in Pavlovian conditioning's experiment (Fanselow, 
2000). Fear-potentiated startle, freezing, tachycardia, analgesia, conditioned 
defensive burying, ultrasonic vocalization and increased release of several 
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hormones can be quantified in rats that have experienced fear conditioning 
(Fendt and Fanselow, 1999). Freezing has been used as an index of conditioned 
fear and assessed by investigation of direct observation. Freezing is defined as 
a state of motionless, including immobility of vibrissae, except movement that 
is associated with respiration. Freezing reduces the impact of shock and 
generally occurs while the animal displays a crouching posture, piloerection 
and lowering of head and tail. Ordinarily, rats never lie down when they are 
freezing, for this reason; freezing is distinguishable from resting or sleeping 
(Fendt and Fanselow, 1999, Fanselow, 2000, Mei et al., 2005). 
Studies have demonstrated that hippocampal lesioned rats showed contextual 
fear deficit, indicating that the hippocampus is required in the processes of the 
formation, storage and consolidate contextual memory. In particular a 
contextual fear memory deficit in animals with lesions made briefly after 
training is greater than animals with lesions made a month or more after 
training. Therefore, the hippocampus is not necessary for old contextual fear 
memories (Fanselow, 2000). The lesioned rats are hyperactive to explore new 
environment, but it is easily interrupted with freezing. This hyperactivity in 
hippocampal lesioned animals is possibly produced by the failure of the 
formation of a cognitive map of spatial location (Fanselow, 2000). 
Besides the hippocampus, it has been found that the amygdala is also involved 
in freezing to a context associated with shock (Fendt and Fanselow, 1999). 
Neural circuitry of contextual fear conditioning is shown in Figure 1. 12. The 
hippocampus functions importantly to provide contextual information to the 
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amygdala, while the lateral and basolateral nuclei of the amygdala are 
importantly required for acquisition of freezing. Particularly, the amygdala 
plays a pivotal role to converge the CS and US information. There is a report 
showing that an impairment of the amygdala block freezing to contextual cues 
(Maren, 2001). Together, an acquisition of contextual fear conditioning IS 
dependent on the association of the hippocampus and amygdala. 
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Figure 1.13 Hypothetical circuit mediating the different aspects of conditioned 
fear. Abbreviations: PAG, periaqueductal gray (Adapted from Fendt and 
Fanselow, 1999). 
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1.12 Aims and objectives 
The studies presented in this thesis were carried out to examme whether 
chronic exposure to VP A produces changes in memory and neurobiology in the 
rat brain. The aim of this research was to determine and investigate the effects 
of VP A on an association of hippocampal memory and neurogenesis, on 
hippocampal neural stem cells and on cell proliferation of three cancer cell 
lines. The objectives of the present studies were as followed: 
• Determine the chronic effects of VP A treatment on behavioural testing 
of recognition memory which were carried out by hippocampus-
dependent tests: novel object location (NOL) task and contextual fear 
conditioning. 
• Examine the effects of exposure to VP A on hippocampal neurogenesis 
by measuring proliferating cell numbers in the dentate gyrus and 
determining levels ofneurtrophin BDNF, DCX and Notchl expression. 
• Assess a correlation between hippocampus-dependent memory tests 
and any changes of neurogenesis within the same animals. 
• Determine the effects of VP A on hippocampal neural stem cells by 
examining cell proliferation and neural stem cells markers: Sox2, 
nestin, c-Myc and Notch 1 in vitro. 
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• To evaluate the effects of VP A on the cell proliferation and on level of 
Notchl expression of 3 cancer cell lines: Epnl an ependymoma, Medl, 
a medulloblastoma and neuroblastoma (SHSY5Y). 
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Chapter 2 
VPAproduces deficits in hippocampus-dependent 
cognition and inhibits cell proliferation in the SGZ 
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2.1 Introduction 
Valproic acid (VPA) is used clinically as an anti-convulsant and mood 
stabilizer in both adults and children and has been proposed as a possible 
treatment for cancers and mv infection (Henry, 2003, Lehrman et al., 2005, 
Buckley, 2008). Its exact mode of action is still not entirely clear but it appears 
to reduce neuronal activity by blocking sodium and calcium channels, 
elevating GABA and reducing aspartate levels within the brain (Kwan et al., 
2001). VPA also functions as a therapeutically useful mood stabilizer by 
stimulating extracellular signal-regulation kinase (ERK) pathway (Hao et al., 
2004). Despite its wide use, VPA has however long been known as a teratogen, 
causing neural tube defects and more recently has been associated with 
behavioural problems in children exposed to the drug during gestation (Meador 
et al., 2008, Nicolai et aI., 2008). These effects are likely to be caused by its 
action as a histone deacetylase inhibitor (Gurvich et al., 2005, Phiel et al., 
2001). Exposure of F9 teratocarcinoma or HeLa cells to 0.25 and 2 mM VP A 
causes hyperacetylation of DNA which leads to increased expression of growth 
arrest and pro-differentiation genes (Gottlicher et al., 2001, Kostrouchova et 
al., 2007). Both in vitro and in vivo, exposure to VPA leads to an inhibition of 
cell proliferation primarily by up regulation of p21/wafl, a cyclin-dependent 
kinase inhibitor, together with an increase in apoptosis (Das et al., 2007, Li et 
al., 2005). 
Despite its low toxicity, a number of reports have documented a range of mild 
to moderate cognitive impairments, including memory deficits, in adult 
patients taking VPA (Senturk et al., 2007, Cysique et al., 2006, Carpay et al., 
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2005, Gualtieri and Johnson, 2006). The association of these 
neuropsychological effects with the treatment rather than other factors 
coexisting with the patients condition is strengthened by reports of 
improvements in cognition when VP A is discontinued (Lossius et al., 2008, 
Ristic et al., 2006, Masmoudi et al., 2006, Hommet et al., 2007). The causes of 
these cognitive changes could be the generalized neuro-suppressant effect of 
this compound, but may also be due to more specific effects on those brain 
regions in which neurogenesis continues. 
There are two regions in the adult mammalian brain which continue to generate 
new neurons throughout life, the sub granular zone (SGZ) of the dentate gyrus 
within the hippocampus and the sub ventricular zone (SVZ) in the lateral walls 
of the lateral ventricles (Abrous et al., 2005, Ehninger and Kempermann, 2008, 
Eriksson et al., 1998). Proliferation of neural stem cells within the SGZ 
continuously produces new granule cell neurons which are incorporated within 
the dentate gyrus (Ehninger and Kempermann, 2008, Abrous et al., 2005). It 
has been postulated that the newly generated neurons in this region contribute 
to hippocampal function and the rate of adult neurogenesis in the hippocampus 
is correlated with the degree of hippocampal dependent learning and memory 
(Kitabatake et al., 2007). Specifically factors which affect neurogenesis are 
also found to affect performance in hippocampal-dependent memory tasks 
(Bruel-Jungerman et al., 2005, Snyder et al., 2005, Mustafa et al., 2008, 
Duman et al., 2001). 
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Two recent papers have looked at the effect of VP A on hippocampal 
neurogenesis and come to opposite conclusions. Hsieh et al. treated rats with 
VPA (300 mglkg) by i.p. injection twice daily for 14 days while also giving 
VP A in drinking water (12 g/litre). At the end of this period, cell proliferation 
in the SGZ was significantly reduced although neuronal differentiation of those 
cells which continued to proliferate had been enhanced (Hsieh et al., 2004). In 
contrast, Hao et al. (2004) treated mice with VPA (20 mg/kg) in their food for 
6 weeks and found an increase in cell proliferation in the SGZ. It is difficult to 
reconcile these two results although the difference in the route of drug 
administration may be significant. In neither study were any behavioural tests 
carried out and so it is unknown whether the reported changes in neurogenesis 
caused changes to hippocampal function. Patients taking VP A may have other 
confounding variables that affect cognition. In particular epilepsy itself has 
been found to cause memory impairments making it difficult to separate the 
effects of VPA from other aspects of a patient condition (Hirsch et al., 2003, 
Loiseau et al., 1983, Kwan and Brodie, 2001). The present study uses an 
animal model to investigate the cognitive effects of VP A exposure in order to 
avoid these confounding variables. 
2.1.1 Aims of this chapter 
The present study was carried out to examine whether exposure to VP A in 
adult animals causes cognitive deficits. The effects of VPA on behavioural 
testing of recognition memory which were carried out by novel object location 
(NOL) and contextual fear conditioning tasks. The hippocampal tissue obtained 
from one half of the brain of the animals at the end of the behavioural testing 
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was used to investigate the effects of VPA on dividing cell numbers in the 
dentate gyrus. This was carried out by immunohistochemistI)' to detect the 
proliferation marker Ki67. Contradictive findings have been reported in the 
literature (Hao et al., 2004, Hsieh et al., 2004). Hippocampal tissue from the 
other cerebral hemisphere of the same brains was processed for Western 
blotting to detect BDNF, DCX and Notch 1 proteins. Measurement of Ki67 was 
carried out to corroborate the effect of VP A on NOL and contextual fear 
conditioning tasks employed in this study. Moreover, measures of BDNF, 
DCX and Notchl proteins aimed to corroborate changes in neurotrophic factor, 
survival of newborn neurons and stem cell marker with cognition and cell 
proliferation. Additionally, BDNF and DCX were measured in the frontal 
cortex of the same cerebral cortex tissue as hippocampus. This was done to 
determine the regional-specificity of the effect of VPA in differentiation 
observed. 
2.1.2 Hypothesis 
• Cell proliferation in the dentate gyrus will be reduced by treatment 
with VP A as found by Hsieh et al 2004 
• Changes in cell proliferation will be associated with changes in Notch 1 
levels as it has been suggested that this receptor is involved in 
controlling neural stem cell proliferation 
• Lower levels of cell proliferation will be correlated with reduced levels 
of DCX indicating that neural differentiation has been affected. 
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• VPA may also affect BDNF levels within the hippocampus and this 
may provide a mechanism to alter hippocampal function independent 
of cell proliferation in the SGZ 
• This change in cell proliferation in the SGZ will be correlated with 
behavioural changes as measured by the novel object location (NOL) 
and contextual fear conditioning. 
• The expression of BDNF and DCX in the frontal cortex tissue will not 
be significant different between control and VPA-treated animals. 
Effect ofVPA will be specific to the hippocampus 
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2.2 Materials and Methods 
2.2.1 Animals 
Adult male Lister hooded rats (Charles River Laboratories, UK), weighting 
approximately 220-250 g were acclimatized to the Biomedical Service Unit 
(BMSU), University of Nottingham) for 11 days before experiments started. 
Prior to experiments, animals were randomly divided into two groups; a control 
group and a drug-treated group. In the control group, cages I and 2 held three 
animals while cage 3 held four animals. In the drug-treated group, similarly, 
cages 4 and 5 held three animals whereas cage 6 held four animals. Animals 
were housed in a temperature-controlled (20 ± 1 ·C) and humidity-controlled 
(45-65%) an animal facility with a 12 h light/12 h dark cycle and had access to 
food and water. The lights were on at 07.00 GMT and the light intensity in 
cages was 100 - 300 lux. During experiments, animals were weighed everyday. 
All behavioural tests were recorded by video cameras mounted above the 
apparatus. All experiments were carried out in accordance with the UK 
Animals (Scientific Procedures) Acts, 1986, under project licence 40/2715 and 
personal licence 40/8885. 
2.2.1.1 Treatment 
Drug-treated animals (n = 10) received two daily intraperitoneal injections 
approximately at 10.00 + 15.00 hr GMT ofVPA (300 mg/kg dissolved in 0.9% 
saline; Sigma) at a volume of 1 rnI/kg for 10 days while control animals (n = 
10) were received equally numbers of saline injections (Fig.2.1). This protocol 
was chosen from a treatment regime which statistically significantly reduces 
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seizure frequency in spontaneously epileptic rats (Nissinen and Pitkanen, 2007) 
and is similar to that used by Hsieh et al. (2004), the difference being that VPA 
was not administered in drinking water as well as by injection. 
dl-dlO dl6 dl7 d23-24 
-1 saline ~ ~ NOL H Contextual fear conditioning r-
dl-dlO dl8 dl9 d23-24 
-1 VPA ~ ~ NOL H Contextual fear conditioning r 
Figure 2.1 Schematic of injection and experimental paradigm. Saline or VPA 
was injected two daily for 10 days (dl- dIO). After treatment, animals were 
habituated I h and then they were assessed for NOL and contextual fear 
conditioning. Abbreviation: H, habituation; NOL, novel object location. 
2.2.2 Behavioural testing 
2.2.2.1 Novel object location (NOL) task 
The NOL was used to perform behavioural testing of hippocampal-based 
recognition memory. This test was modified from Dix and Aggleton (1999) 
and recorded with a video camera mounted directly above each test arena, 
which was connected to a computer using a program called Etho Vision® 
(EthoVision®, Version 3.1, Noldus, Wageningen, The Netherlands) as 
described previously by Mustafa et al (2008). Etho Vision® tracked a rat's 
position by comparing and contrasting its movement and colour to its 
surroundings. Task apparatus consisted of two open square translucent Perspex 
boxes (39x23.5x30 cm, Whatmore Creative Plastic, UK) which were called 
Arena 1 and Arena 2. Experiments were performed in constant light (80 Lux at 
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floor level in the arena) between 10.00 and 14.00 h. The objects to be explored 
were identical blue commercial plastic water bottles of height 7 cm which had 
cartoon faces on them. Each object was weighed down with metal bars inside 
them so that they could not be displaced by the rats. Before starting 
behavioural testing, each animal was habituated for one hour in the Perspex 
boxes to be familiar with the arena and environment. After habituation, animals 
were returned back to the same home cage. On the test day, the trial was 
divided into two trials; a familiarization trial and a choice trial. In the 
familiarization trial, animals were placed in the arenas for three minutes to 
explore two identical objects which were placed firmly in each arena at specific 
locations. The starting location of objects in the familiarization trial could be 
either in adjacent corners of the arena or in opposite corners. After three 
minutes, control and treated rats were removed back to their home cages for 
five minutes the inter-trial interval (ITI). Prior to the choice trial, the objects 
and the boxes were cleaned thoroughly with 20% ethanol to eliminate olfactory 
clues. One object was moved to the adjacent or opposite corner depending 
upon their location in the familiarization trial. Initial object locations (in 
adjacent or opposite corners) was randomized (Fig.2.2). In the choice trial, 
animals were placed back in the arenas to explore the objects for three minutes 
and then returned back to their home cages. The exploration time of a rat was 
recorded in seconds using stopwatches. The exploratory activity was defined as 
actively exploring by directing the nose towards the object at a distance of less 
than 2 cm (Dix and Aggleton, 1999), not including turning around or sitting on 
the object. Exploratory activity data in the choice trial was converted to a mean 
score of discrimination index. Discrimination index is defined as the difference 
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in exploration time between the two objects in the choice trial (Dix and 
Aggleton, 1999). Determination of discrimination index was to measure 
whether the mean scores differed from zero and this would also contribute to 
analyse discrimination of experimental groups individually by comparing them 
to zero. 
Familiarization Trial 
Inter-trial Interval 
• 
Choice Trial 
Figure 2.2. Schematic representation of novel object location protocol. This 
protocol was divided into two trials; a familiarization trial and a choice trial. In 
the first trial, a rat was placed in the familiarization trial to explore two 
identical objects, A and B for three minutes. Then the rat was returned back to 
its home cage for a five minute inter-trial interval. In the choice trial, the rat 
explored the duplicates of the objects which one object was placed in the same 
location (familiar location, FL) and the other was moved to a novel location 
(NL) in the corner opposite to its original location. The location of the objects 
was randomly located in both familiarization and choice trials. 
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2.2.2.2 Contextual fear conditioning 
The procedure of contextual fear conditioning was modified from Resstel et al. 
(Resstel et al., 2006). This trial was carried out in two sessions of testing which 
comprised two days of trials. On day 1 or shock day, each rat was individually 
placed in the chamber (width x length x height = 24 cm x 25 cm x 26 cm) with 
a metal grid floor. The floor of the chamber was connected to a shock 
generator which produced an output of 0.4 mA and also connected to an 
oscillator in order to measure the electric impulse. Rats were allowed to 
explore the chamber for one minute before shock and the period of shock 
delivery was 10 minutes. During the shock period, each rat was received 10 
shocks at one minute intervals and each shock was approximately one second. 
Subsequently, rats were returned to their home cages. The chamber was 
cleaned with 20% ethanol between each set of trials to ensure the absence of 
olfactory cues. On day 2, rats were placed into the same chamber for 10 
minutes without any shocks. Simultaneously, freezing behaviour was scored 
continuously during the first three minutes. Freezing was defined as the 
complete immobility, including movement of vibrissae except for movement 
related to respiration, whereas animals were usually in crouching posture for a 
minimum of 0.5 s (Saxe et al., 2006). Scoring the first three minutes of 
behaviour was chosen as a previous investigation showed that differences 
between shocked and unshocked animals were most marked during this period. 
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2.2.3 Brain tissue analysis for cell proliferation by using Ki67 
2.2.3.1 Brain tissue preparation 
The animals were killed 15 days after behavioural analysis by cervical 
dislocation, the brains removed, one half was used for immunohistochemistry 
and the hippocampal formation and frontal cortex dissected from the other for 
Western blotting. For Immunohistochemistry, half brains were cryoprotected in 
30% sucrose for 30 minutes at 4°C to prevent tissue damage due to freezing. 
Then each brain was placed in plastic moulds filled with OCT compound 
(VWR International Ltd., UK). After that, the moulds were snap-frozen by 
submerging in iso-pentane (used to prevent damage of blocks of tissue) which 
was cooled in liquid nitrogen. Frozen brains were stored at -80°C prior to 
sectioning and examination. For sectioning, frozen brain blocks from each 
group were sectioned through the whole dentate gyrus at a thickness of 20 J.lm 
(between Bregma -2.3mm to -6.3mm) in the coronal plane using a cryostat 
(Leica CM 1900). Sections were mounted on APES (3-
aminopropylmethoxysaline) coated slices (See Appendix ALl), with three 
sections per slide. Slides were kept at -20'C until further analysis. 
2.2.3.2 Immunofluorescent staining 
For quantification of cell proliferation in the SGZ of the dentate gyrus every 
20th section was selected for staining throughout the entire length of the 
dentate gyrus (in a total of 8 sections) using a systemic random sampling 
method to provide an efficient and unbiased sample (Mayhew and Burton, 
1988). The sections from each brain were quantified for the number of Ki-67 
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positive cells in the SGZ of the hippocampal dentate gyrus. Only dividing cells 
within 3 cell diameters of the inner edge of the dentate gyrus were scored as 
this is normally taken as the location of the SGZ (Kempermaan, 2006). 
Previous studies have shown that over 70% of dividing cells in this region 
contribute neurons in the dentate gyrus (Zhao et al., 2006). 
For the staining protocol, the selected slices were defrosted for 10 minutes. A 
PAP marker pen (Vector Labs, UK), which is a hydrophobic barrier, was used 
to circle around each individual section. All washing was done with phosphate 
buffered saline (PBS) and all procedures were done at room temperature (RT) 
in a covered humidity chamber. After the PAP markings were dry, the sections 
were washed three times to remove the OCT compound. The sections were 
fixed with 0.5% paraformaldehyde (PFA) (See Appendix ALl) for three 
minutes and washed three times. The sections were then treated with the 
primary antibody monoclonal Mouse Ki67 (Novocastra NCL-KI-67-MMI) at a 
concentration of I: 150 in PBS for 60 minutes. Following this, the sections were 
washed gently three times and then treated with the secondary antibody Alexa 
488 Rabbit Anti-mouse IgG (Molecular Probes) at a 1 :300 working dilution in 
PBS for 40 minutes. Then, the sections were once again washed three times. 
Before investigation, all the sections were counter stained with Propidium 
iodide (Sigma-Aldrich, Inc, St.Louis, USA), a nuclear stain which was diluted 
with PBS to a I :3,000 working solution, for 30 seconds. After staining was 
complete, the sections were washed three times and mounted in glycerol and 
cover-slipped for observation by fluorescence microscopy. 
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2.2.3.3 Fluorescence microscope 
The fluorescein isothiocyanate (FITC) fluorescence filter was used to quantify 
Ki67 stained sections using a X40 objective on a Nikon EDF-3 Fluorescence 
Microscope. Nuclei stained with propidium iodide (PI) on the same sections 
were observed using the red (TRITC) filter. Images of the dentate gyrus 
regions were viewed by a SPOT QE version 4.2 digital camera run by the 
SPOT advanced software run on a PC using Microsoft XP operating system. 
2.2.3.4 Microscopic qlUllltiflCation 
To avoid scoring artefacts only Ki67 positive cells in the SGZ which also 
showed a PI positive nucleus were counted. The dividing cells were counted 
along the entire length of the upper and lower blades of the dentate gyrus, 
starting from where the upper and lower blades meet. The number of dividing 
cells in 2-3 adjacent sections on the same slide was averaged and then the 
averaged counts of eight slides from each brain were compiled to get a measure 
of the sum of proliferating cells in one dentate gyrus in each animal. The mean 
number of proliferating cells from both control and drug-treated groups were 
calculated and statistically analysed. The sum of proliferating cells from both 
control and drug-treated groups were multiplied 22 to produce estimates of 
proliferating cell number (Huang and Herbert, 2006) and statistical analysis 
was performed to compare the number of the cell counts. 
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2.2.4 Western blot analysis 0/ BDNF, DCX and Notch signalling expression 
in hippocampus and /ronJaI cortex 
2.2.4.1 Sample preparation 
Hippocampus and frontal cortex from half of each brain was lysed in lysis 
buffer (20mM Tris-HCl, pH 7.6, ImM EGTA, 320 mM Sucrose, 0.1 % Triton 
XIOO, ImM NaF, 10mM Beta glyceronphosphaste) to produce a 100 mg/ml 
solution. The samples were homogenized with a pestle to ensure all protein 
was released and then rotated on a wheel for 10 minutes at 4°C. Then, the 
samples were centrifuged at 13000rpm for 10 minutes at 4°e. The supernatant 
was removed and from each sample was pipetted 20 III into an eppendorf to 
quantify protein concentration by Lowry assay. The remaining sample was 
added 6X solubilisation buffer to solubilise the protein and stored at -20°e. 
2.2.4.2 Lowry test/or protein concentration 
A standard curve was set up using 1 mglml stock solution of bovine serum 
albumin (BSA) diluted in distilled water to prepare the concentration range of 0 
to 0.5 mglml (See Appendix Al.2). 20 III of the homogenized sample was 
diluted (1: 10) in distilled water to a volume of 200 Ill. All diluted BSA 
standards and homogenized samples were added to 1 ml of Lowry AB solution 
(See Appendix Al.2) and incubated at room temperature for 10 minutes. Folin 
reagent was diluted 1: 1 with distilled water and added at 100 III per sample and 
incubated at room temperature for 45 minutes. After Folin reagent had reacted 
with the Lowry AB for 45 minutes, each standard and sample was placed, in 
triplicate, into a 96 well plate and the optical density (OD) was read at 750nm., 
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using a Dynex MRX Model 96 Well Plate Reader (MTX Lab Systems Inc., 
USA). The colourimetric reading and the protein concentration value within 
each sample were analysed and presented by Revelation software (MTX Lab 
Systems Inc., USA). All the samples were then normalized with 2X 
solubilisation buffer diluted 1: 1 with lysis buffer. 
2.2.4.3 Casting the gel 
During this study, 0.75 mm, 1.0 mm or 1.5 mm gel were used for 
electrophoresis depending upon the volume of sample to be loaded. The 
components and the volumes for 8%, 10% and 12% gel preparation are shown 
in Appendix A 1.2. The glass plates were cleaned with IMS and distilled water 
before casting the gel and then placed them into a cast. The resolving gel was 
pi petted into the cast and pi petted 1 00 ~ l l of saturated butanol onto the top of 
the gel to remove any bubbles. The gel was allowed to set for 20 minutes. After 
the gel had set, the butanol was poured off and the gel was washed three times 
with distilled water. Blotting paper was used to remove excess water to make 
sure the gel was dry. The stacking solution was pi petted on top of the resolving 
gel and a comb was placed into the gel to create wells. Once set, the comb was 
removed and the gel was washed thoroughly with distilled water, especially all 
the wells. 
2.2.4.4 Running and transferring the gel 
Prior to protein separation, the solubilised samples were denatured by warming 
them on a heat block at 95°C for 5 minutes and then vortexed and centrifuged 
at 1300rpm for 1 minute. The gel was placed into an electrophoresis tank (BIO-
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RAD Laboratories, Hertfordshire, UK) and filled with IX rwming buffer in 
distilled water. 30 ~ g g proteins per lane were subjected to 12% SDS-PAGE to 
assess BDNF and DCX while 50 ~ g g proteins per lane were subjected to 8% 
SDS-PAGE to assess Notchl. Additionally, 2 ~ l l of a molecular weight marker 
(PageRuler plus Prestained protein ladder, Fermentas DAB, Lithuania) was run 
parallel to the samples to determine the size of the protein of interest. The gel 
was run for approximate 45 minutes at 200V. 
Subsequently, the proteins from the gel were transferred onto a nitrocellulose 
membrane (HybondlM, Amersham Biosciences, Buckinghamshire, UK). In 
transferring process, the gel was placed into a cassette, placed onto a piece of 
blotting paper and then a piece of nitrocellulose membrane was placed on top 
of the gel which followed by another piece of blotting paper. The cassette was 
closed and placed into a transfer tank filled with transfer buffer and an ice 
pack. This process was run at 4°C for 60 minutes at IOOV. After transferring, 
the nitrocellulose membrane was stained with Ponceau solution (Sigma-
Aldrich, Inc, St,Louis, USA) to indicate the amount of protein successfully 
transferred. The membrane was washed in Tris-buffered saline tween-20 
(TBST) solution (See Appendix A1.2) to remove the Ponceau solution. 
2.2.4. 5 Immunodetection 
Prior to immunodetection, the membrane for detecting BDNF and DCX was 
blocked with 5% milk solution (dried milk powder dissolved in TBST) 
whereas the membrane for detecting Notch I was blocked with Odyssey buffer 
(LI-COR Biosciences) 1: 1 diluted in PBS, shaking platform for 1 hour at room 
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temperature. The membrane was incubated overnight with primary antibodies 
diluted in 5% milk solution and placed on a constant shaking platform. The 
primary antibodies used in this study are as follow: anti-BDNF (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA) diluted 1 :500, polyclonal anti-
doublecortin (DCX) antibody diluted l: 1000 (Cell Signaling Technology; 
Danvers, MA, USA), polyclonal anti-Notchl (C20) diluted 1 :200 (Sc-60l4, 
Santa Cruz Biotechnology, Santa Cruz, CA, USA) or monoclonal Mouse anti-
g1yceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody diluted 
1 :20000 (Abcam, Cambridge, UK). Afterwards, the membrane was rinsed 3 
times, and then washed for 5 minutes 3 times and 15 minutes 3 times with 
TBST at room temperature. Subsequently, the membrane was incubated with 
secondary antibodies: lRDye 800CW goat anti-mouse (1 :20000 diluted in 5% 
milk solution, U-COR Biosciences), lRDye 680CW goat anti-rabbit (1 :20000 
diluted in 5% milk solution, LI-COR Biosciences) or lRDye 800CW donkey 
anti-goat (LI-COR Biosciences) 1 :20000 diluted in Odyssey buffer (1: 1 diluted 
in PBS). The membrane was analyzed in accordance with the manufactures 
instructions using on an Odyssey scanner (Licor) at both wavelengths, 700nm 
(red emission) and 800nm (green emission), and Odyssey software 
(Application software version 3.0). 
2.2.4.6 Quantification/or protein and data analysis 
Hippocampal and frontal cortex tissue samples from both control and VPA-
treated groups were nm and repeated three times. Quantitative measurement of 
protein level was performed using Odyssey software (Application software 
version 3.0) by measuring the intensity of the protein band. Intensity levels of 
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BDNF and DCX expression were measured at 700nm while intensities of 
Nocthl and GAPDH expression were measured at 800nm. The intensity values 
of BDNF, DCX and Notch 1 for each sample were normalized by their 
corresponding GAPDH intensity values run on the same gel. The intensity 
values of each experimental group were pooled together and presented as the 
mean of BDNF, DCX and Notchl protein expression. All pictures of the blots 
showed in this chapter were visualised using Adobe Photoshop Version 7.0 
(Adobe Photoshop, USA) to increase contrast only to allow visible hardcopy 
prints for figures especially red and green images. 
2.2.5 Statistical analysis 
All statistical parameters were calculated using GraphPad Prism Version 4.03 
(GrapbPad Software Inc., USA). One- and two-way repeated measures 
ANOV A were used to analyze weight data For the behavioural testing, 
unpaired Student's t-test was used to analyze total exploratory time between 
control and VP A-treated groups in sample and choice trials. The data of NOL 
within each group was analyzed using paired Student's t-test to compare means 
of exploratory time in the sample and choice trials. Comparisons of mean 
exploratory times between groups were performed using two-way repeated 
measures ANOV A. Analysis of the discrimination index and contextual fear 
conditioning were calculated using one sample t-test and unpaired Student's t-
test. Proliferating cell COW1t and Western irnmunoblotting data were analyzed 
by unpaired Student's t-test. Normality distribution of all data was analyzed 
using Column statistics (KS normality test, D'Agostino & Pears on omnibus 
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normality test or Shapiro-Wilk normality test). A probability level of p < 0.05 
was considered statistically significant. 
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2.3 Results 
2.3.1 Weight 
To investigate the effect of VPA on weight gain, the weight of animals was 
monitored daily throughout the treatment. During the administration, the VP A-
treatment rats showed a significant weight loss, approximately 16 grams (p < 
0.0001; one-way repeated measures ANOVA, Fig. 2.3), while animals received 
saline showed a slightly increase of weight gain, approximately 21grams (p < 
0.0001; one-way repeated measures ANOVA, Fig. 2.3). Further analysis 
showed that the rats administered VPA showed a significant weight loss 
compared to animals received saline treatment (F(I,162) = 8.958, P = 0.0078, 
treatment variable, two-way repeated measures ANOV A). There was a 
significant change in the amount of weight gained in both control and VPA-
treated animals over the time period observed (F(9,162) = 5.918, p < 0.0001, 
main effect of time, two-way repeated measures ANOVA, Fig. 2.3). 
Furthermore, a significant interaction between treatment and time was 
observed, indicating that treatment affected the rate of weight gain over the 
monitored period (F(9,162) = 44.92, p < 0.0001, interaction, two-way repeated 
measures ANOVA, Fig. 2.3). 
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Figure 2.3 Mean body weight (± S.E.M) of the rats in each group was 
monitored during drug treatment (Days 1-10). This experiment compared 
between control and drug-treated groups which were received normal saline 
and 300 mg/kg VPA. Both control and VPA-treated animals showed a 
significant change in the rate of weight gain, p = 0.0001. Mean of weight gain 
in the drug-treated group (n = 10) was significantly lower than those in the 
control group (n = 10) (p < 0.05, two-way repeated measures ANOVA). There 
was a significant interaction effect between treatment and time (p < 0.0001 , 
interaction). All comparisons were calculated using one- and two-way repeated 
measures ANOV A. 
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2.3.2 Novel object locatioll (NOL) 
To test the behavioural effect of VPA in hippocampal dependent task, the 
performance of drug and control treated animals were compared 7 days after 
drug administration using the NOL test (Fig. 2.1). Results were assessed by 
comparing the total time animals spent on objects in either novel or familiar 
locations and by calculating the discrimination index for each group. In both 
the familiarization and choice trial , where one object is moved to a new 
location, the total exploring time of control and treated animals showed no 
statistically significant difference (P = 0.2569, unpaired Student's t-test, Fig. 
2.4), indicating that VP A-treatment did not affect overall motor activity. 
Total exploratory time 
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Figure 2.4 Total exploratory time during the NOL testing in controls and VP A 
treated animals. There was no significant difference in the amount of time 
exploring the objects between the control and VPA-treated animals (p = 
0.2569). All statistic parameters were analyzed using unpaired Student's Hest. 
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Figure 2.5 Time spent on each object in familiarization and choice trials by 
control and VP A-treated animals. (A) Control animals (n = 10) in the 
familiarization trial did not display a preference for the two objects located in 
A and B locations (p = 0.0518). In the choice trial , there was a significant 
increase in the exploratory time spent on objects in the novel location (NL) 
compared with the familiar location (FL) ( *** P = 0.0002). (B) VPA-treated 
animals (n = 6) (7 days post treatment) spent the same amount of time 
exploring the objects in A and B locations in the famjliarization trial (p = 
0.1291). In the choice trial there was no significant difference in the time spent 
between objects in familiar and novel location (p = 0.9601). All comparisons 
assessed using paired Student's t-test. 
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In the familiarization trial, neither control nor drug treated groups showed any 
difference of exploratory time between the objects, p = 0.0518 and 0.1291 
(paired Student's Hest), respectively (Fig. 2.5). Control animals in the choice 
trial however spent significantly more time attending to the novel object (* p = 
0.0002, paired Student's t-test, Fig. 2.5A). In contrast, the drug treated animals 
showed no significant difference in the time spent exploring between novel and 
familiar objects (p = 0.9601, paired Student's t-test, Fig. 2.5B). There were 
significant effects of location and treatment x location interaction on the 
exploratory time (F(l,14) = 23.66, p = 0.0003 and F(l,14) = 15.33, p = 0.0016, 
two-way repeated measures ANOVA). Bonferroni post hoc tests confirmed 
that the control animals spent significantly more time on the object located in 
the novel position in comparison with the rats in VPA-treated group (I = 3.275, 
P <0.01, two-way repeated measures ANOVA). In contrast to this, the time 
spent exploring the object located in the familiar position exhibited no 
difference between the two groups (I = 0.4107, p >0.05, two-way repeated 
measures ANOVA, Fig. 2.5). This indicates that VPA-treated animals showed 
a significant deficit is a spatial working memory task. 
In order to further analyse these results, the exploratory times in the choice trial 
were converted into a discrimination index to compare the ability of the 
animals to discriminate the familiar and novel objects between control and 
VP A-treated groups. The discrimination index between the novel and the 
familiar location after treatment were significantly above zero in control group 
(p = 0.0002, one sample t-test, Fig. 2.6) while the discrimination index in the 
VPA-treated group were not significantly different from zero (p = 0.1563, one 
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sample Hest, Fig. 2.6). Comparisons of the discrimination index between 
control and VPA-treated groups demonstrated a significant difference after 
treatment (p = 0.0016, unpaired Student's t-test, Fig. 2.6). These findings 
indicate that animals which received VP A did not discriminate the object 
remained in the familiar and the novel objects in this test. 
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Figure 2.6 The discrimination index of control and VPA-treated rats in the 
novel location recognition task after treatment. The discrimination index is 
defined as the difference in exploration time between the two objects in the 
choice trial . The mean discrimination index of each group was compared 
against o. The discrimination index of control group was significant greater 
than 0 (*** p = 0.0002). In contrast, VPA-treated animals had a discrimination 
index value that was not significant different from 0 (NS, p = 0.1563). The 
discrimination index showed a significant difference in comparison between 
groups (** p = 0.0016,). Statistic analysis was carried out using one sample t-
test and unpaired Student's t-test. 
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2.3.3 Contextual/ear conditioning test 
Freezing behaviour was assessed by scoring the freezing time during the first 
three minutes and means of the freezing time were then calculated for each 
group. The results showed no significant difference between the freezing 
behaviour of control and drug-treated animals (p = 0.8075 ; unpaired Hest, Fig. 
2.7). 
CER 
Figure 2. 7 Effect of shock on freezing behaviour after treatment in control (n = 
10) and VP A-treated (n = 6) animals. Data represents mean ± S.E.M of 
freezing time in minutes. Analysis of freezing behaviour between control and 
drug-treated animals was not found significantly different either before or after 
treatment, p-value = 0.7797 (unpaired Student's Hest). 
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2.3.4 Quantification of proliferating cells in tile SGZ 
To investigate the possible causes of the deterioration In the hippocampal 
spatial memory, the level of cell proliferation in the SGZ of the dentate gyrus 
was determined by staining for the cell proliferation maker Ki67 (Fig. 2.9). 
Ki67 positive cells were found in the SGZ adjacent to the inner edge of the 
dentate gyrus as described by previous investigators. The number of Ki67 
positive cells per hippocampus in VPA-treated animals was significantly 
decreased (- 2-fold) in comparison with control animals (mean ± SEM; control 
group: 2106 ± 129.9; VPA treated group: 1100 ± 84.55 ; P <0.0001 , unpaired 
Student's t-test, Fig. 2.8). The results indicate that VP A reduced cell 
proliferation in the SGZ of the dentate gyrus of adult rats. 
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Figure 2.8 VPA reduced cell proliferation in the hippocampus. The number of 
Ki67 positive cells per hippocampus in VPA-treated animals (n = 10) was 
significantly decreased in comparison with control animals (n = 10, *** P < 
0.0001 , unpaired Student's t-test) . 
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Figure 2.9 (A, D) Clusters of Ki67 positive cells (green). (B, E) The section of the dentate gyrus seen in (A, D) counterstained with Propidium 
iodide (PI), showing red nuclear staining of all cells. (C, F) The images A or D and B or E merged to show Ki67 positive cells located in the SGZ 
adjacent to the dentate gyrus. Upper panels control (saline-treated) rat, lower panels VPA-treated rat. 
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2.3.5 BDNF, DCX and Notchl expression 
Western blotting analysis was performed to investigate the effects of VPA on 
levels of BDNF and DCX expression in the hippocampus and frontal cortex. 
Whole brain and recombinant BDNF were used as positive control for DCX 
and BDNF respectively. 
Immunoblots probed for BDNF expression showed a band at approximately 15 
KDa (Fig. 2.10). The present study showed a significant reduction in BDNF 
levels within the hippocampal formation in VPA-treated animals compared to 
control animals (p = 0.0053, unpaired Student's t-rest, Fig. 2.11A). Conversely, 
BDNF levels in frontal cortex did not differ between control and VP A-treated 
groups (p = 0.5352, unpaired Student's t-test, Fig. 2.11A). 
Probing for the cytoskeletal associated protein DCX which is transiently 
expressed in immature neurons, showed a band at approximately 45 KDa (Fig. 
2.10). Protein levels of DCX did not show a significant reduction compared 
between control and VPA-treated groups in the hippocampus and frontal 
cortex, p = 0.5736 and 0.8769, respectively (unpaired Student's t-test, Fig. 
2.11B). 
The receptor Notch 1 is expressed on undifferentiated neural stem cells where it 
is involved in controlling proliferation and in postmitotic neurons where 
promotes dendritic branching. Western blot analysis was used to detect a band 
of Notchl at approximately 120 KDa (Fig. 2.12A). VPA-treated animals 
95 
showed a significant decrease of Notch 1 expressIOn In the hippocampus 
compared with controls (p = 0.01 , unpaired Student's Hest, Fig. 2.12B). 
These results indicate that VPA treatment led to a significant decrease of 
BDNF and Notch 1 but not DCX in the hippocampus. 
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Figure 2.10 Photomicrographs of representative immunoblots showing 
detection of BDNF at 15 KDa and doublecortin at 45 KDa in the hippocampus 
(A) and frontal cortex (B). The positive control consisted of recombinant 
BDNF (lane 3) and whole brain for doublecortin (lane 2). GAPDH was 
observed at 36 KDa and was used as a loading control. 
Cont = control , VPA = valproic acid and Mwt = Molecular weight marker. 
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Figure 2.11 Graphs showing the effects of VP A on BDNF and DCX 
expression in hippocampus and frontal cortex. (A) In the hippocampus, VPA-
treated animals (n = 8) showed a significant decrease of BDNF expression 
compared to control animals (n = 8) (** p = 0.0053). On the other hand, the 
levels of BDNF in VPA-treated animals was not significant different in 
comparison with control animals in frontal cortex (n = 9) (p = 0.5352). (B) 
DCX expression in both hippocampus (n = 8) and frontal cortex (n = 9) did not 
displayed a significant difference between control and VP A-treated groups, p = 
0.5736 and 0.8769, respectively. Statistical significant was determined using 
unpaired Student's t-test. 
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Figure 2.12 Western blot analysis for levels of Notch 1 in animals administered 
VPA in hippocampus. (A) Photomicrographs illustrating immunoblot bands 
detected at 120 KDa. The expression of Notch 1 was reduced in VPA-treated 
animals as indicated by the presence of fainter bands compared with control 
animals. GAPDH was used as a loading control. (B) Normalized wavelength at 
800nm revealed that there was a significant decrease of Notchl expression in 
VPA-treated animals (n = 9) in comparison with controls animals (n = 9) (* P = 
0.01 , unpaired Student's t-test). Cont = control, VPA = valproic acid and Mwt 
= Molecular weight marker. 
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2.4 Discussion 
The present study aimed firstly to investigate the effects of VP A exposure on 
behaviour using the NOL and contextual fear conditioning tests. After 
completion of the behavioural testing, cell proliferation in the SGZ was 
assessed from half of each brain while the other half was used to quantify 
BDNF, DCX and Notch 1 protein levels. This was done to see if VP A affected 
cell proliferation in the hippocampal neurogenic region, as reported previously, 
and whether this could be correlated with changes in behaviour and other 
markers of neurogenesis or hippocampal function which might explain the 
effect of the drug. As discussed below the reduction in cell proliferation was 
confirmed and correlated with a behavioural change in one test and with some 
but not all biochemical markers of hippocampal neurogenesis and function. 
Weight gain was tkcreased by VPA 
The present study of the adult rats exposed to VPA, showed that the weight 
gain of VP A-treated animals was significantly decreased compared to control 
animals which gained in weight throughout the experiment. There are 
conflicting reports on the effects of VP A on weight gain in patients. Exposure 
of women to anticonvulsant drugs during pregnancy results in decreased birth 
weights (Fonager et al., 2000) in contrast to a report comparing monozygotic 
twins or children treated with VP A which found a weight gain (Klein et al., 
2005, Demir and Aysun, 2000). Weight change is not thought to be a normal 
side effect of VP A and the mechanism which could bring this about is not well 
understood. 
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VPA produced cognitive deficits in NOL but not contextual fear conditioning 
VP A treatment did not affect locomotor activity or total exploration time in the 
NOL test compared to control animals. The NOL test which requires animals 
to recall the spatial layout of objects in an arena is regarded as a test of spatial 
working memory (Dix and Aggleton, 1999). The test uses the natural tendency 
of rats to spontaneously explore an object placed in new position without 
primary reinforcement, spatial learning or the learning of response-reward 
association which is needed in other behavioural tests. Therefore, it needs very 
little pretraining and does not cause arousal or stress (Dere et al., 2007). This 
test using the novelty-preference paradigm is closely related to human 
recognition memory observed in everyday life (Ennaceur and Delacour, 1988). 
Results from the choice trial, where control animals showed significantly more 
interest in the object moved to a novel location, showed that drug treated 
animals failed to show this behaviour. Animals treated with VP A showed an 
inability to discriminate between an object in a novel location and one in a 
familiar location. This result indicates that VP A can cause spatial memory 
deficits after chronic exposure. 
In terms of the hippocampal formation the NOL test requires an intact dentate 
gyrus for animals to be able to carry it out (Mumby et al., 2002, Lee et al., 
2005). The inability of VP A animals to discriminate between novel and 
familiar object locations suggests a deficit in the function of this particular 
brain region. As discussed later since the dentate gyrus is one of the few brain 
areas to continuously incorporate new neurons a decline in neurogenesis may 
be one reason for the cognitive impairment shown in this behavioural test. 
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In addition to the NOL test, the present study also scored freezing behaviour 
after exposure to an aversive stimulus in a particular location (contextual fear 
conditioning). This test also used the hippocampus but is thought to also 
involve other brain areas including the amygdala and brain stem 
(periaqueductal grey matter) (Fanselow, 2000). In contrast to the NOL test, the 
behaviour of control and drug-treated animals was not found to be significantly 
different. 
Although the contextual fear test is not as specific a test of hippocampal 
function as the NOL, a reduction of neurogenesis in the hippocampus by focal 
X irradiation or genetic ablation of GF AP containing neural progenitors has 
previously been reported as causing an impairment in contextual fear 
conditioning (Saxe et al., 2006). This would suggest an association between 
neurogenesis and the ability to perform the test. 
The results predicted here however do not suggest this connection. There are a 
several possible reasons for this. Firstly, the number of electric shocks used in 
this study (10 shocks) is greater than that used in some studies (3 shocks) (Saxe 
et al., 2006). Increasing the number shocks may not lead to an improvement in 
memory and in fact may cause difficulties for the brain in interpreting the 
association between stimulus and context and so reduce the ability to learn. In 
line with a human study, it has been reported that patients who are under 
conditions of high fear or hunger can not usually be assessed for learning and 
memory capacities (Ennaceur and Delacour, 1988). Additionally, the rats in 
this study were administered VP A before the contextual fear conditioning 
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testing. This time scale is different from post-training hippocampal lesions 
where animals were injected with VPA 120 and 30 minutes before the passive 
avoidance test which showed cognitive deficits (Balakrishnan and Pandhi, 
1997; Pandhi and Balakrishnan, 1999). Support this view comes from the 
finding that post-training hippocampal lesions cause severe impairments in 
contextual fear conditioning. In post-training hippocampal lesions, the 
hippocampus is required for assembling the contextual stimuli into a context 
representation. Then, the context representation comes into association with 
footshock in the amygdala to acquiring contextual fear conditioning. On the 
other hand, contextual stimuli can come into association with footshock in the 
amygdala without using a configural strategy in pre-training hippocampal 
lesions (Maren, 2001). Thus they may be two of the reasons that made freezing 
behaviour show no significant difference between drug and control groups in 
this study. 
JPA reduced proliferating cells in the SGZ of the hippocampal dentate gyrus 
Adult neurogenesis in the hippocampus is confined to producing new granule 
cells in the dentate gyrus. These cells are derived from a proliferating pool of 
neural stem cells in the SGZ adjacent to the dentate gyrus. Recent work has 
shown that it is newly formed granule cells which are preferentially used in 
spatial learning tasks (Dupret et al., 2008, Kee et al., 2007). This observation 
explains why levels of neurogenesis in the hippocampus generally strongly 
correlate with hippocampal-dependent cognition (Zhao et al., 2008). Treatment 
with VPA significantly inhibited cell proliferation in the SGZ by the end of the 
experiment, a result in agreement with a previous study (Hsieh et al., 2004). 
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The route of administration of VPA is similar to that used by Hsieh (twice 
daily injections for 14 days) but without the additional VPA in drinking water. 
In contrast, administration of VP A only with food for 6 weeks has been 
reported as increasing hippocampal neurogenesis (Hao et al., 2004). It is 
unknown what the relative serum concentrations of VPA are by these two 
methods of drug administration but it is likely that i.p. injections lead to a 
higher peak serum concentration than that obtained through diet. It is possible 
that VP A has different effects at different concentrations, possibly stimulating 
proliferation at low concentrations while inhibiting it at higher concentrations. 
The correlation between reduced proliferation in the SGZ and cognitive deficits 
is in line with recent work by Mustafa et al (2008) and other studies stating that 
pharmacological, environmental or physical influences on cell proliferation in 
this region correlate with changes in cognition (Drapeau et al., 2003, 
Kempermann, 2002, Madsen et al., 2003, Raber et al., 2004a, Shors et al., 
2001). In particular the results presented here parallel those studies in which 
anti-mitotic drugs have been shown to reduce proliferation in the SGZ and 
impair cognition (Seigers et al., 2008, Shors et al., 2001). There have been 
some disagreements in what role hippocampal neurogenesis plays in spatial 
learning. Some authors have found a good correlation between neurogenesis 
and learning and have shown that reducing neurogenesis leads to deficits in this 
modality (Kee et al., 2007, Raber et al., 2004b, Kempermann et al., 
1998). Others however have not found this association or have demonstrated 
improvements in cognition independent of neurogenesis and have queried the 
link between neurogenesis and spatial learning (Saxe et al., 2006, Shors et al., 
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2002, Meshi et al., 2006). Recently a genetic approach to blocking 
neurogenesis has shown that a reduction in neurogenesis is associated with a 
significant decrease in spatial memory (Imayoshi et al., 2008). As discussed in 
this reference the differences in results may be due to differences in the extent 
neurogenesis is inhibited or to non specific effects on brain function. 
VPA redllced hippocampal BDNF but not DCX 
In addition to effects on behaviour and cell proliferation in adult rats, VP A 
treatment caused a significant decrease in BDNF expression in the 
hippocampus but not frontal cortex. The neurotrophin, BDNF, is expressed by 
dentate gyrus granule cells (Conner et al., 1997, Wetmore et al., 1990). BDNF 
has been shown to be important both in the process of learning and in adult 
neurogenesis as well as mediating the effects of antidepressants (Nibuya et al., 
1995, Shirayama et al., 2002). BDNF is required for long term potentiation 
(LTP), a process required for memory consolidation (Bekinschtein et al., 2008, 
Korte et al., 1995, Lu et al., 2008, Minichiello et al., 1999). In the process of 
neurogenesis within the SGZ, BDNF is required for the survival, migration and 
maturation of newly formed neurons and promotes their dendritic growth and 
branching. Reducing BDNF levels or BDNF signalling in the brain is 
associated with impaired spatial memory (Minichiello et al., 1999, Mustafa et 
al., 2008). Two reports have found that chronic in vivo VP A treatment can 
elevate BDNF levels in the hippocampus (Fukumoto et al., 2001) while a 
further study showed a non significant reduction or no effect. In both cases 
where BDNF levels were increased, BDNF levels were measured immediately 
after the end of drug treatment. Within 24 hours however BDNF levels had 
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fallen to control levels (Fukumoto et al., 2001). In the present study, BDNF 
levels were measured after the behavioural testing, 2 weeks after the end of 
drug dosing. BDNF is required to maintain the synaptic plasticity underlying 
memory but is also produced and secreted in response to learning reviewed in 
(Lu et al., 2008). The lower BDNF levels found in VPA treated animals are 
consistent with their impairment in learning during the behavioural tests but 
could be due to the action of VP A on BDNF production or to reduced 
hippocampal activity which may be occurring in animals which fail to develop 
spatial memories. 
After VP A treatment, animals showed a non significant reduction in DCX 
levels within the hippocampus. DCX is a microtubule associated protein which 
is required for neuronal cell migration and is transiently expressed maturing 
neurons in the SGZ and dentate gyrus (Couillard-Despres et al., 2005). During 
neurogenesis in the dentate gyrus, newly differentiating neurons appear to 
retain expression of DCX for several weeks during which time they complete 
their migration into the dentate gyrus and extend dendrites and axons (Rao and 
Shetty, 2004). DCX levels may have been increased in these animals by the 
differentiation promoting effects of VPA which as well as inhibiting cell 
proliferation can accelerate neuronal progenitor differentiation (Gottlicher et 
al., 2001, Hsieh et al., 2004). 
VPA did not decrease BDNF and DCX injrontal cortex 
BDNF and DCX levels in frontal cortex were also determined to investigate 
that not only newborn neurons in the hippocampus was affected by VPA 
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treatment but also the frontal cortex could be affected. BDNF and DCX 
expression were detected within the frontal cortex; however, there were no 
significant changes of BDNF and DCX expressions in VP A-treated animals 
compared to the control animals in this brain region. BDNF is considered to 
have an important role to contributing generation and/or survival of newly 
generated neurons in the adult olfactory bulb (Zigova et al., 1998). It has been 
revealed that level of DCX expression is substantially observed in newborn 
neurons of the olfactory bulb (Nacher et al., 2001). The expression of DCX in 
the dissected frontal cortex included the SVZ, RMS and main and accessory 
olfactory bulbs suggests that this portion comprises the second neurogenic zone 
in the adult brain (Abrous et al., 2005). This lack of effect on neurogenesis in 
the frontal cortex indicates that the VP A administration in this study did not 
affect the generation and/or survival of new neurons in the frontal cortex of the 
adult brain. 
VPA caused a reduction ofreceptor NotchI expression in the hippocampus 
VP A treated animals in the present study showed a significant reduction in 
Notch 1 protein levels within the hippocampus which correlated with their 
reduced performance in a spatial learning task. Although the contribution of 
reduced Notchl levels to cognitive impairment is unclear, it is likely that it is 
affecting the generation, maturation and synaptic plasticity of newly formed 
neurons within the dentate gyrus. Notch comprises a family of four cell surface 
receptors activated by ligands on adjacent cells (Yoon and Gaiano, 2005). 
Notch receptors and their ligands are expressed throughout neural development 
and expression is retained in discrete regions of the adult brain including strong 
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expression in the SGZ and dentate gyrus (Breunig et al., 2007, Stump et al., 
2002). Signalling through Notch appears to have several effects on the receptor 
expressing cells. During neural development and probably in the germinal 
zones of the adult brain, activation of the Notch! receptor prevents neural 
differentiation and maintains neural precursor and the stem cell proliferation 
(Breunig et al., 2007, Hitoshi et al., 2002). In post mitotic neurons, Notchl is 
important for the later stages of granule cell maturation and dendritic branching 
(Redmond et al., 2000, Breunig et al., 2007). Given these functions it is not 
surprising that alterations in the level of Notch 1 expression have been found to 
influence learning and memory. Transgenic mice with reduced expression of 
Notch 1 show reduced L TP which can be rescued by addition of Notch 
signalling components (Wang et al., 2004). Homozygous Notchl knock out 
mice die before birth while heterozygous knock out animals survive but show 
impaired spatial learning (Costa et al., 2003). 
Untreated epilepsy itself causes cognitive impairments (Aldenkamp and 
Bodde, 2005, Hirsch et al., 2003) and this is associated with increased but 
aberrant hippocampal neurogenesis in animal models (Crespel et al., 2005, 
Jessberger et al., 2007). VPA is able to normalize neurogenesis after induction 
of seizures in animal models and this may be one of the mechanisms by which 
it helps epileptic patients (Hsieh et al., 2004). However, it is worth nothing that 
treatment with VP A when neurogenesis is normal can produce cognitive 
impairments associated with reduced neurogenesis. This may be significant in 
the use of VPA as a mood stabiliser in conditions where neurogenesis is not 
elevated or aberrant. 
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Chapter 3 
The effect of Valproic acid on cell proliferation 
and Notch signalling expression in hippocampal 
neural stem cells 
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3.1 Introduction 
Valproic acid (VPA) has been clinically employed as an antiepileptic drug and 
a mood stabilizer for several decades. Although, VPA has been known to 
increase y-aminobutyric acid (GABA) ergic function and block sodium and 
calcium channels, the mechanisms of action are currently not entirely clear 
(Eyal et al., 2004). In addition to its effects on neurotransmitters and ion 
channels, VP A has the potential to affect chromatin structure, which is 
important in determining whether stem cells either self-renew or differentiate 
(Hsieh et al., 2004). VPA has been shown to decrease cell proliferation and 
enhance neuronal differentiation which might be via the inhibition of HDACs. 
Suppression of cell proliferation and induction of apoptosis by VPA has been 
known to arrest the cell cycle at a GO/I phase in multiple myeloma cells in 
vitro (Murabe et al., 2007). In vivo studies have shown that VPA also regulates 
differentiation and inhibits the proliferation of neuronal progenitor cells 
suggesting that the actions of VP A in controlling neural production could be 
modified for therapeutic use in patients (Jung et al., 2008). Exposure of 
embryonic rat cerebral cortex neural progenitor cells to 1 mM VPA induces a 
marked up-regulation of p21 expression, increasing differentiation and 
inhibiting cell proliferation (Jung et al., 2008). 
Adult neural stem cells (NSC) residing in the SGZ of the hippocampal dentate 
gyrus give rise new granule cells for the entire life of the organism. New born 
neurons functionally contribute to existing circuits within the dentate gyrus 
(Ehninger and Kempermann, 2008, Abrous et al., 2005, Farioli-Vecchioli et al., 
2008, Hsieh and Gage, 2004). Moreover, newly generated neurons in the SGZ 
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are used preferentially in aspects of hippocampal function such as learning and 
memory (Kitabatake et al., 2007) suggesting that adult hippocampal 
neurogenesis may be essential for these behaviours. NSCs in the mammalian 
CNS have been extensively used to investigate a model of the molecular 
mechanisms that control cell-fate specification (Hsieh and Gage, 2004). The 
undifferentiated NSCs maintain the potential to proliferate and self-renew 
which is the most important intrinsic capacity of stem cells (Shi et al., 2008, 
Galli et al., 2003). Stem cell self-renewal and differentiation are regulated by 
transcription factor, chromatin remodelling and epigenetic factors (Shi et al., 
2008). In monolayer culture, proliferation of hippocampal progenitor cells 
treated with 1 mM VPA for 24 hours was dramatically decreased compared to 
untreated cells using BrdU staining (Hsieh et al., 2004). 
In the previous chapter (Chapter 2), adult rats were administered two daily 
intraperitoneal injections of VPA at a dose of 300 mglkg. This resulted in 
significant cognitive impairment as shown by the novel object location (NOL) 
test and a significant reduction of cell proliferation in the SGZ of the 
hippocampal dentate gyrus. VP A also produced a decrease in the levels of 
BDNF and Notch 1 expression in hippocampal tissues. The cognitive deficit 
produced by VP A treatment might be due directly to the action of the drug on 
cell proliferation leading to a reduction in neurogenesis but could also be 
indirect, through changing levels of neurotrophic factors (e.g. BDNF); acting 
on the stem cell niche (e.g. Notchl) or affecting other brain regions (e.g. 
frontal cortex) which then influence hippocampal function. To further 
understand the direct effect of VP A on the neural stem cells in the SGZ of the 
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hippocampus investigations were carried out in vitro to see what changes in 
proliferation and gene expression occurred with VPA treatment. This approach 
has become a widely used as an important new tool for predicting drug effects 
and estimating their toxicity. 
Treatment of a range of cell lines with a therapeutic dose (0.3 -0.7 mM) of 
VPA has been reported to inhibit histone deacetylases (HDACs) and enhance 
the acetylation of core histones in HeLa, F9 teratocarcinoma and Neuro2A 
neuroblastoma cells (Murabe et al., 2007). Thus, VPA can potentially directly 
affect transcription, which might cause stem cells to lose control over their 
ability to proliferate, differentiate, apoptosis or senesce. Taking as a starting 
point the results from the previous in vivo study, it was decided to look at the 
effects of VP A on cell proliferation and the expression of Notch 1, Sox2, nestin 
and c-Myc genes in hippocampal NSCs in vitro. Both proliferation and Notch 1 
levels were reduced by VPA treatment in vivo while nestin, Sox2 and c-Myc 
are genes known to be expressed by neural stem cells and changes in their level 
of expression may indicate changes in the ability of NSCs to self-renew. 
Alteration of gene expression and proliferation in adult hippocampal NSCs 
could have direct effects on neurogenesis leading to subsequent changes in 
hippocampal function. 
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3.1.1 Aims of this chapter 
To determine the direct effects of VPA on hippocampal neural stem cells by 
examining their proliferation and expression of the neural stem cells markers: 
Sox2, nestin, c-Myc and Notch 1 , in vitro. 
3.1.2 Hypothesis 
• Neurosphere and cell proliferation of hippocampal NSCs in culture will 
be significantly reduced by treatment with VP A. 
• Levels of Notch 1 , Sox2, nestin and c-Myc gene expressIOns 10 
hippocampal NSCs will be significantly decreased by treatment with 
VPA. 
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3.2 Materials and Methods 
3.2. / Analysis of effects of VPA on adult hippocampal NSCs 
3.2.1./ Isolation and propagation of adult rat hippocampal NSCs 
Adult Lister hooded rats (Charles River Laboratories, UK), weighing 
approximately 160-200 g were killed by decapitation, the brains were removed 
from the skulls and then immersed into ice cold PBS. The hippocampus was 
dissected and diced into small pieces «1 mm3). Following the dissection, all 
dissected tissue was pooled into a 30 rnl universal tube. PBS was removed 
prior to tissue digestion. In order to digest the tissue, 1 ml of accutase 
(Millipore, California, USA) was added to the tube, followed by incubation for 
45 minutes at 37°C to facilitate the dissociation of the tissue. During digestion, 
the tissue dissociation was aided by gentle pipetting using blue tips and PIOOO 
until only very small clumps were present or the suspension looked cloudy. 10 
ml of PBS was added to dilute the accutase and the tube was shaken to ensure 
the tissue was completely dissociated The tissue was then centrifuged at 200g 
for 5 minutes and PBS was removed from the cell pellet. The tissue was 
resuspended in 4 rnl of neural stem cell (NSC) medium [Dulbecco's Modified 
Eagles MediumlHam's FI2 (DMEMlFl2 1: 1, Invitrogen, CA, USA), 
Neurobasal media (Invitrogen, CA, USA), N2 supplement (Invitrogen, CA, 
USA), B27 (Invitrogen, CA, USA), 0.5% Pen/Strep (Sigma-Aldrich, Inc, 
St.Louis, USA), EGF (Sigma-Aldrich, Inc, St.Louis, USA) and FGF-2 
(Invitrogen, CA, USA)] (see Appendix AI.4). 2 ml of the cell suspension was 
placed in a 6-well plate (Coming) and cultured at 37°C with 5% CO2. The next 
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day, the medium is replaced with new medium ensure a fresh supply of 
nutrients. Every 3-4 days, the medium was replaced with new medium for 
actively growing culture. 
Figure 3.1 Phase contrast photograph of neurospheres of adult rat hippocampal 
NSCs. 
3.2.1.2 Cell proliferation of adult rat hippocampal NSCs 
Cultures of hippocampal NSC were assigned in one of three groups: control, 
0.3 mM VPA or 1 mM VPA. Hippocampal neurospheres were transferred from 
a T75 tissue culture flask (Coming, Sigma-Aldrich, Inc, St.Louis, USA) to a 30 
ml universal tube and centrifuged at 200rpm for 5 minutes. The medium was 
removed using an aspirator being careful not to disturb the cell pellet. 0.5-1 ml 
of accutase was added and the pellet resuspended. The cells were incubated for 
5-10 minutes at 37°C to facilitate the dissociation of the cells. To dissociate the 
cells into single cell s, the sol ution was gently pi petted using 1000P and then 
PBS was added to dilute the accutase. The density of the cells was counted 
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using an Improved Neubauer Hemocytometer (See Appendix AI.3). The cells 
were cultured at 2 X 105 cells in a T75 flask in 15 ml of NSC medium 
containing 20 ng/rnl ofEGF and FGF-2, maintained at 3TC with 5% CO2. The 
following day, the NSCs were treated with 0, 0.3 or 1 mM VPA. After 72 
hours in vitro, floating sphere colonies (neurospheres) which were bigger than 
a few cells were counted. Following neurosphere count, neurospheres were 
triturated with 0.5-1 rnl of accutase, incubated at 37°C for 5-10 minutes. The 
neurospheres were dissociated into single cells and the density of neural stem 
cells was then assessed in control and VP A treated cultures by staining cells 
with Trypan blue. Quantification of numbers of neurospheres and single cells 
was performed in triplicate on separate cultures (Appendix AI.3). Means of the 
total number of neurosphere-forming NSCs and the density of neural stem cells 
were calculated and subjected to the statistical analysis. 
3.2.1.3 Iso/anon and propaganon of adult mouse hippocampal NSCs 
Three brains of mice (male and female adult 129 and MEl mice, Biomedical 
Service Unit (BMSU), University of Nottingham) were dissected and the 
hippocampi isolated. The hippocampi were transferred into ice cold PBS and 
then proceeded as detailed previously in section 3.2.1.1, chapter 3. 
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Figure 3.2 Phase contrast photograph of neurospheres of adult mouse 
hippocampal NSCs. 
3.2.1.4 Cell proliferatioll of adult mouse hippocampal NSCs 
Adult hippocampal neurospheres were dissociated with accutase as described 
previously (section 3.2.1.1 , chapter 3) and then seeded at 12.5 X 106 cells in 5 
rn1 of NSC medium in a T25 flask. Hippocampal NSCs were incubated for 2 
hours at 3TC and then treated with 0, 0.3 and 1 mM VPA. Following 48 hours 
incubation, numbers of hippocampal NSCs were counted by staining cells with 
Trypan blue as detailed previously (section 3.2.1.2, chapter 3). Analysis of 
density of adult mouse hippocampal NSCs was performed a total of three times 
on different samples per condition (n = 3) (Appendix Al.3). 
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3.2.2 AlIIllysis of quantitative real-time reverse transcription polymerase 
chain reaction (qPCR) of Sox2, c-Myc, nestin and Notch1 gene expressions 
in JPA treated adult mouse hippocampal NSCs 
3.2.2.1 JPA treatment 
Cultures of mouse hippocampal NSCs were assigned in one of three groups: 0, 
0.3 or I mM VPA. Hippocampal neurospheres were transferred from a T25 
flask (Coming, Sigma-Aldrich, Inc, St.Louis, USA) to a 30 ml universal tube 
and centrifuged at 200g for 5 minutes. The medium was removed using an 
aspirator being careful not to disturb the cell pellet. 0.5-1 ml of accutase was 
added and the pellet resuspended. The cells were incubated for 5-10 minutes at 
37°C to facilitate the dissociation of the cells. To dissociate the cells into single 
cells, the solution was gently pipetted using 1000P and then the accutase was 
diluted by adding PBS. The density of the cells was counted using Trypan blue 
assay. The cells were cultured at 1.25 X 106 cells in a T25 flask in 5 ml of NSC 
medium containing 20 nglml of EGF and FGF-2, maintained at 37°C with 5% 
CO2. After 2 hours, the NSCs were treated with 0, 0.3 or 1 mM VPA. After 48 
hours in vitro, the hippocampal neurospheres were removed from the T25 flask 
to a 30 rnl universal tube and centrifuged at 200g for 5 minutes. Then the 
hippocampal neurosphere-forming NSCs were washed with cold PBS and 
centrifuged at 200g for 5 minutes. The pellet of the hippocampal neurosphere-
forming NSCs was collected for cDNA preparation. The treatment was 
performed in triplicate. 
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3.2.2.2 RNA extraction 
The hippocampal neurosphere-forming NSCs were lysed in TRI REAGENT 
(Sigrna-Aldrich, Inc, St,Louis, USA) at 5-10 X 106 cells per 1 ml of the reagent 
by repeated pipetting. The sample was incubated for 5 minutes at room 
temperature to ensure complete dissociation of nucleoprotein. Then, 
chloroform (Fisher Scientific UK Ltd, Leicestershire, UK) was added to the 
sample at 0.2 ml per ml of TRI REAGENT used. The sample was shaken 
vigorously for 15 seconds and incubated for 2-15 minutes at room temperature. 
The sample was centrifuged at 12,000g for 5 minutes at 4°C. This resulted in 
the sample being separated into 3 phases: a red organic phase (containing 
protein), an interphase (containing DNA) and a colourless upper aqueous phase 
(containing RNA). The aqueous phase was transferred to a new tube and 0.5 ml 
of isopropanol (Fisher Scientific UK Ltd, Leicestershire, UK) per ml of TRI 
REAGENT added. Then the sample was mixed very well and incubated for 5-
10 minutes at room temperature. After incubation, the sample was centrifuged 
at 12,OOOg for 10 minutes at 4°C. Once a pellet of the RNA precipitate was 
form on the side and bottom of the tube, the supernatant was removed and the 
RNA pellet washed with at least 1 ml of 75% ethanol per 1 ml of TRI 
REAGENT used. The sample was vortexed and then centrifuged at 13,000g for 
5 minutes at 4°C. After washing with 75% ethanol, the supernatant was 
removed without disturbing the pellet by using a pipette. The RNA pellet was 
dried briefly for about 5 minutes by turning the tube up side down and put on a 
paper towel. Once the RNA pellet dried but was not completely dry, 10-30 ~ I I
of DEPC-treated water (Invitrogen, CA, USA) was added to the sample. Then 
the sample was mixed and centrifuged for a few seconds. 1.2 ~ l l of RNA 
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sample was analysed for RNA concentration usmg a Nanodrop 1000 
Spectrophotometer (Thermo Fisher Scientific, DE, USA) and recorded 260/280 
values were used to confirm the purity of samples. The RNA sample could be 
stored at -80°C. 
3.2.2.3 First-strand complementary deoxyriboneuclease (cDNAJ 
synthesis 
RNA purification was preceded by elimination of DNA usmg 
Deoxyribonuclease I, Amplification Grade (DNase I, Amp Grade) (Invitrogen, 
CA, USA) prior to RNA-PCR amplification. 3 Jlg RNA sample, 2 I.d DNase I 
(Amp Grade, 1 U/I.d) and 1.5 JlI lOX DNase I reaction buffer were added into a 
1.5 - 2 rnl eppendorf and then DEPC-treated water (Invitrogen, CA, USA) was 
added to make 15 Jll. The sample was thoroughly mixed and centrifuged for a 
few seconds and then was incubated for 40 minutes at room temperature to 
deactivate DNA. The sample was heated for 10 minutes at 65°C to reactivate 
RNA and the sample was ready to use in reverse transcription, prior to 
amplification. After DNA purification, the concentration of the sample would 
be 200 ng/Jll. 
For cDNA synthesis, duplicate 0.5 rnl eppendorfs are prepared for positive and 
negative reverse transcriptase samples which are used in the amplification 
reaction. For 20 Jll reaction volume, 1 JlI random primer (Promega, WI, USA), 
1 Jll 10 mM deoxyribonucleoside triphosphate (dNTP) mix (Promega, WL 
USA) and 2 Jlg RNA for the positive reverse transcriptase sample or 1 Jlg RNA 
for the negative reverse transcriptase sample were added into the eppendorf 
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and then added DE PC-treated water (Invitrogen, CA, USA) to 13 J..ll. Before 
incubation, the sample was mixed thoroughly and then centrifuged for a few 
seconds. The sample was heated for 5 minutes at 65°C and incubated on ice for 
at least 1 minute. The sample was centrifuged for a few seconds. The sample 
was mixed with 4 J..lI 5X first-strand buffer (Invitrogen, CA, USA), 1 J..lI 0.1 M 
dithiothreitol (DIT) (Invitrogen, CA, USA) and 1 J..lI superscript III reverse 
transcriptase (Invitrogen, CA, USA) was added to the positive reverse 
transcriptase sample (omitted from the negative reverse transcriptase sample). 
The sample was mixed by pipetting gently up and down and centrifuged for a 
few seconds. After that, the sample was incubated for 5 and 45 minutes at 25°C 
and 50°C respectively. For inactivating the reaction, the sample was heated for 
15 minutes at 70°C. The sample was centrifuged for a few seconds and then 
could be used as a template for amplification or stored at -20°C. The 
concentration of the sample would be 100 mg/Ill. 
3.2.2.4 Reverse transcriptase poly1tU!rase chain reaction (RT-PCR) 
For a 10 J..lI reaction, 1 III IOX High yield reaction buffer with 25 mM MgClz 
(Buffer A) (Kapabiosystems, MA, USA), 0.8 III 10 mM dNTP 
(Deoxyribonucleotide triphosphate) mix (Promega, WI, USA), 0.1 5U/IlI 
KapaTaq DNA polymerase (Kapabiosystems, MA, USA), 0.2 J..lII0 J..lM p-actin 
forward primer (Eurotins MWG Operon, Ebersberg, Germany) or mouse Sox2 
forward primer (Eurotins MWG Operon, Ebersberg, Germany), 0.2 J..lI 10 IlM 
p-actin reverse primer (Eurofins MWG Operon, Ebersberg, Germany) or 
mouse Sox2 reverse primer (Eurotins MWG Operon, Ebersberg, Germany), 
6.7 J..lI HPLC water (Invitrogen, CA, USA) and 1 J..lI cDNA (100 J..lg/IlI for 
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positive reverse transcriptase sample and 50 ~ g I ~ 1 1 for negative reverse 
transcriptase sample) were added into an RNase-free, 0.5 ml microcentrifuge 
tube. The sample was heated for 10 minutes at 95°C to denature the double 
strand melts open to single stranded DNA. For the amplification, the sample 
was firstly denatured at 95°C for 30 seconds. In the annealing step, the 
temperature was lowered to 60°C for 30 seconds allowing the primer to bind to 
the single-stranded DNA. After annealing, Tag polymerase synthesized a new 
DNA strand complementary to the DNA template strand by adding dNTPs at 
72°C for 45 seconds. These reactions were performed for 35 cycles. Then the 
PCR products were ready for agarose gel electrophoresis. 
Table 3.1 Summary oftinal concentration of 10 J.1I RT-PCR reaction 
Components Volume (pi) Final concentration 
HPLC water 6.7 -
10mMdNTP 0.8 0.8 mM 
1 0 ~ M M Forward primer 0.2 200nM 
1 0 ~ M M Reverse primer 0.2 200nM 
5 U / ~ I I KapaTaq polymerase 0.1 0.05 U / ~ I I
10X Buffer (A) I IX 
25mMMgCh - 2.5 mM 
1 00 n g l ~ 1 1 cDNA 1 100 nglreaction 
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Table 3.2 Nucleotide sequence of the forward and reverse primers for 
qPCR in mouse hippocampal NSCs 
Gene name Gene identity primers (5'-3') Total 
mNestinRTF CGC TGG AAC AGA GAT TGG AAG G (22 bp) 376 bp 
mNestinRTR GTC TCA AGG GTA TTA GGC AAG (21 bp) 
mSox2qF AGG GCT GGG AGA AAG AAG AG (20 bp) 94 bp 
mSox2qR CCG CGA TTG TTG TGA TTA GT (20 bp) 
mMycQF AGC CCC TAG TGC TGC ATG A (19 bp) 110 bp 
mMycQR TCC ACA GAC ACC ACA TCA A TT TC (23 bp) 
clath up GAC AGT GCC ATC ATG AAT CC (20 bp) 600 bp 
clath dn TIT GTG CTT CTG GAG GAA AGA A (22 bp) 
GAPDH f-GGG TGG AGC CAA ACG GGT C (19 bp) 500bp 
r-GGA GTT GCT GTT GAA GTC GCA (21 bp) 
18s rRNAF GGT CCG ACC ATAAAC GAT GCC (21 bp) 130bp 
18s rRNA R TGG TGG TGC CCT TCC GTC AAT (21 bp) 
Notchl F TCAATGCCGTGGATGACCTA 100bp 
Notchl R CCTTGITGGCTCCGITCTTC 
3.2.2.5 Agarose gel electrophoresis 
The PCR products were analyzed on 1.4% (w/v) an agarose gel, dissolved 0.7 g 
of agrose (Invitrogen, CA, USA) in 50 ml of IX Tris-Acetate-EDTA (TAB) 
buffer (Appendix AI.5) by heating to boiling in a microwave. After that, 5 III 
of ethidium bromide (10 mg/ml, Sigma-Aldrich, Inc, St.Louis, USA) was 
added into the gel solution to get a final concentration of 0.1 Ilg/ml. The gel 
solution was poured into a casting tray and a comb was placed into the gel to 
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create wells. The gel was allowed to solidify before removing the comb. After 
gel casting, the gel was submerged into Ix T AE buffer. Before loading, 1 III of 
5x gel-loading buffer (New England Biolabs) was added into the PCR 
products. 1 kb or 100 bp (New England Biolabs) (200 ng) were run alongside 
the PCR products to identify sizes of PCR products of interest. 8 III of the PCR 
products were loaded into the wells. The gel was run in 1 X T AE buffer in an 
electrophoresis tank (BIO-RAD Laboratories, Hertfordshire, UK). The gel was 
run in 1 X T AE buffer at 120 V for 10 minutes and then visualized in a 
MultiMage light cabinet and photographed using an AlphaImager 1220 
Documentation & Analysis System (Alpha Innotech Corporation). 
3.2.2.6 Selection of suitable reference genes 
Quantitative PCR was performed in a volume of 25 Ill/reaction. 12.5 III 
Brilliant SYBR Green QPCR Master Mix (Stratagene, Aligent Technologies 
Company, CA, USA), 0.375 III 10 IlM GAPDH forward primer (Eurofins 
MWG Operon, Ebersberg, Germany) or 0.375 III 10 IlM 18s forward primer 
(Eurofins MWG Operon, Ebersberg, Germany) or c1athrin forward primer 
(Eurofins MWG Operon, Ebersberg, Germany), 0.375 III 10 IlM GAPDH 
reverse primer (Eurofins MWG Operon, Ebersberg, Germany) or 18s reverse 
primer (Eurofins MWG Operon, Ebersberg, Germany) or c1athrin reverse 
primer (Eurofins MWG Operon, Ebersberg, Germany), 0.375 III 20 IlM Rox 
reference dye (Stratagene, Aligent Technologies Company, CA, USA), 10.9 III 
HPLC water (Invitrogen, CA, USA) and 0.5 III 100 Ilg/Ill cDNA sample were 
added into an RNase-free, 0.5 rn1 microcentrifuge tube. The reaction was 
divided into three segments. Firstly, the reaction mixture was heated to 95°C 
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for 10 minutes. Secondly, the reaction mixture was performed in 40 
amplification cycles of denaturation at 95°C for 30 seconds, annealing at 60°C 
for 30 seconds and extension at 72°C for 45 seconds. Finally, the mixture was 
incubated at 95°C, 55°C and 95°C for 1 minute, 30 seconds and 30 seconds, 
respectively. All qPCRs were performed in triplicate using the Mx3005p qPCR 
system (Stratagene, Aligent Technologies Company, CA, USA). 
Table 3.3 Summary of final concentration of 25 pi qPCR reaction 
Components Volume (pi) Final concentration 
HPLC water 10.9 
-
2X Master mix 12.5 IX 
10 IlM Forward primer 0.375 150nM 
10 IlM Reverse primer 0.375 150nM 
20 IlM Rox reference dye 0.375 300nM 
100 ng/IlI cDNA 0.5 50 ng/reaction 
3.2.2.7 Effect of VPA on Notch}, Sox2, nestin and c-Myc gene 
expressions using qPCR 
The 25 III of PCR mixture included 12.5 III Brilliant SYBR Green QPCR 
Master Mix (Stratagene, Aligent Technologies Company, CA, USA), 0.375 III 
10 IlM 18s forward primer (Eurofins MWG Operon, Ebersberg, Germany) or 
mouse Notchl forward primer (Eurofins MWG Operon, Ebersberg, Germany) 
or mouse Sox2 forward primer (Eurofins MWG Operon, Ebersberg, Germany) 
or mouse Nestin forward primer (Eurofins MWG Operon, Ebersberg, 
Germany) or mouse c-Myc forward primer (Eurofins MWG Operon, 
124 
Ebersberg, Germany), or 18s reverse pnmer (Eurofins MWG Operon, 
Ebersberg, Germany) or mouse Notchl reverse primer (Eurofins MWG 
Operon, Ebersberg, Germany) or mouse Sox2 reverse primer (Eurofins MWG 
Operon, Ebersberg, Germany) or mouse Nestin reverse primer (Eurofins MWG 
Operon, Ebersberg, Germany) or mouse c-Myc reverse primer (Eurofins MWG 
Operon, Ebersberg, Germany), 0.375 J..ll 20 J..lM Rox reference dye (Stratagene, 
Aligent Technologies Company, CA, USA), 10.9 J..ll HPLC water (Invitrogen, 
CA, USA) and 0.5 J..ll 100 J..lg/1l1 cDNA sample. All qPCRs were performed in 
triplicate. The reaction was performed as described earlier (section 3.2.3.6, 
chapter 3). The expression of each gene was normalized to 18s in order to 
calculate relative levels of transcript. 
3.2.3 Statistical analysis 
The data were expressed as mean ± SEM and analyzed by GraphPad Prism 
Version 4.03 (GraphPad Software Inc., USA). Statistical analysis was 
performed using one-way ANOV A followed by the Bonferrini's multiple 
comparison test. The significant level was set atp < 0.05. 
Prior to qPCR analysis, all the samples were assessed cDNA quality using gel 
electrophoresis. Discrete intact RNA bands should be observed in the RT -PCR 
products but not the no RT-PCR products. This would verify that all the 
samples were not contaminated with genomic DNA. 
In qPCR experiments, it was necessary to quantify reference gene as 
normaliser gene side-by-side with the gene of interest. The results were 
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calculated as relative quantity to the control, where the control sample was 
assigned an arbitrary quantity of "1" and all the other samples were examined 
in terms of their difference to this sample. This was done in accordance with 
previous publications and the manufacturer instructions (Stratagene, Aligent 
Technologies Company, CA, USA). 
For accurate data analysis and meaningful statistics, negative controls known 
as no template control (NTC) were determined in every run. Ideally, signal 
amplification should not be detected in the NTC sample wells. NTCs were 
provided to control for external contamination or other factors that could result 
in a non-specific increase in the fluorescence signal. 
At the end of the amplification reaction, qPCR products from each sample 
were run as a melting curve, also known as dissociation curve, to determine 
whether anything other than the gene of interest was amplified in the qPCR 
reaction. Most qPCR products would melt somewhere in the range of 80 -
90°e. Ideally, the melting temperature should be the same in all the reactions 
where the samples were amplified. If any secondary peaks or shoulders were 
seen on the peak of interest, it indicated that something other than the gene of 
interest was present among the reaction products. If these secondary peaks 
were present in the NTC wells, it might indicate primer dimer formation or the 
present of contamination by a sequence that was also amplified during the 
reaction. Since primer dimers would typically have a lower melting 
temperature and smaller peak. All melting curves showed a single peak. 
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3.3 Results 
3.3.1 VPA reduced cell proliferation of adult rat hippocampal NSCs 
In the present study, hippocampal neurospheres and NSCs were quantified in 
order to investigate the effect of VP A treatment on cell proliferation of adult 
rat hippocampal NSCs. Rat hippocampal NSCs were cultured and treated with 
either 0.3 or 1 mM VPA for 72 hours. Following the treatment, the numbers of 
floating sphere colonies (neurospheres) were counted (Fig. 3.5). Neurosphere 
formation of adult rat hippocampal NSCs was reduced by VP A (0.3 and 1 mM) 
to 44% and 10%, respectively. The results showed that there was a significant 
difference among the experimental groups (p < 0.001, one-way ANOVA, Fig. 
3.4 A). Comparison of treatment groups with control group, VPA treatment 
significantly decreased the rate of neurosphere-forming NSCs in a dose 
responsive manner compared to control culture ("''''''' p < 0.001, one-way 
ANOVA, Fig. 3.4 A). 
Following quantification of hippocampal neurospheres, the neurospheres were 
triturated into single cells and then counted to investigate cell proliferation of 
adult hippocampal NSCs. Total number of single cells was 27% and 3%, 
respectively, when 0.3 and 1 mM VPA were added for 72 hours compared to 
untreated culture. The hippocampal NSC numbers in 0.3 and 1 mM VPA 
treatment groups showed a significant decrease in comparison to untreated 
culture ("''''''' p < 0.001, one-way ANOVA, Fig. 3.4 B). The results also 
revealed that comparison of total numbers of NSCs was significantly different 
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in a dose-dependent manner among the experimental groups (p < 0.001 , one-
way ANOVA, Fig. 3.4 B). 
In addition, the average of NSC number per neurosphere showed a significant 
decrease among experimental groups (p < 0.0001 , one-way ANOVA, Fig. 3.3) 
Moreover, the number of NSCs per neurosphere significantly decreased in a 
concentration dependent fashion between 0.3 and 1 mM VPA in comparison to 
control group (*p < 0.01 and ** p < 0.001 respectively, one-way ANOVA, Fig. 
3.3). 
These results indicated that VPA reduced neurosphere formation , total number 
of single cells and number ofNSCs per neurosphere in a concentration manner. 
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Figure 3.3 The effects of VPA on number of NSCs per neurosphere. 
Comparing the number of NSCs per neurosphere among experimental groups, 
there was a significant decrease (p < 0.0001). The number of NSCs per 
neuIOsphere showed a significant reduction in dose-dependent manner in 0.3 
and 1 mM VPA treatment groups compared with untreated culture (* *p < 0.01 
and *** p < 0.001 , respectively). All statistic analysis was assessed using one-
way ANOVA. 
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Figure 3.4 The effects of VP A treatment on cell proliferation of adult rat 
hippocampal NSCs. CA) Comparison of the effect of VPA treatment on adult 
rat hippocampal neurosphere numbers. Total number of neurosphere-forming 
NSCs showed a significant among experimental groups (p < 0.001). There 
were also a significant reduction the numbers of neurospheres in a dose 
responsive manner in 0.3 and 1 mM VPA treatment groups compared with 
untreated culture (*** p < 0.001). (B) The effect ofVPA on hippocampal NSC 
proliferation was concentration dependent. 0.3 and 1 mM VPA-treated cultures 
revealed a significant decrease in number of hippocampal NSCs in comparison 
to untreated culture (*** p < 0.001). Comparing total hippocampal NSC 
number of all experimental groups showed that there was a significant 
difference (p < 0.001). All statistic analysis was assessed using one-way 
ANOVA. 
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Figure 3.5 Phase contrast photomicrographs ill ustrating the effect of VP A on 
neurosphere formation of adult rat hippocampal NSCs. Photographs of 
neurosphere-forming NSCs treated with 0 mM VPA or untreated culture (A), 
neurosphere-forming NSCs treated with 0.3 mM VPA (B) and neurosphere-
forming NSCs treated with I mM VPA (C). 
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3.3.2 VPA reduced cell proliferation of adult mouse hippocampal NSCs 
Following 48 hours VPA treatment, the neurospheres (Fig. 3.7) were triturated 
into single cells and then counted to investigate cell proliferation of adult 
hippocampal NSCs. At 0.3 and 1 mM adult mouse hippocampal NSC viability 
was reduced to approximately 29% and 19%, respectively. The hippocampal 
NSC numbers in 0.3 and 1 mM VP A treatment groups showed a significant 
decrease in comparison to untreated culture (## p < 0.01 and ** p < 0.01 , 
respectively, one-way ANOVA, Fig. 3.6). The results also revealed that 
comparison of total numbers of mouse hippocampal NSCs was significantly 
different in a dose-dependent manner among the experimental groups (p < 
0.0008, one-way ANOVA, Fig. 3.6). 
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Figure 3.6 The effect of VPA on adult mouse hippocampal NSC proliferation 
was concentration dependent. Comparing total hippocampal NSC number of all 
experimental groups revealed that VPA treatment statistically significant 
decreased cell proliferation (p = 0.0008). There was a statistically significant 
reduction in number of hippocampal NSCs in 0.3 and 1 mM VPA-treated 
cultures in comparison to untreated culture (## p < 0.01 and ** p < 0.0 I, 
respectively). All statistic analysis was assessed using one-way ANOV A. 
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Figure 3.7 Phase contrast photomicrographs illustrating the effect of VP A on 
neurosphere formation of adult mouse hippocampal NSCs. Photographs of 
neurosphere-forming NSCs treated with 0 mM VPA or control culture (A), 
neurosphere-forming NSCs treated with 0.3 mM VPA (B) and neurosphere-
forming NSCs treated with 1 mM VPA (C). 
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3.3.3 p-actin and Sox2 gene expression using RT-PCR 
All cDNA samples were checked to investigate the quality of the cDNA 
preparation. This was achieved by comparing the RT-PCR with a no RT, PCR 
reaction to determine rnRNA expressions of p-actin and Sox2 in each sample. 
The results showed that the mRNA expressions of p-actin and Sox2 in all 
positive reverse transcriptase samples were detected at 500 and 94 bp 
respectively but not the negative reverse transcriptase samples (Fig. 3.8 and 
3.9). These results indicate that all samples were not contaminated with 
genomic DNA. 
Figure 3.8 Expressions of p-actin in adult mouse hippocampal NSC samples 
from three treatments. The positive reverse transcriptase samples were detected 
at 500 bp. By contrast, no p-actin was detected in the negative reverse 
transcriptase samples. 
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Figure 3.9 Expressions of Sox2 in adult mouse hippocampal NSC samples 
from three treatments. The positive reverse transcriptase samples were detected 
at 94 bp whereas the negative reverse transcriptase samples were not detected. 
134 
3.3.4 Expression of reference genes following VPA treatment in adult nwuse 
hippocampal NSCs using qPCR 
The three reference genes displayed a different range of threshold cycle (Ct) 
values (Fig. 3. lOA) and dissociation curve (Fig. 3.108). The dissociation curve 
plot of these genes showed three fluorescence peaks: 18s rRNA, centred 
approximately 84°C; GAPDH, centred approximately 86°C and c1athrin, 
centred approximately 80T (Fig. 3.108). Comparative quantitation of levels of 
Ct value of 18s rRNA, GAPDH and clathrin between untreated or control 
samples and VPA-treated samples were performed using comparative 
quantitation module in the MxPrOTM software (Stratagene, Aligent 
Technologies Company, CA, USA). Then, the data was shown as Ct value of 
each reference gene (Figure 3.10). There was no statistically significant 
difference of Ct values of GAPDH and clathrin genes between control and 
VP A-treated samples (p > 0.05, one-way ANOV A, Fig. 3.11). Similarly, Ct 
values of 18s rRNA remained unaffected in both the control (untreated) as well 
as VPA-treated samples (p> 0.05, one-way ANOVA, Fig. 3.11). These genes 
were not affected by treatment with VP A, indicating tolerance to cellular 
activation and experimental conditions. However, expression of 18s rRNA 
showed the greatest consistency in different samples as compared to GAPDH 
and clathrin (Fig. 3.11). Therefore, 18s rRNA was chosen as the most suitable 
reference gene for gene expression profile in this study. This is in line with a 
report demonstrated that 18s rRNA is suitable reference gene for use as internal 
control for relative gene expression quantification (Saviozzi et al., 2006). 
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Figure 3.10 Amplification plots and dissociation curve of the three reference 
genes following VPA treatment in adult mouse hippocampal NSCs. (A) Ct 
values for each reference gene were shown in a different range. (B) 
Dissociation temperature of each gene was displayed without any primer dimer 
contamination and unintended amplification products. 
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Figure 3.11 Quantitative PCR analysis of reference genes following VPA 
treatment in NSCs. Levels of Ct values of 18s rRNA (p > 0.05), clathrin (p > 
0.05) and GAPDH (p > 0.05) show no significant differences between control 
(untreated) and treated samples. The data shown here represents the average of 
three different experiments performed each sample in triplicate using the same 
conditions. All statistic analysis was assessed using a one-way ANOV A. 
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3.3.5 The effect of VPA treatment on Notchl gene expression in adult nwuse 
h i p p o c a ~ a l N S C S S
To investigate the role ofVPA in Notchl gene expression ofneurosphere-like 
NSCs, the amount of Notch I and 18s rRNA mRNA was quantified after 48 
hours of VP A treatment. Using qPCR, the results of amplification plots of Ct 
values and dissociation curves are shown in Figure 3.13. These results showed 
no amplification signals in the NTC (no template controls) wells. At the end of 
amplification reaction, all the samples were run a melting curve known as 
dissociation curve to determine if anything other than the gene of interest was 
amplified in the qPCR reaction. The results obtained from dissociation curve 
showed two fluorescence peaks of Notch I (centred around 83"C) and 18s RNA 
(centred around 84°C), indicating that there was no primer-dimer or some other 
non-specific product contamination in this experiment. For the comparative 
quantification of mRNA of Notchl expressions, Ct values of Notchl were 
normalized to 18s rRNA and then presented as relative quantity expressions 
(Fig. 3.12). Levels of Notchl expression revealed statistically significant 
difference between these experimental groups (p < 0.0001, one-way ANOVA, 
Fig. 3.12). Bonferroni's multiple comparison tests confirmed that levels of 
Notch I gene expression in hippocampal NSCs exposed to I mM VP A was 
statistically significant lower than the untreated cells (p < 0.001, one-way 
ANOVA, Fig. 3.12). In contrast, Notchl gene expression in 0.3 mM VPA-
treated cells was not different from the untreated cells (p > 0.05, one-way 
ANOVA, Fig. 3.12). 
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Figure 3.12 Effects of VPA on Notchl gene expressIOn In adult mouse 
hippocampal NSCs. Levels of Notch 1 expression revealed statistically 
difference between these experimental groups (### p < 0.0001). The effect of 
VPA on Notch1 mRNA levels differed significantly between 1 mM VPA-
treated and control samples (p < 0.001). In contrast, there was no significant 
difference between 0.3 mM VPA and untreated samples (p > 0.05). The data 
showed the average of relative quantity expression from 3 experiments 
performed each sample in triplicate using the same conditions. Statistical 
significance was determined using one-way ANOV A. 
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Figure 3.13 Amplification plots (A) and dissociation curve (B) of Notch 1 and 
18s rRNA genes following VPA treatment in adult mouse hippocampal NSCs. 
When the amplified products of Notch1 and 18s rRNA were sUbjected to 
dissociation curve analysis, the fluorescence peaks were detected 
approximately at 83 °C and 84°C respectively. 
140 
3.3.6 Effects of VPA Sox2 gene expression in mouse hippocampal NSCs 
Comparative quantification of Sox2 mRNA and 18s rRNA in adult mouse 
hippocampal NSCs was determined following 48 hours of VP A treatment. 
Amplification plots of Ct value and dissociation curves are displayed in Figure 
3.15. The amplification curve did not show an amplification signal in the NTC 
wells showing no contamination. The dissociation curve analysis of PCR 
products amplified in the presence test showed two fluorescence peaks of Sox2 
and 18s rRNA centred around 77°C and 84 CC respectively. These verified that 
the results were free from the signal of primer-dimers or other non-specific 
products. Relative quantification expressions of Sox2 normalized to the 18s 
rRNA reference gene, showed a statistical difference between the control 
(untreated) and VPA-treated hippocampal NSCs (p = 0.0002, one-way 
ANOV A, Fig. 3.l4). There was a significant decrease in Sox2 expression in 
NSCs derived from the hippocampus treated with 1 mM VP A compared to 
untreated cells (p < 0.05, one-way ANOVA, Fig. 3.14) while Sox2 expression 
in hippocampal NSCs treated with 0.3 mM VP A was not significantly different 
from untreated cells (p> 0.05, one-way ANOVA, Fig. 3.14). 
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Figu.re 3.14 Effects of VPA on Sox2 gene expression determined by qPCR 
Levels of Sox2 expression revealed a statistical difference between these 
experimental groups (p = 0.0002). 1 mM VPA produced a significant reduction 
of Sox2 mRNA levels in hippocampal NSCs compared to control cells (* p < 
0.05). Conversely, Sox2 gene expression was not affected in 0.3 VPA-treated 
samples as compared to the control samples (p > 0.05). The data showed the 
average of relative quantity expression from 3 experiments performed in 
triplicate using the same conditions. All statistic analysis was assessed using 
one-way ANOV A. 
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Figure 3.15 Quantitative PCR amplification plots (A) and dissociation curve 
(B) of a reaction with Sox2 and 18s rRNA genes following VP A treatment in 
adult mouse hippocampal NSCs. The amplified products of Sox2 and 18s 
rRNA were melted approximately at 77°C and 84°C respectively. 
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3.3.7 VPA down-regulates nestin gene expression in adult mouse 
hippocampal NSCs 
Determination of the effect of VP A on nestin gene expression in adult mouse 
hippocampal NSCs is shown in amplification and dissociation plots (Fig. 3.17). 
After completion of dissociation, two fluorescence peaks were observed: nestin 
in the reaction centred around 85°C and 18s rRNA centred around 84°C (Fig. 
3.17). Non-specific amplification signal was not observed in NTC wells. These 
results indicated that non-specific amplification, which might affect the quality 
of amplification data, was not detected in these reactions. Comparison of 
relative quantitative expression of nestin mRNA after normalization to 18s 
rRNA demonstrated a statistically significant difference between these 
experimental groups (p < 0.0001, one-way ANOVA, Fig. 3.16). Nestin mRNA 
levels were significantly reduced in 1 mM VP A-treated samples as compared 
to the control samples (p < 0.001, one-way ANOV A, Fig. 3.16) whereas nestin 
mRNA remained unaffected in 0.3 mM VPA-treated samples in comparison 
with the control samples (p > 0.05, one-way ANOV A, Fig. 3.16). 
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Figure 3,16 Effects of VP A on nestin gene expressIOn In aduJt mouse 
hippocampal NSCs. Significant difference in nestin gene expression was 
detected in these experimental groups (p < 0.0001). The effect of VPA on 
nestin mRNA levels differed significantly between 1 mM VPA-treated and 
control samples (*** p < 0.001). In contrast, there was no significant difference 
between 0.3 mM VPA and control samples (p > 0.05). The data showed the 
average of relative quantity expression from 3 experiments performed in 
triplicate using the same conditions. Statistic significance was determined 
using one-way ANOV A. 
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Figure 3.17 Amplification plots (A) and dissociation curve (B) of detection of 
nestin and 18s rRNA gene expression following VP A treatment in adult mouse 
hippoacampal NSCs using qPCR. The fluorescence peaks of nestin and 18s 
rRNA were detected approximately at 85 °C and 84°C respectively. 
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3.3.8 Effects of VPA on c-Myc gene expression in adult nwuse hippocampal 
NSCs 
The action of VPA in influencing c-Myc gene expression of NSCs was 
determined using qPCR. Fluorescence signals from the PCR reactions were 
monitored in real-time, Ct values of c-Myc and 18s rRNA were displayed as an 
amplification plot (Fig. 3. 19A), which reflected in fluorescence during cycling. 
The dissociation curve was shown two fluorescence peaks centred around 81 T 
(c-Myc) and centred around 84 DC (18s rRNA), indicating that no primer-dimers 
or non-specific amplification would artificially increase fluorescence. The 
expression of c-Myc gene was normalized to 18s rRNA reference gene in order 
to calculate relative levels of transcription. The results showed no statistically 
difference between the control (untreated) hippocampal NSCs and VPA-treated 
hippocampal NSCs (p = 0.0522, one-way ANOVA, Fig. 3.18). 
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Figure 3.18 Effects of VPA on c-Myc gene expressIon In adult mouse 
hippocampal NSCs. c-Myc gene expression was not affected in 0.3 and 1 mM 
VPA-treated samples as compared to the control samples (p = 0.0522). The 
data showed the average of relative quantity expression from 3 experiments 
performed in triplicate using the same conditions. Statistical significance was 
determined using one-way A av A. 
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Figure 3.19 Amplification plots CA) and dissociation curve (B) of c-Myc and 
18s RNA genes were detected in VPA-treated hippocampal NSCs by qPCR. 
The amplified products of c-Myc and 18s rRNA were melted approximately at 
81 0 e and 84°e respectively. 
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The results show that VP A produced a dose dependent reduction in cell 
proliferation in mouse and rat hippocampal derived NSCs. Furthermore, VP A 
did not affect the expression of the house keeping genes GPDH, 18s and 
clatherin. At higher dose VP A reduced Notch 1, Sox2 and nestin expression but 
did not affect c-Myc expression. 
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3.4 Discussion 
The chronic VPA administration in the previous chapter showed a significant 
decrease of cell proliferation in the SGZ of the dentate gyrus together with 
decreases in BDNF and Notch 1 levels which were correlated with poorer 
performance in a spatial memory test. The present chapter sought to investigate 
whether VP A was having a direct effect on hippocampal neural stem cells 
isolated from the influences that might be coming from surrounding tissues. 
Two concentrations (0.3 and 1 mM) of VPA were used to treat cells. Both 
concentrations are within the human therapeutic range (50 - 150 mg/l or 0.35 -
1.04 mM) (Hao et al., 2004). Even the higher concentration has been reported 
as being non toxic to progenitor cells in the hippocampus (Jung et al., 2008). 
The results show that VPA (0.3 and 1 mM) inhibited hippocampal neurosphere 
formation and cell proliferation in a concentration-dependent manner (Fig. 3.5 
and 3.7). Additionally, 1 mM VPA reduced levels of Notch 1 , Sox2 and nestin 
mRNA expression but not 0.3 mM VPA. In contrast, both 0.3 and 1 mM VPA 
had no effect on levels of c-Myc mRNA expression. 
VPA inhibited adult hippocampal neural stem cell (NSC) proliferation 
The results show that VPA inhibited hippocampal neurosphere formation and 
cell proliferation in a concentration-dependent manner (Fig. 3.5 and 3.7). This 
result was obtained with both mouse and rat hippocampal NCSs. VP A is well 
known to inhibit cell proliferation in vitro (Takai et al., 2004). Other 
investigators have shown an effect in both cerebral cortex derived cells and 
hippocampal NCSs at 0.3 and 1 mM (Jung et al., 2008, Hsieh et al., 2004). In a 
non-toxic concentration (1 mM) to the hippocampal progenitor cells ofVPA, it 
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has been recently shown that VP A treatment for 48 hours decreases cerebral 
cortex progenitor cell proliferation (JWlg et al., 2008). Moreover, there is a 
dramatic reduction of hippocampal neuronal progenitor cells treated with 1 
mM VPA for 24 hours in comparison with untreated cells (Hsieh et al., 2004). 
These data fit well with the results of the present study which shows an 
inhibition of neurosphere formation (Fig. 3.5 and 3.7) and also a reduction of 
cell proliferation of hippocampal NSCs after exposure to VPA in a dose 
dependent manner. The previous study revealed that VPA caused a significant 
decrease of dividing cells in the hippocampal dentate gyrus (section 2.2.4, 
Chapter 2), which is in line with a report showing that VPA (300 mglkg) 
induces cell proliferation inhibition of adult hippocampal neural progenitor 
cells in vivo (Hsieh et al., 2004). In culture, VPA has been reported to 
gradually decrease embryonic stem cell proliferation in a dose-dependent 
manner by inhibiting HDACs (Murabe et al., 2007). Inhibition of histone 
deacetylation in vitro and in vivo has been fOWld to suppress cell proliferation 
and that this effect is associated with hyperacetylation of histones. This causes 
chromatin relaxation and compaction, leading access to promoter DNA for 
transcriptional activators and consequently, activation of gene expression 
(Murabe et al., 2007, Mai et al., 2005, Hsieh et al., 2004). In addition, VPA 
regulates cell proliferation in neuronal progenitor cells via p21 pathway which 
is a common target of transcription protein expression for HDAC inhibitor 
(JWlg et al., 2008, Hsieh et al., 2004, Yu et al., 2009). NSCs are precursor cells 
that generate granule cells in the adult dentate gyrus. Adult newly generated 
granule neurons are not only functionally incorporated with hippocampal 
circuits and existing granule neurons but also express gene and protein known 
152 
to play a crucial role in synaptic plasticity related to memory formation 
(Emsley et al., 2005, Bruel-Jungerman et al., 2007, Gould et al., 1999). The 
present study shows that exposure of adult hippocampal progenitors to VP A 
directly reduces their proliferation, independent of effects on surrounding 
tissues. This reduction in one of the stages of neurogenesis may therefore 
explain the cognitive impairment found after in vivo treatment. In vitro 
treatment reduced the number of neurospheres forming and also reduced their 
size. This may indicate that VP A is toxic to progenitor cells and inhibits their 
proliferation. 
Levels of Notch} gene expression in adult mouse hippocampal NSCs was 
decreased by higher concentrations of VPA 
The present study demonstrates that I mM VP A treatment significantly 
decreased levels of receptor Notch I gene expression in hippocampal NSCs 
while 0.3 mM VPA did not show a reduction of Notchl gene expression 
compared to untreated cells (Fig. 3.12 and 3.13). This result does not seem to 
be due to a non specific reduction in genome transcription as both house 
keeping and Sox2 and Nestin expression is unaffected by this concentration of 
VPA. The reduction in Notchl expression in NSCs parallels the reduction in 
Notch) protein found in vivo after VPA treatment (Chapter 2). The in vivo 
study looked at Notch I levels in the whole hippocampal formation. However 
Notch I is expressed both by proliferating NSCs in the SGZ and on the 
molecular layer dendrites of postmitotic granule cells (Breunig et al., 2007) 
making it difficult to know whether VPA is affecting Notchl on dividing or 
post-mitotic cells. The Notch signal is important in proliferation, apoptosis and 
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differentiation and is transmitted through the Notch cell swface receptor in 
combination with other cellular factors (Artavanis-Tsakonas et al., 1999). 
According to some reports, Notch 1 activation is essential for the maintenance 
and generation mammalian NSCs (Oishi et al., 2004, Chojnacki et al., 2003, 
Nyfeler et al., 2005). During neural development, Notch pathway is 
importantly involved in maintaining multipotency (Tokunaga et al., 2004, 
Kohyama et al., 2005). Moreover, it has been revealed that Notchl prevents 
neural differentiation and maintains neural precursor and stem cell proliferation 
in order to regulate neurogenesis and cell fate determination (Breunig et al., 
2007, Wang et al., 2004, Hitoshi et al., 2002). In addition, it has been found 
that Notch 1 signalling regulates NSC self-renewal and promotes survival of 
neural progenitor cells (Hitoshi et al., 2002, Potten et al., 2006). Notch 
signalling has been found to be involved in regulating of maintenance and 
proliferation of NSCs by their density in culture (Mori et al., 2006). Notch is 
known to inhibit neuronal differentiation and maintain neural stem cells by 
forming complex with RBP-J and then this complex becomes a transcriptional 
activator and induces Hesl and Hess expression (Kageyama et al., 2005). 
Notch signalling is mediated through expression of effector genes from the 
lIES family. Hes genes control NSC maintenance and self-renewal by 
repressing proneuronal genes, such as Mash 1 , Math and Neurogenin (Ngn) (Qu 
and Shi, 2009). Notch signalling also controls NSC maintenance, self-renewal 
and differentiation by mediating the membrane-associated protein Numb (Qu 
and Shi, 2009). In NSCs, however, induction of Hes genes by RBP-Jk 
mediated Notch 1 activation maintains stem cell character and inhibits 
neurogenesis (Shimizu et al., 2008). Recent evidence indicates that the absence 
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of Notch signalling pathway promotes a decrease of dividing cells and 
premature differentiation of the early-born cell types (Kageyama and Ohtsuka, 
1999). Disruption of Notchl expression inhibits neurogenesis by impairing 
survival of neural progenitor cells, causing apoptosis (Crews et al., 2008). 
Notch, RBP-Jk and Hes genes function to maintain dividing precursor cells by 
inhibiting cell differentiation (Kageyama and Ohtsuka, 1999). Unlike a 
reduction of Notch 1 expression, induction of Notch 1 gene expression enhances 
the rate cell proliferation of NSCs (Zhang et al., 2008). In cultures, activations 
of Notch 1 are essential for promoting self-renewal and cell proliferation to 
form neurospheres in rodents (Kohyama et al., 2005, Chen et al., 2008). In 
contrast, ablation of Notch 1 signalling by a y-secretase inhibitor or use of 
deficient in PS 1 mice impairs neurosphere formation (Chen et al., 2008). Taken 
together, a reduction of Notch 1 gene expression in the hippocampal NSCs 
caused by 1 mM VP A in the present study might impair survival and self-
renewal of hippocampal NSCs. Furthermore, it might inhibit neurogenesis and 
induce cell differentiation. Notchl expression in neuroendocrine cells was also 
induced by VPA as discussed in Chapter 4. 
Levels of nestin gene expression in adult mouse hippocampal NSCs were 
reduced by higher concentrations of VPA 
This study shows that VP A (I mM) significantly inhibited expression of nestin 
in hippocampal derived NSCs. Nestin, an intermediate filament protein, is 
known as a protein marker for neural stem/progenitor cells (Gilyarov, 2008). 
Nestin is expressed in dividing cells of SVZ of the lateral ventricle and the 
hippocampal dentate gyrus (Korzhevskii et al., 2008, Gilyarov, 2008). There is 
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a report revealing that 0.30 and I mM VPA enhances neuronal differentiation 
of adult progenitor cells (Hsieh et al., 2004) but nestin was not looked at. 
During the differentiation period, it has been found down-regulation of nestin 
while the progenitor cells exit the cell cycle and start to differentiate. Also, loss 
of nestin expression has been detected in an early stage of NSC differentiation 
both in vivo and in vitro (Mellodew et al., 2004). Nestin is not found in fully 
differentiated cells, therefore, loss of nestin can be considered as the earliest 
signification of the progression from precursor to differentiated phenotypes 
(Mellodew et al., 2004, Gilyarov, 2008). In the SGZ of the hippocampal 
dentate gyrus, nestin is expressed in NSCs and transiently amplifying 
progenitor cells but not neuroblasts (Kempennann et al., 2004). Thus, a 
decrease of nestin in NSCs indicates a reduction of NSCs and transiently 
amplifying progenitor cells. 
Loss of nestin in an early event of NSC differentiation has been discovered to 
be regulated by Notch signalling. Moreover, Notch signalling pathway controls 
the alteration of nestin degradation to maintain the undifferentiated state of 
stem cells (Mellodew et al., 2004). Notchl mRNA has been detected in nestin-
containing cells rather than post-mitotic neurons in neurosphere assay (lrvin et 
al., 2001). Similarly, nestin which is a progenitor marker has been found on 
Notch l-expressing cells on the surface of neurospheres. It is interesting to note 
that, in vitro, down-regulation of Notch 1 expression results in a decrease of 
nestin-expressing cells. This suggests that Notch 1 is involved in nestin 
expression. Therefore, differentiation of both NSCs and transiently amplifying 
cells is possibly modulated by alteration of Notch I signalling (Nyfeler et al., 
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2005). Additionally, it has been revealed that down-regulation of nestin 
activates apoptosis of neuronal progenitor cells, suggesting that nestin plays an 
important role in survival determinant (Sahlgren et al., 2006). The hippocampal 
NSCs were treated with 0.3 and I mM VPA in the present analysis to 
investigate the effect of VP A on nestin gene expression. The results show that 
I mM VPA decreased level of nestin expression but not 0.3 mM VPA (Fig. 
3.16 and 3.17). These findings indicate that loss of nestin may be due to a 
reduction of receptor Notch I which functions to maintain progenitors. It is 
possible that a decrease of nestin expression in hippocampal NSCs may lead to 
differentiating of both NSCs and transientIy amplifying cells and apoptosis. 
VPA reduced levels of Sox2 gene expression in adult mouse hippocampal 
NSCs 
Sox2, a transcription factor, is known to have the potential to regulate 
sternness, neural stem cell proliferation and neurogenesis (Cauffman et al., 
2009, Episkopou, 2005). Interestingly, cell proliferation of precursor cells in 
neurogenic regions is decreased in Sox2 heterozygous knockout mice. Thus it 
is likely that Sox2 is essential for precursor cell proliferation and/or for 
maintaining NSCs (Episkopou, 2005). Similarly, it has been found that Sox2 is 
needed to maintain NSCs in the hippocampus in vivo and in neurosphere 
cultures (Favaro et al., 2009). Premature differentiation of precursors, which is 
one of the three processes of neurogenesis, is induced when Sox2 is inhibited 
by dominant-negative construct. This was caused by promoting the exit of 
neural progenitors from the cell cycle and mediating the expression of early 
neuronal markers (Episkopou, 2005). Furthermore, inefficient neurogenesis has 
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been found in Sox2 mutant adult mice by showing a reduction of 
stem/precursor cell number and the ability of neuronal differentiation of their 
progeny in the dentate gyrus (Ferri et al., 2004). 
In an embryonic stem cell differentiation assay, expression of Sox2 levels have 
been shown to be higher under the condition of 1.5 mM VPA compare to 0,0.3 
and 0.7 mM VPA (Murabe et al., 2007). This appears to contradict the previous 
literature and the findings in the present study. I have demonstrated no 
alteration ofSox2 mRNA expression in hippocampal NSCs exposed to OJ mM 
VP A whereas I mM VP A produced a reduction of Sox2 mRNA expression. 
Our results are consistent with the reduction in cell proliferation found. 
Regulation of Notch], Sox2 and Nestin 
Sox2 and Notch 1 appear to be able to regulate each others expression. Sox2 
has been reported to have the ability to control neural stem cell maintenance 
and self renewal in embryonic brains and the adult nervous system by 
activating the Notch downstream effector gene Hes5 (Qu and Shi, 2009). Some 
studies demonstrate that Notch is essential for up-regulating Sox2 in the neural 
tube formation. Furthermore, Notch signalling and Sox2 are equally required to 
repress neuronal differentiation (Van et al., 2009). However, some studies have 
revealed that Notch 1 expression is increased by over-expression of Sox2 to 
upstream of Notch signalling. Notch signalling pathway is greatly inhibited in 
retina-specific Sox2 ablation while the Notch signalling downstream effectors 
Hes5 is moderately reduced in the hippocampus ofSox2 mutants (Favaro et al., 
2009). There also is evidence that Notch 1 is directly affected By Sox2 (Pevny 
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and Nicolis, 2009). These might reveal an association regarding how Sox2 and 
Notch signalling interface which is in line with the simultaneous reduction of 
Sox2 and Notch 1 mRNA expressions in hippocampal derived NSCs in the 
present study. 
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Figure 3.20 Cell intrinsic regulators in neural stem cell maintenance. 
The reduction of Sox2 gene could be due to the action of 1 mM VP A might 
affect a powerful function of Sox2 to maintain sternness by self-renewing to be 
stem cells rather than transit amplifying progenitor cells. In stem cell biology, 
type-l cells and type-2 cells correspond to stem cells and transit progenitor 
amplifying cells, respectively. Transit progenitor amplifying cells have less 
potentially ability than stem cells for self-renewal but have higher probability 
of undergoing terminal differentiation (lones and Watt, 1993). Sox2 can be 
detected in type-I and type-2a cells but not type-2b (Kempermaan, 2006). 
Likely to Sox2, type-2a cells are also expressed nestin whereas type-2b cells 
are not positive for nestin. Moreover, type-3 cells or neuroblasts are not 
expressed Sox2 and nestin (Kronenberg et al ., 2003 , Ehninger and 
Kempermann, 2008). Additionally, the reduction of Sox2 and nestin expression 
in hippocampal NSCs treated with 1 mM VP A might be caused by an 
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induction of cell differentiation. VPA has been reported that 1 mM VPA 
produced an increase of neuronal differentiation (Yu et al., 2009, Jung et al., 
2008). Interestingly, nestin positive cells are extremely reduced in the dentate 
gyrus of Sox2 mutant adult mice (Ferri et al., 2004). In adult mice, ablation of 
Sox2 in Sox2-expressing cells produces a dramatic decrease in nestin-positive 
stem/precursor cells and cell proliferation in the dentate gyrus (Favaro et al., 
2009). 
Taken together, the reduction of Sox2 and Notchl expression in hippocampal 
NSCs treated with 1 mM VP A might change the balance between maintaining 
the self renewal of stem cells and allowing cells to differentiate. Moreover, 
Sox2 and nestin gene expression in hippocampal NSCs exposed to 1 mM VP A 
in this research was lower than untreated cells, suggesting that these cells had 
been driven to become type-2b and type-3 rather than type-I and type-2a. 
VPA did not alter levels of c-Myc gene expression in adult nwuse 
hippocampal NSCs 
Evaluation of alteration of c-Myc gene expression is essential for determining 
the effect ofVPA on cell proliferation via molecular mechanisms that regulates 
cell-fate. The present study reveals that 0.3 mM and 1 mM VPA did not alter 
levels of c-Myc gene expression in hippocampal NSCs in comparison with 
untreated cells (Fig. 3.18 and 3.19). In contrast, both rat and mouse adult 
hippocampal NSC proliferation in the previous study was significantly 
inhibited by VPA in a dose-dependent manner. These are not in line with a 
study which shows gradually down-regulation of c-Myc protein levels of acute 
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myeloid leukemia (AML) caused by 0.5, 1 and 3 mM VPA. Besides the levels 
of c-Myc protein reduction, level of c-Myc mRNA expression is down-
regulated in AML cells treated with I mM VPA for 24 hours (Cheng et al., 
2007). Moreover, inactivation of c-Myc causes an inhibition of granule cell 
precursor proliferation and self-renewal (Nagao et al., 2008). Corresponding to 
the down-regulation of c-Myc expression, ectopic expression of c-Myc 
enhances neural progenitor cell proliferation in vitro and in vivo (Fults et al., 
2002). VPA also has a potential to decrease c-Myc expression and enhance 
apoptosis and differentiation of AML cells (Cheng et al., 2007). Similarly to 
the stem cell investigation, c-Myc is involved in regulation of cell proliferation, 
self-renewal and cell differentiation (Murphy et al., 2005, Nagao et al., 2008). 
Expression of c-Myc also induces self-renewal of neural progenitor cells in 
neurosphere culture (Kerosuo et al., 2008). However, this lack of effect on c-
Myc gene expression in the hippocampal NSCs suggests that c-Myc might not 
be the major target responsible for the observed effects ofVPA treatment in the 
present study. 
In conclusion, the research in this chapter provides evidence for direct effects 
of 0.3 and 1 mM VPA treatment on hippocampal NSCs. The result shows a 
dose-dependent reduction of neurosphere formation and hippocampal NSC 
proliferation. This is in agreement with the animal model in the previous study 
was used to demonstrate the side effects of VPA which shows a decrease of 
cell proliferation in the hippocampal 00. However, VPA inhibited the 
expression of three markers of stem cells, Notch 1, Sox2and nestin, but not c-
Myc. This stem cell study indicates that VP A might cause a reduction of 
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hippocampal NSC proliferation via Notch 1, Sox2 and nestin mechanisms 
rather than c-Myc. 
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Chapter 4 
The effect of Valproic acid on cell proliferation 
and Notch 1 expression in EpnI, MedI and 
SHSY5Y cancer eelllines 
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4.1 Introduction 
As described previously, VPA is a potent inhibitor of cell proliferation both in 
l'i\'() and in vitro. This effect being linked to its action as a histone deacetylase 
inhibitor (Eyal et aI., 2004, Chen et al., 2007, Gurvich et al., 2004). I have 
shown in Chapter 2 that VPA treatment in vi\'() reduced the expression of the 
receptor Notch I and this was associated with a reduction in proliferation in the 
SGZ of the hippocampus. 
The role of Notch I is "context dependent", that is it can have different effects 
in different tissues and cell types. Activation of Notch I during neural 
development is associated with increased cell proliferation, an inhibition of 
differentiation and the maintenance of a stem cell phenotype (Guentchev and 
McKay, 2006, Shimizu et al., 2008). However recent papers indicate that, in 
some cancers, VPA reduces cell proliferation but also induces the expression of 
Notch I. To further investigate the effects of VPA on Notch I expression, a 
series of cancer cell lines were treated with VPA to test what the effects of this 
drug are on Notch I levels. In cancer Notch 1 can act as an oncogene promoting 
cell proliferation and suppressing differentiation or can induce cell cycle arrest 
and apoptosis (Kunnimalaiyaan and Chen, 2007). 
VP A appears to always inhibit cell proliferation, induce cell cycle arrest and 
apoptosis in many types of cancer both in vitro and in vivo. For instance, VPA 
induces cell cycle arrest and apoptosis in small cell lung cancer, human thyroid 
cancer and endometrial tumour derived cells (Platta et al., 2008, Shen et aI., 
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2005, B1aheta et al., 2005). Similarly in neuronal tumours, VPA suppresses cell 
proliferation in neuroendocrine tumour derived cells (Greenblatt et al., 2007). 
The Notch 1 signalling pathway, is not active in all tissues, but is expressed at 
several stages of neural development where it has been reported to have a 
powerful influence. Notch 1 is involved in regulating cell fates, cell 
proliferation and cell death (Bray, 2006). In some cancers, Notchl per se can 
function as an oncogene that induces proliferation and suppresses apoptosis 
and cell differentiation, promoting malignancy (Kunnimalaiyaan and Chen, 
2007). In these cases increased expression of Notch 1 is associated with 
increased growth of the tumour (Wang et al., 2006c, Wang et al., 2006b, Wang 
et al., 2006a). In contrast, in some cancers, induction of expression of Notch 1 
signalling by VPA is associated with a reduction in tumour growth, cell cycle 
arrest and apoptosis. These cancers include small cell lung cancer and 
medullary thyroid cancer cells (Platta et al., 2008, Greenblatt et al., 2008). In 
the nervous system, VP A produces growth arrest in neuroendocrine cancer 
cells, in vitro and in vivo, and this is associated with an activation of Notch 1 
signalling (Greenblatt et al., 2007). 
As Notch 1 expression appears to have significant but sometimes contradictory 
effects on cell proliferation or cell cycle arrest it was decided to test the effects 
of VP A on cell proliferation and Notch 1 levels in a variety of cancer cell lines. 
These provide a comparison to its effects on primary hippocampal neuronal 
stem cells. 
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Cell lines 
Epn I is a human cancer cell line which was cloned from an ependymoma 
(obtained from the Children Brain Tumour Research Centre, Nottingham, UK). 
This type of tumour is a form of glioma that arises from the ependymal cells 
lining the ventricular system (Puget et al., 2009, Agaoglu et aI., 2005). 
Ependymomas are relatively rare tumours, accounting for 3% of all primary 
brain tumours and 50% of these tumours are found in children younger than 6 
years old (Reni et al., 2004, Puget et al., 2009). The etiology of ependymomas 
is not well understood, current treatment includes surgery, radiotherapy and 
chemotherapy, but survival rates remain poor (Bouffet and Foreman, 1999). 
The cell line Medl was isolated from human medulloblastomas (obtained from 
the Children Brain Tumour Research Centre, Nottingham, UK). These tumours 
originate in the cerebellum or posterior fossa and are described as primitive 
neuroectodermal tumours (PNET) (Li et al., 2005). Unlike other brain tumours, 
this tumour type is invasive and spreads via the cerebrospinal fluid to various 
locations in the brain and spine. Approximately 15% to 40% of all childhood 
brain tumours and 30% to 40% of all posterior fossa tumours are 
medulloblastomas (Greenberg et al., 2001). Medulloblastomas in children tend 
to occur near the vermis that connects the two cerebellar hemispheres, whereas 
in adults this tumour arises in the cerebellar hemispheres (Greenberg et al., 
2001). Prognosis of medulloblastomas remains poor, especially in infants and 
young children (Li et al., 2005) and the cause of medulloblastomas is 
unknown. 
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The SHSY5Y cell line is derived from human neuroblastoma (Biedler et al., 
1973). This type of tumour occurs mostly in infancy and children younger than 
5 years old, with an annual incidence of a hundred new cases diagnosed in the 
UK each year. It is the most common solid cancer in childhood and 
approximately 15% of all children with cancer will die from neuroblastoma (de 
Ruijter et al., 2005). The average survival period of children with intracranial 
neuroblastoma is normally not more than 1 year from time of diagnosis (Gao et 
al., 2007). Although the cause of neuroblastomas is unknown, they arise from 
neural crest cells of the sympathetic nervous system, and are also known as 
neuroendocrine tumours (de Ruijter et al., 2005, Stockhausen et al., 2005). 
VPA, a well-tolerated anticonvulsant, has demonstrated a potential as a novel 
therapeutic agent due to its HDAC inhibitor effects on transcriptional 
regulation within cancer cells (Gottlicher et al., 2001). Transcriptional control 
by acetylation is one of the most important mechanisms by which the N-
terminal tails of histones determine cell fate. Therefore, affecting acetylation 
by VP A affects transcription and is a possible potential approach in cancer 
therapeutics (Chen et aI., 2006, Sakajiri et al., 2005). 
This study was aimed to investigate the ability of VPA to reduce proliferation 
in Epnl, Medl and SHSY5Y cells and to see if this effect was associated with 
changes in Notch 1 levels. It is important to understand whether Notch 1 
signalling plays a role in controlling proliferation in these cells and whether it 
is acting as a tumour suppressor or an oncogene. Thus, alteration of Notch I 
signalling by VP A may be an effective new therapy for these types of cancer 
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and may produce milder side effects compared to the currently used 
chemotherapeutic treatment with or without radiotherapy. 
4.1.1 Aims of this chapter 
Determine effect of VPA on Epnl, Medl and SHSY5Y cell proliferation. 
Determine whether these cell lines express Notch 1 and whether this is affected 
by VP A treatment. 
4.1.2 Hypothesis 
• Cell proliferation of Epnl, Medl and SHSY5Y cells in culture will be 
significantly reduced by treatment with VP A. 
• Levels of Notch 1 expressions, if present, in Epn 1, Medl and SHSY 5Y 
cells will be significantly altered by treatment with VP A. 
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4.2 Materials and Methorb 
4.2.1 Effects of VPA treatment on Epn1 and Med1 cell lines 
4.2.1.1 Growing and culturing of Epn1 and Med1 
Human ependymoma cell line (Epnl) and human medulloblastoma cell line 
(Med I ), were kindly provided from the Children Brain Tumour 
Research Centre, Nottingham, UK. These cell lines were derived by passaging 
primary tumour samples and selecting lines that continued to grow. The cell 
lines were grown in Dulbecco's Modified Eagles Medium (DMEM) 
(GibcoBRL, Paisley, UK), 10% Fetal Bovine Serum (FBS; GibcoBRL, Paisley, 
UK), 1% L-Glutarnine (Sigma-Aldrich, Inc, St.Louis, USA) and 0.5% 
Penicillin/Streptomycin (Sigma-Aldrich, Inc, St.Louis, USA). Cells were 
grown at 3 TC and the media was changed every 2-3 days. 
4.2.1.2 Cell proliferation assay 
Epnl and Medl were seeded into 6-well plates at a density of 7500 cells per 
well. The next day, the medium was replaced with cell culture medium 
containing 0, I, 2 and 3 mM VPA (Sigma-Aldrich, Inc, St.Louis, USA) and 
then incubated for 72 hours. Before the cells reached 80% confluence, the cells 
were washed with pre-warmed IX PBS to remove any residual growth media. 
Trypsin (0.5% trypsin, 0.53mM EDTA; Sigma-Aldrich, Inc, St. Louis, USA) 
was then applied to the side of each well to completely cover the monolayer. 
The 6-well plates were incubated at 37°C for a couple of minutes or until the 
cells had detached. After two minutes, the medium was added to the well and 
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then the cells were removed to a universal tube. The density of cells in control 
and VPA treated groups was quantified by staining with Trypan blue. 
Quantification of numbers of Epnl and Medl cells were carried out in 
triplicate. The mean ± standard error of the mean (SEM) of triplicate samples 
was calculated for each condition. 
4.2.1.3lmmunostaining/or cell proliferation by using Ki67 
Cultures of Epnl and Medl cell lines were assigned to one of two groups: 
control group or VPA-treated group. The cell lines were seeded 200 cells per 
well. After incubating the cells for 24 hours at 3TC, the control cells received 
new fresh culture medium while the treated culture received culture medium 
contained 2.5 mM VPA. The cells were incubated for 3 days at 37°C. Next, 
immunofluorescence analysis was performed. The cells were fixed with 1% 
paraformaldehyde (PF A) in PBS for 3 minutes at room temperature and 
followed by washing three times with PBS. The cells were then incubated for 
60 minutes at room temperature with Mouse anti-rat monoclonal anti-Ki67 
(Novocastra NCL-KI-67-MMI), diluted I: 150 in PBS. Following washes with 
PBS 3 times, the binding of primary antibodies were detected by incubating 
with Alexa 488 Rabbit anti-Mouse IgG (1 :300, Molecular Probes, Invitrogen, 
Paisley, UK) for 40 minutes at room temperature. The secondary antibody was 
removed by three washes in PBS. Subsequently, all cell cultures were subject 
to nuclear counterstaining with Propidium iodide (PI) (Molecular Probes, 
Invitrogen, Paisley, UK), diluted 1 :3,000 in PBS. Then, the cultures were 
incubated for 30 seconds at room temperature and washed 3 times with PBS. 
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Positive staining was quantified usmg the Nikon Optiphot-2 mIcroscope 
(Nikon, Surrey, UK) and viewed using the SPOT advanced software, version 
3.5 (Diagnostic Instruments Inc, Michigan, USA). Systemic random sampling 
was used to observe 5 different fields of view per sample (n = 3). Ki67 positive 
cells were quantified using the fluorescein isothiocyanate (FITC) fluorescence 
filter and all nuclei were observed using the red (TRITC) filter. Two pictures 
taken per field were merged using the filters as described previously to show 
the image of Ki67 positive cells associated with their nuclei. Cell proliferation 
was determined and presented as means of Ki67 positive cell number. 
4.2.1.4 Optimisation of detection of Notch 1 using the C2C12 myoblast 
cell line for Western blot analysis 
The detection of Notch 1 was optimized using the C2C 12 mouse embryonic 
myoblast cell line obtained from the American Type Culture Collection 
(ATCC) as a positive control for Western blot assay. C2C12 cells were 
harvested when they reached approximately 80% confluence. The cells were 
washed with 5 ml of ice cold PBS and then added 5 ml of ice cold cell 
dissociation buffer (Sigma-Aldrich, Inc, St.Louis, USA) to the cultured flask. 
After incubating the flask on ice for 5minutes, the cells were removed using a 
cell scraper and thoroughly transferred into a 30 ml universal tube. The flask 
were added a further of 5 ml of ice cold cell dissociation buffer to ensure all 
cells were removed from the flask and removed the buffer into the tube. The 
sample was kept on ice at all times. The universal tube was centrifuged at 
1000rpm for 5 minutes at 4°C. The supematant was removed using a suction 
pump being careful not to disturb the cell pellet. Lysis buffer (20mM Tris-HCl, 
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pH 7.6, ImM EGTA, 320 mM Sucrose, 0.1% Triton XI00, ImM NaF, 10mM 
Beta glyceronphosphaste) was added into the tube to resuspend the sample. 
The sample was transferred into a new eppendorf and homogenized using a 
pellet pestle to ensure all protein was released and then rotated on a wheel for 
30 minutes at 4°C. After rotating 30 minutes, the sample was centrifuged at 
14000rpm for 5 minutes at 4°C. Following the homogenization, the supematant 
was removed and placed 5 III of each sample into an eppendorf for the Lowry 
test to determine protein concentration as described in Chapter 2 (section 
2.2.4.2). The remaining sample was resuspended in 6X of Sodium 
dodecylsulphate polyacrylarnine gel electrophoresis (SOS-PAGE) loading 
buffer. After the Lowry assay, the sample was normalized to the same 
concentration with 2X SOS-PAGE loading buffer. 50 Ilg proteins per lane were 
loaded onto 10% SOS-polyacrilamide gel, electrophoresed for 45 minutes at 
200v and blotted onto nitrocellulose membrane for 90 minutes at 100v, 4 DC. 
The membrane was blocked with Odyssey buffer (1: 1 diluted in PBS, LI-COR 
Biosciences) on the shaking platform for 1 hour at room temperature. 
Following the blocking process, the membrane was incubated overnight at 4 QC 
with either a Goat anti-Notchl (1:200, Sc-6014, Santa Cruz Biotechnology, 
Santa Cruz, CA, USA) or a Mouse anti-GAPOH antibody (1 :20000, Abeam, 
Cambridge, UK), diluted in 5% dried milk solution. Then, binding of the 
primary antibody was detected by incubating the membrane with either lRDye 
800CW donkey anti-goat (LI-COR Biosciences) or lRDye 800CW goat anti-
mouse (LI-COR Biosciences), 1 :20000 diluted in Odyssey buffer (1: 1 diluted 
in PBS). Immunoreactivity was determined using Odyssey scanner (Licor) at 
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wavelengths 800nm (green emission), and Odyssey software (Application 
software version 3.0). 
Notch1 
GAPDH 
Figure 4.1 The expressIOn of receptor Notch1 in C2C12 cell line and 
hippocampal brain tissue. The nitrocellulose membrane was scanned using 
Odyssey scanner (LICOR) at wavelength 80Onm. Immunoblot bands were 
detected at 120 and 36 KDa for Notch1 and GAPDH respectively. Mwt = 
Molecular weight marker, C2C12 = C2C12 cell line and Hippo = hippocampal 
brain tissue. 
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4.2.1.5 Effects of VPA on Notchl expression in Epnl and Medl cell 
lines using Western blot analysis 
Epnl and Medl cell lines were seeded at a density of 10 X 104 cells/ml. The 
following day, the medium was replaced with new cell culture medium 
containing 0, 1, 2 and 3 mM VP A. Following 72 hours incubation at 37°C, the 
samples were harvested and prepared for Western blot assay as described in 
section 4.2.1.4. 
For each cell line, western blotting was performed a total of three times on 
different samples per condition (n = 3). After scanning each blot using Odyssey 
scanner (LICOR), intensity of the immunoblot bands were measured using 
Odyssey software (Application software version 3.0). Intensity measurement 
was used to quantify protein levels of Notch 1 expression at 800nm and then 
normalized against intensity levels of GAPDH. The normalized intensities 
were calculated into means of Notchl expression levels. Adobe Photoshop 
Version 7.0 (Adobe Photoshop, USA) was used to increase contrast only in 
order to allow visible hardcopy prints for figures especially red and green 
images in this chapter. 
4.2.2 Effects of VPA treatment on SHSY5Y cell line 
4.2.2.1 Growing and culturing of SHSY5Y 
The SHSY5Y cell line was obtained from the ATCC. The cell line was 
cultured in Dulbecco's Modified Eagles Medium (DMEM) (GibcoBRL, 
Paisley, UK), 10% Fetal Bovine Serum (FBS; GibcoBRL, Paisley, UK), 1% L-
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Glutamine (Sigma-Aldrich, Inc, St.Louis, USA) and 5% 
Penicillin/Streptomycin (Sigma-Aldrich, Inc, St.Louis, USA). Cells were 
cultured at 3TC 5% CO2 and the media was changed every 2-3 days. 
4.2.2.2 Cell proliferation assay 
SHSY5Y cells were seeded at a density of 6.69 X 104 cells into a T25 flask. 
Following overnight incubation, SHSY5Y cells was treated with media 
containing VP A at a concentration of 0, 1, 2 or 3 mM and maintained at 3 TC 
for 72 hours. Following the incubation, the cell reached approximately 80% 
confluence, the cells were washed with pre-warmed IX PBS to remove any 
residual growth media. Trypsin (0.5% trypsin, 0.53mM EDTA; Sigma-Aldrich, 
Inc, St. Louis, USA) was then applied to the side of the flask to completely 
cover the monolayer. The flask was incubated at 37°C for a couple of minutes 
or until the cells had detached. After two minutes, the medium was added to 
the flask and then the cells were removed to a universal tube. The density of 
SHSY5Y cells in non-treated and treated groups was determined using Trypan 
blue staining. Quantification of numbers of SHSY5Y cells were carried out in 
triplicate. The mean ± the standard error of the mean (SEM) of triplicate 
samples was calculated for each condition. 
4.2.2.3 Quantification of Notchl expression in SHSY5Y by SDS-
PA GE and immunoblotting 
SHSY5Y cell line was seeded at a density of 10 X 104 cells/ml. The following 
day, the medium was replaced with new cell culture medium containing 0, 1,2 
and 3 mM VP A, maintained at 37°C for 72 hours. After the cells reached 
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approximately 80% confluence, they were harvested as described earlier 
(section 4.2.1.4, chapter 4) to prepare samples for Western blot assay. Binding 
of primary antibody was detected by incubating the membrane with either 
IRDye 680CW donkey anti-goat (LI-COR Biosciences) or lRDye 800CW goat 
anti-mouse (LI-COR Biosciences). 
Western blotting was performed a total of three times on different samples per 
condition (n = 3). Each blot was scanned as described in section 4.2.1.5 in this 
chapter. Intensity measurement was used to quantify protein levels of Notch I 
expression at 700nm and then normalized against intensity levels of GAPDH 
expression at 80Onm. The normalized intensities were calculated into means of 
Notchl expression levels. Adobe Photoshop Version 7.0 (Adobe Photoshop, 
USA) was used to increase contrast only in order to allow visible hardcopy 
prints for figures especially red and green images in this chapter. 
4.2.3 Statistical analysis 
The data of cell proliferation and Notchl expression were expressed as mean ± 
SEM values and analyzed by GraphPad Prism Version 4.03 (GraphPad 
Software Inc., USA). One-way analysis of variance (ANOV A) was used to 
determine significant difference among the experimental groups followed by 
Bonferrini's multiple comparison test to compare between groups. The 
criterion for statistical significance was p < 0.05. 
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4.3 Resuhs 
4.3.1 VPA inhibited eell proliferation o/Epn1 and Med1 eelllines in euhure 
Following 72 hours treatment, a comparison of the number of Epn 1 cells in all 
experimental groups revealed that there was a significant difference among the 
experimental groups (p = 0.0019, one-way ANOVA, Figure 4.2). VPA (1,2 
and 3 mM) reduced Epnl cell proliferation to 98%, 83% and 60%, of control 
culture respectively. Cell proliferation in Epnl cells treated with 1 and 2 mM 
VP A groups was not significantly reduced as compared to untreated cells 
(both; p > 0.05, one-way ANOVA, Figure 4.2). In contrast, there was a 
statistically significant reduction of cell proliferation in 3 mM VPA-treated 
group compared to untreated group (p < 0.01, one-way ANOVA, Figure 4.2). 
Similarly treated cultures of Medl cells showed a statistically significant 
reduction in proliferation (p = 0.0046, one-way ANOVA, Figure 4.3). Cell 
proliferation of MedI exposed to 1, 2 and 3 mM VPA was reduced to 91%, 
85% and 63% of control cultures, respectively. The degree of cell proliferation 
in 3 mM VPA-treated Medl cells was significant lower than untreated cells (p 
< 0.01, one-way ANOVA, Figure 4.3). However, both 1 and 2 mM VPA-
treated groups did not show a statistically significant reduction in comparison 
to untreated group (p > 0.05, one-way ANOVA, Figure 4.3). 
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These results indicate that VPA appeared to produce a dose dependent 
reduction in cell proliferation in Epn 1 and Med] cells. 3 mM VP A treatment 
caused significant reductions of cell proliferation in both Epn L and Med 1 cell 
lines but not in 1 and 2 mM VP A-treated groups. 
Effect of VPA on Epn1 
Control 1mM 2mM 3mM 
Figure 4.2 Analysis of the effect of VPA treatment on cell proliferation of 
Epn1 cell line. Graphs represent the mean (± SEM) of numbers of cells . 
Overall, cell proliferation showed a significant difference among the 
experimental groups (p = 0.0019). Bonferrini ' s multiple comparison analysis 
revealed unaltered cell proliferation in 1 and 2 mM VP A groups in comparison 
to control group (p > 0.05). Numbers of Epnl cells exposed to 3 mM VPA 
were significantly reduced in comparison to control culture (** p < 0.01). 
Statistic analysis was carried out using one-way ANOV A. 
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Figure 4.3 Alteration of Med1 cell proliferation after VPA treatment. 
Following 72 hours treatment, there was a statistically significant change in the 
number of cell proliferation amongst these experimental groups (p = 0.0046). 
Bonferrini ' s multiple comparison analysis confirmed that 3 mM YPA 
treatment caused a reduction of Med1 cell proliferation compared to control 
culture (p < 0.01) but Med1 cells in 1 and 2 mM YPA-treated groups remained 
unaffected as compared to control group (p > 0.05). All comparisons assessed 
using one-way ANOY A. 
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4.3.2 Numbers of Ki67 positive cells of Epnl and Medl cell lines were 
reduced by VPA 
To confirm the previous results, Epnl and Medl cultures were stained for the 
proliferation marker Ki67 (Figure 4.5 and 4.6). Comparing untreated and 
treated Epnl cells showed that the numbers of Ki67 positive cells in 2.5 mM 
VP A-treated group was significantly lower than the untreated group (p < 
0.0428, unpaired Student's Hest, Figure 4.4). Similarly, staining for Ki67 in 
Medl cell line demonstrated that there was a decrease of the numbers of Ki67 
positive cells in 2.5 mM VPA-treated cells in comparison to control cells (p < 
0.0475, unpaired Student's Hest, Figure 4.4). VPA at 2.5 mM was potent in 
reducing cell division ofEpnl and Med1 , by 21% and 19%, respectively. 
Figure 4.4 Quantification of Ki67 positive cells of Epn1 and Med1 in the 
presence or absence of 2.5 mM VPA. All data shown are from three 
experiments in parallel cultures. This analysis revealed that the numbers of 
Ki67 positive cells in control culture was significant greater than 2.5 mM VP A 
culture in both Epn1 and Med1 cell lines (*p < 0.0428 and ** p < 0.0475). All 
comparisons were calculated using unpaired Student's t-test. 
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Control culture 2.5 mM VP A culture 
Figure 4.5 Fluorescent photomicrographs demonstrating the expression of the 
cell proliferation marker Ki67 in Epnl cells after VPA treatment. Ki67 positive 
cells were immunostained green in control (A) and 2.5 mM VPA-treated 
cultures (B). Total nuclei were counterstained with propidium iodide (red) 
corresponding to image C (control culture) and D (2.5 mM VPA-treated 
culture). (E and F) Merged images of control and 2.5 mM VPA-treated cultures 
clearly shows nuclei expressing Ki67 are also positive for propidium iodide. 
There was a significant reduction of Ki67 positive cell number in VPA-treated 
culture compared to control culture. The cells stained for Ki67 and propidium 
iodide are indicated by arrows. 
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Control culture 2.5 mM VP A cultu.·e 
Figure 4.6 Fluorescent photomicrographs illustrating the effect of VP A 
treatment on Med1 cell proliferation expressing the division marker Ki67. In 
control (A) and 2.5 mM VPA-treated (B) cultures, Ki67 positive cells were 
immunostained green. Total nuclei counterstained with red nuclear dye, 
propidium iodide, control (C) and 2.5 mM VPA-treated cultures (D). Merged 
images of control (E) and 2.5 mM VPA-treated cultures (F) clearly shows 
nuclei expressing Ki67 were also positive for propidium iodide. The average 
number of Ki-67 positive cells in VPA-treated culture was significantly 
decreased in comparison with control culture. Arrows indicate the cells that are 
positive for Ki67 and propidium iodide. 
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4.3.3 VPA reduced cell proliferation of SHSY5Y cel/line 
To evaluate whether changes in cell proliferation of SHSY5Y cells occur 
during VP A treatment, the number of untreated SHSY5Y cells was compared 
with the cells treated with 1, 2 or 3 mM VPA for 72 hours (Figure 4.8). The 
results showed that there was a significant difference among the experimental 
groups (p < 0.001 , one-way ANOVA, Figure 4.7). Interestingly, cell 
proliferation of SHSY5Y cells treated with 1, 2 and 3 mM VPA groups was 
significantly lower than untreated cells in a concentration dependent manner 
(* * p < 0.01 and *** p < 0.001 , one-way ANOVA, Figure 4.7). Treatment 
with VPA (1 , 2 and 3 mM) for 72 hours, the inillbition rates of SHSY5Y cell 
proliferation were 32%, 55% and 64%, respectively. 
VPA 
Figure 4. 7 Bar graph illustrating the effect of varying concentration ofVPA on 
the cell proliferation of SHSY5Y cell line. Numbers of SHSY5Y cells exposed 
to 1, 2 and 3 mM VPA were significantly reduced in comparison to control 
culture (** p < 0.01 and *** p < 0.001). Comparison of experimental groups 
showed that there was a significant difference between their means of total cell 
number (p < 0.001). All statistic analysis was assessed using one-way 
ANOVA. 
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Figu.re 4.8 Phase contrast photomicrographs of SHSY5Y cells. (A) Photograph 
of SHSY5Y cells treated with 0 mM VPA or control culture. (B) SHSY5Y 
treated with 1 mM VPA at X20 magnification. (C) SHSY5Y treated with 2 
mM VPA at X20 magnification. (D) SHSY5Y treated with 3 mM VPA at X20 
magnification. 
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4.3.4 Westem blot analysis of levels of reeeptor Notclll expression in EpllJ 
and M edJ eel/lines 
To see if the reduction in cell proliferation brought about by VPA could be 
correlated with changes in Notchl , levels of this protein was quantified by 
Western blot. 
Following 72 hours treatment, there was no Notch 1 expression in 0, 1, 2 and 3 
mM VPA-treated cultures in Epnl and Med! cell lines compared to Notch] 
expression in the positive controls (C2Cl2 cell line) which was detected at 
approximately 120 KDa (Figure 4.9). These results suggest that receptor 
Notchl was not expressed in either untreated or VPA-treated cells in EpnL and 
Med 1 cell lines. 
130 KOa 
95KDa 
72 KOa 
55KDa 
36 KOa 
Con1rOl 1 rrI.l 'IPA 2 mM 'IPA 3 mM VPI\ Con1ro1 1 mM 'IPA 2 mM 'IPA 3 mM 'IPA 
Figure 4.9 Photorni crographs ill ustrating the detection of Notch 1 at 120 KDa. 
C2C12 cell line was used as a positive control (lane 2) for Notch 1. GAPDH 
was detected at 36 KDa and used as a loading control. A representative blot 
revealed that there was no Notchl expression in Epnl and Medl cells as 
indicated by comparing to Notch 1 expression in C2C12 in lane 2. 
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4.3.5 VPA illducedNotcltl expressioll o/SHSY5Y cells 
Western blot analysis of control and treated SHSY5Y cells was carried out to 
evaluate if VPA administration had any effect on the level of Notch] 
expression. Following optimization of Notch I antibody, immunoblot band was 
observed at 120 KDa (Figure 4.10). Intensities of each band was detected at 
700nm and then normalized against intensities of GAPDH expression of each 
sample which were also observed at 800nm. The intensities of Notch 1 
expression in SHSY5Y cells exposed to 1, 2 and 3 mM were significant higher 
than non-treated cells (* p < 0.05 and ** p < 0.01 , Figure 4.11). Levels of 
Notch 1 expression also revealed statistical difference between these 
experimental groups (p < 0.01 , Figure 4.11). 
130 KOa 
Notch 1 
95 KOa 
Mwt C2C12 0 mM VPA 1 mM VPA 2 mM VPA 3 mM VPA 
Figure 4.10 The effect of increasing concentrations ofVPA on the expression 
of Notch 1. Notch 1 was detected at 120 KDa. A representative blot of Notch 1 
expression in SHSY5Y cells exposed to 0, 1, 2 and 3 mM VPA, respectively. 
C2C 12 cell line was used as a positive control (lane 2) for Notch 1. GAPDH 
was detected at 36 KDa and used as a loading control. The expression of 
Notch 1 was increased in treated SHSY5Y cultures as indicated by the presence 
of darker bands compared with untreated culture. 
186 
1. 
E 
c: 
o 1. 
o 
CO 
11 1 
.r:. . 
... 
Cl 
c: 
Cl) 1.00 
G) 
> ~ ~
" ~ ~
* * 
VPA 
Figure 4.11 Protein analysis of Notch1 signalling expression in control and 
VP A-treated SHSY5Y cell line. Bar graph showed an assessment of Notch 1 
expression after VPA treatment. The results are normalized at 800nm to 
GAPDH expression. Levels of Notch 1 expression in SHSY5Y cells exposed to 
1, 2 and 3 mM were significant higher than non-treated cells (* p < 0.05 and ** 
p < 0.01). Levels of Notch1 expression also revealed statistically difference 
between these experimental groups (p < 0.01). Statistical significance was 
determined using a one-way ANOV A. 
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4.4 Discussion 
In the current study, VP A decreased cell proliferation of ependymoma (Bpn l), 
medulloblastoma (Medl) and neuroblastoma (SHSYSY) cancer cell lines in a 
dose-dependent way. 
VPA induced expression of Notchl signalling in SHSYSY cell line while 
Notchl signalling was not detected in the Epnl and Medl cell lines. These 
results indicate that the potent anti cell proliferative activities of VPA in Epnl 
and Medl were not correlated with Notchl signalling whereas increased 
Notch 1 protein expression in SHSYSY cell line, induced by VP A, is correlated 
with its anti cell proliferation effect. 
VPA decreased cell proliferation of Epnl, Medl and SHSY5Y 
In the current study, the in vitro anti proliferative effect of VP A in Epn l, Med 1 
and SHSYSY was concentration dependent (1,2 and 3 mM, respectively). This 
is in agreement with evidence that human neuroblastoma (SHSYSY and SK-N-
BE(2» cell proliferation is inhibited by VPA (1, 2 and 4 mM) in a dose-
dependent manner (Stockhausen et al., 200S). Treatment with VPA (O.S- 2 
mM) also results in growth inhibition of human thyroid cancer cells (Shen et 
al., 200S). Similarly, a previous study shows that at doses of O.S - 3 mM VPA 
decrease growth of thyroid cancer cells (Catalano et al., 2005). More than 50% 
of cell proliferation of human medulloblastoma cell lines (0283 -MED and 
DAOY) is attenuated by VPA at therapeutic safe doses (0.6 and 1 mM) (Li et 
al., 2005). VPA (0.5 - SO mM) suppresses M14 melanoma cell proliferation in 
a dose-dependent manner. M14 cell growth is inhibited about 2S% and 60% 
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after treated with 1 mM VPA for 24 and 72 hours, respectively. Moreover, it 
has been found 50% growth inhibition or ID,o at the concentration of 2.99 mM 
for 72 hours (Valentini et al., 2007). Treatment of DMS53 human small cell 
lung cancer cells with doses ranging from 1 to 10 mM VPA shows a dose-
dependent inhibition of cell proliferation (Platta et al., 2008). Additionally, cell 
viability of rat hepatoma cell line (FaO) is significantly decreased by exposing 
to VPA greater than 300 J.tM in a dose-dependent reduction. Interestingly, 60% 
of FaO cell viability is impaired at a maximal concentration of 700 J-lM VP A 
after 144 hours (Phillips et al., 2003). In addition to the in vitro study, daily i.p. 
administration of 400 mg/kg VP A for 4 weeks significantly suppresses growth 
of two medulloblastoma (D283-MED and DAOY) xenografts in severe 
combined immunodeficient mice (Li et al., 2005). Also, daily i.p. injection of 
VP A (1.25 mM/kg) induces growth inhibition and attenuates metastasis of MT-
450 breast cancer cells in animal experiments (Gottlicher et al., 2001). 
Besides the anti-cell proliferative activities of VPA, the reduction of viable 
cells in the current study could be due to an increase of cell death caused by 
VPA. A report has shown that VPA (0.6 and 1 mM) enhances cell cycle arrest 
and apoptosis in human medulloblastomas (D283-MED and DAOY) (Li et al., 
2005). Treatment of rat hepatoma cells with concentrations of 400 to 600 J-lM 
VP A induces apoptosis, which was investigated by chromatin condensation 
and DNA fragmentation assay (Phillips et al., 2003). Furthermore, induction of 
apoptosis in carcinoma cells, transformed hematopoietic progenitor cells, and 
leukemic blasts from AML patients is occurred after exposure to as low as 0.2 
mM or 1 mM VPA for 72 hours (Gottlicher et al., 2001). It has been also 
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demonstrated that MI4 melanoma cells treated with 2.5 and 5 mM VPA are 
enhanced 50% and 80% of apoptosis compared to untreated cells (Valentini et 
al., 2007). The anti cell proliferative influence of VPA on the cell cycle is 
detected to be in the GI phase (Martin and Regan, 1991, Greenblatt et al., 
2007). Similarly, M 14 human melanoma cells, human ovarian carcinoma cells 
and human multiple myeloma cells are progressively arrested at the Go/G) 
phase of the cell cycle after treatment with VPA (Takai et al., 2004b, Valentini 
et al., 2007, Kaiser et al., 2006). At a dose of 1 mM VPA, which is slightly 
greater than the therapeutic serum concentration used in epileptic patients, cells 
are arrested in GI phase (Catalano et al., 2005). Additionally, exposure to 
doses of 0.5 and 1.5 mM VPA decreases pro survival gene expression by 10% 
to 60010, but induces proapoptosis gene expression 23% to 85% in human 
thyroid cancer cells (Shen et al., 2005). 
VP A is also known as a histone deacetylase (HDAC) inhibitor which causes 
hyperacetylation of the N-terrninal tails of histones H3 and H4 in vitro and in 
vivo (Gottlicher et al., 2001, Li et al., 2005). This induces transcription activity, 
up-regulates cell cycle arrest and apoptosis. It has been found that VP A inhibits 
cell proliferation and enhances cell cycle arrest and apoptosis which is 
associated with increased expression of p21 (a cyclin-dependent kinase 
inhibitor) (Li et al., 2005, Takai et al., 2004a, Kaiser et al., 2006). This tumour 
suppressor protein plays an important role in blocking cell proliferation and 
cell cycle arrest in the GI phase (Mai et al., 2005). Moreover, VPA, functions 
as a HDAC inhibitor, causes suppression of cell proliferation and induction of 
apoptosis in human multiple myeloma KM3 cells in vitro via down-regulating 
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vascular endothelial growth factor (VEGF) receptor (Dong et al., 2007). VEGF 
is a protein that binds to receptor tyrosine kinases on endothelial cells to 
promote angiogenesis (lin et al., 2002). Lack of VEGF expression caused by 
VPA indirectly induces inhibition of proliferation, migration and tube 
formation of endothelial cells (Michaelis et al., 2004). 
VPA induced expression of Notchl receptor in SHSY5Y but not in Epnl and 
Medl 
Notch I has multifunctional roles in regulating cellular differentiation, 
development, proliferation and survival in the animal kingdom. Notchl in 
human cancer cells can function as either a tumour suppressor or an oncogene 
(Kunnimalaiyaan and Chen, 2007, A1lenspach et al., 2002). Therefore, 
determination of an association between the antiproliferative effect of VP A and 
expression of Notch 1 receptor in human Epnl, Medl and SHSY5Y cell lines 
may throw some light on the role of Notch 1 in different cancers and whether 
VPA is exerting its effect through this signalling pathway. The results show 
VPA inhibited cell proliferation after exposure to I, 2 and 3 mM VPA in a 
dose-dependent manner in all the cancer cell lines but only SHSY5Y cells 
expressed Notchl. Treatment with VPA significantly up regulated Notchl 
expression in SHSY5Y cells but had no stimulatory effect on expression in the 
other cell lines. The induction of Notch 1 expression in SHSY5Y in the present 
study is in accordance with the suggested tumour suppressor function of 
Notch 1 signalling in these and other cancer cells (Stockhausen et al., 2005, 
Greenblatt et al., 2008, Greenblatt et al., 2007). In addition, VPA can induce 
apoptosis in medullary thyroid cancer (MTC) and carcinoid cancer cells 
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(Greenblatt et al., 2008, Greenblatt et al., 2007) and neuroblastoma cells 
(Stockhausen et al., 2005). Moreover, inhibition of medullary thyroid cancer 
and small cell lung cancer cells is caused by Notchl signalling via cell cycle 
arrest in Gl phase associated with p21 activation (Sriuranpong et al., 2001, 
Kunnimalaiyaan et al., 2006). Both the reduced proliferation and increased 
apoptosis are suggested to be effects of increased Notch 1 signalling (Greenblatt 
et al., 2008). 
In the present investigation VP A treatment produced a dose-dependent 
decrease in cell proliferation. However the effect of VP A did not seem to 
produce a dose-dependent effect on Notch 1 expression as the lowest doses of 
VP A produced similar increases in Notch 1 to the higher doses. It is possible 
that lower doses ofVPA may show a more graded effect on Notchl expression 
but we have not investigated whether their direct association between induction 
of Notch 1 and cell proliferation. 
In contrast to the induction of Notch 1 protein expression by VPA in SHSY5Y 
cells, Notchl protein expression was not detected in both VP A-treated and 
untreated Epnl and Medl cells in the present study. Not all cancers express 
Notch 1 for example it is low or absent in prostate cancer, and it is not present 
in all neuroendocrine tumours (NETs) (Kunnimalaiyaan and Chen, 2007). 
The lack of expression and induction of Notch 1 in Epn 1 and Med 1 strongly 
suggests that Notch signalling is not playing a part in the growth of these 
cancers. 
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Besides the tumour suppressive function, it has been revealed that Notch 1 in 
human cancer cells can act as a tumour oncogene (Kunnimalaiyaan and Chen, 
2007). For instance, Notchl induces cell proliferation and inhibits cell cycle 
arrest in human T -cell neoplasia and medulloblastoma (DAOY and PFSK cell 
lines) (Kunnimalaiyaan and Chen, 2007, Fan et al., 2004). In addition, Notch 1 
plays a crucial role in promoting cell proliferation and the formation of cancer 
stem cell-like cells in human glioma (Zhang et al., 2008b). Recently, Notchl 
has been reported to inhibit VEGF receptor expression, disrupting vessels and 
decreasing tumour viability in murine skin. This suggests that Notch 1 is 
required for expression of VEGF-induced angiogenesis (Funahashi et al., 
2008). In addition, it has been demonstrated that Notchl is involved in 
angiogenesis in embryonic vascular development in vivo (Rehman and Wang, 
2006). Up-regulation of Notch 1 in SHSY5Y cells by VPA might induce cell 
cycle arrest and increase p21, causing inhibition of cell proliferation. 
Furthermore, the induction of Notch 1 receptor by VP A might inhibit VEGF 
receptor expression, causing inhibition of angiogenesis and tumour growth. 
Altogether, Notchl signalling appears to play a tumour suppressor role in 
SHSY5Y cells in the present study. The lack of Notch 1 signalling in Epn 1 and 
Medl led to future investigation of its potential role in influencing proliferation 
and/or survival in these cancers. Thus, understanding of Notch signalling in 
regulating normal development and malignant transformation may be essential 
for novel cancer therapeutics. 
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In summary, the effect ofVPA was shown to inhibit cell proliferation in Epnl, 
Medl and SHSY5Y cells. The antiproliferative effect of VP A is associated 
with up-regulation of Notchl signalling in SHSY5Y cells; however, Notch I 
protein was not found in Epnl and Medl cells. These findings clearly indicate 
that the effect of anti cell proliferation activities of VP A might modulate cancer 
cell growth via Notchl signalling pathway in SHSY5Y but not in Epnl and 
Med!. Therefore, these findings suggest that anti-tumour activities of VPA 
mediated Notchl signalling pathway might serve as an effective drug for a 
novel therapeutic option in neuroblastoma treatment. 
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Chapter 5: 
General discussion 
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5.1 Introduction 
The principle aim of this present project research was to use a rodent model to 
test the effect of VP A on hippocampal dependent spatial and recognition 
memory and to see if any changes in cognition could be correlated with 
changes in neurogenesis in the sub granular zone (SGZ) of the hippocampal 
dentate gyrus. This was done firstly to see if patient reports of cognitive 
impairment could be modelled in this rodent model and secondly to investigate 
if a mechanism causing these deficits could be found in the process of 
neurogenesis in the hippocampus. 
To further investigate the impact of VPA, neural stem cells (NCS) were 
isolated and together with three neural cancer cell lines and these were treated 
in vitro, to determine the effects of the drug on their proliferation and 
expression of stem cell markers. 
The main findings of this project were as follows: 
1. Administration of VPA (300 mg/kg) twice daily for 10 days produced an 
impairment in the performance of the novel location discrimination test which 
is a test of hippocampal dependent spatial memory but did not impair 
performance in the contextual fear conditioning test (Chapter 2). 
2. Treatment in vivo also reduced proliferation of cells in the SGZ of the 
dentate gyrus (Chapter 2). 
3. Chronic in vivo VPA treatment caused reduced levels of the neurotrophin 
BDNF and the receptor Notch 1 in the hippocampus but did not significantly 
reduce DCX levels (Chapter 2). 
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4. Exposure to VPA (0.3 and 1 mM) for 48 hours significantly suppressed 
neurosphere formation and cell proliferation of adult hippocampal NSCs in 
vitro (Chapter 3). 
5. Quantitative RT-PCR showed that the reduction in proliferation of adult 
hippocampal NSC was correlated with a reduction of Notch 1 , Sox2 and nestin 
gene expression after exposure to 1 mM VPA but not 0.3 mM VPA (Chapter 
3). 
6. Treatment ofVPA (1, 2 and 3 mM) reduced cell proliferation ofEpnl, Medl 
and SHSY5Y cells in a concentration-dependent manner (Chapter 4). 
7. Treatment of VPA (1, 2 and 3mM) induced expression of Notch 1 receptor 
protein in SHSY5Y as shown by Western blotting. However, VPA did not alter 
Notchl protein expression in Epnl and Medl cells. Notchl expression was not 
detected in untreated SHSY5Y cells (Chapter 4). 
Overall the results of the present project provide evidence that VPA treatment 
can produce a cognitive impairment, confirming previous patient reports. The 
decline in spatial memory is associated with a suppression of adult 
hippocampal NSC proliferation which VP A can produce both in vivo and in 
vitro. Both cells (in vitro) and hippocampal tissue show a reduction in the 
expression of the NSC markers; Notchl (in vivo and in vitro), Sox2 and Nestin 
(in vitro) after VPA treatment. Additionally, VPA reduced BDNF levels within 
the hippocampus. As both NSC proliferation and BDNF are components of the 
process of hippocampal neurogenesis their reduction after VP A treatment 
provides a plausible mechanism to explain the cognitive decline. 
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In human patients, VP A is a widely prescribed medication; trade names include 
Depakane, Valproate and Valrelease (Vadney and Kraushaar, 1997). Its 
primary uses are to prevent seizures caused by epilepsy and as a mood 
stabiliser in bipolar disorders (Lagace et al., 2004, Henry, 2003). It is normally 
taken orally using capsules resistant to degradation in the stomach. It has low 
systemic toxicity, the major problems are liver failure in young children and 
some reports of pancreatitis (Henry, 2003, Straussberg et al., 1998). Patient 
web sites (http://www.psycheducation.org/depression/meds/valproate.htm) and 
published studies, however report a range of side effects including hair loss, 
weight gain (Henry, 2003) and memory loss (Vermeulen and Aldenkamp, 
1995, Straussberg et al., 1998, Goldberg and Burdick, 2001). Higher doses are 
given to epileptic patients compared to bipolar patients. The dose for epileptic 
patients is determined empirically starting with a low dose and increasing it 
until seizures are prevented. Dosage range is from 750 mg per day up to 3000 
mg per day (Ristic et al., 2006, Park-Matsumoto and Tazawa, 1998, Jamora et 
al., 2007). The average of these doses is approximately 25 mg/kg. 
The dose ofVPA given in the present study (300 mg/kg, by i.p. injection twice 
daily for 10 days) was chosen as it has previously been shown to prevent 
seizures in spontaneously epileptic rats (Nissinen and Pitkanen, 2007) and a 
similar dosing regime (the same series of injections but VP A also given in 
drinking water) has been used in recent investigations of the action of VP A in 
preventing Kainic acid induced seizures in rats (Jessberger et al., 2007, Hsieh 
et al., 2004). From this it is likely that this dose is approximately equivalent to 
the clinically effective dose given to epileptic patients to prevent seizures. 
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Conversion of the dose given in the present study to a human equivalent dose 
(Reagan-Shawet al., 2008) gives a figure of 113.5mg/kg which is somewhat 
higher than the 13 mg/kg - 50mg/kg dose range given to patients. 
5.2 Cognitive effects of VPA in the adult hippocampus 
Studies in the present thesis examined the effect of VPA on hippocampal-
dependent memory using an animal model. Memory was tested using two 
established behavioural tests; the novel object location (NOL) and the 
contextual fear conditioning tests (Chapter2). In the NOL task, the results 
showed that rats receiving VP A displayed significant impairments in their 
ability to discriminate between the familiar and novel locations of objects 
compared to control animals. This is taken to indicate an impairment in spatial 
working memory (Dix and Aggleton, 1999, Mustafa et al., 2008). 
In contrast, treated rats, did not show a significant difference in the duration of 
freezing behaviour after exposure to an aversive stimulus in the contextual fear 
conditioning task. 
5.2.1 The NOL test 
The NOL task uses the naturally spontaneous behaviour of rats that tend to 
explore novel stimuli without the requirement of positive or negative 
reinforcements, i.e. food and foot shock. These reinforcements can cause 
arousal or stress (Ennaceur and Delacour, 1988, Dere et al., 2007). The 
novelty-preference paradigm used in this study is more closely related to 
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human location memory as observed in everyday life (Ennaceur and Delacour, 
] 988). 
In tenns of spatial memory, the hippocampus is involved in consolidating and 
recalling memories. As might be expected, the hippocampus shows an increase 
in activity when animals are exploring a novel context compared to a familiar 
context (Aggleton and Brown, 1999). These observations indicate the 
importance of this brain region in performance of the NOL task. 
Lesion studies of the hippocampus have further demonstrated the critical role 
this structure plays in carrying out the NOL. In rodents, animals with lesions to 
the dentate gyrus and CA3 are unable to perform the NOL test (Lee et al., 
2005). This suggests that the connection between dentate gyrus and CA3, 
which uses the dentate gyrus granule cell axons, is essential for this type of 
spatial memory. Rats with hippocampal lesions show a significant NOL deficit 
when a 5 minute inter-trial interval is used (Dere et al., 2007). This length of 
delay, which was used in the current investigation, between initial exposure to 
the arena and recall, requires the hippocampus to consolidate the spatial 
memory. The NOL test was used in the present investigation as it was 
suspected that deficits in dentate gyrus neurogenesis could be the cause of any 
cognitive deficits. Other spatial memory tests could have been used, for 
example the novel object recognition test or Morris water maze. Lesions to the 
hippocampus do not always lead to deficits in the performance of these tests 
(Saxe et al., 2006, ShOTS et al., 2002) indicating that other brain regions are 
being used in the performance of these tests. In addition the Morris water maze 
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requires training over 8 days. It has been shown that this training itself affects 
hippocampal neurogenesis as both an increase and a decrease in neurogenesis 
at different time points during the learning procedure have been reported 
(Dupret et al., 2(07). This would significantly complicate analysis of the 
effects of VPA on neurogenesis which was one of the objectives of this 
investigation. 
The present results showed that treated animals were significantly reduced in 
their performance in the NOL test. This would indicate that the dentate gyrus 
and CA3 connection is impaired leading to a reduction in memory. As 
discussed later this may relate to the reduction in cell proliferation in the SGZ. 
5.2.2 Contexhull fear conditioning test 
Contextual fear conditioning is modelled using contextual (conditional) stimuli 
to predict aversive (unconditional) stimuli such as foot shock (Maren, 2001, 
Fanselow, 2000, Fendt and Fanselow, 1999). The present test followed the 
procedure of Resstel (Resstel et al., 2006) where the contextual stimulus is the 
box in which the animal receives the shocks. Association between shocks and 
context is tested the following day by measuring the degree of freezing 
behaviour. Performance in this test is thought to require input from several 
brain regions including the hippocampus, amygdala and brain stem 
(periaqueductal grey matter) (Fanselow, 2000). As such it is riot as 
hippocampal specific as the NOL but provides information on the functions 
and integration of several brain regions associated with this type of learning. 
Importantly, lesions to the hippocampus do not prevent performance in this test 
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(Shors et al., 2002). Animals treated with VPA did not show any reduction in 
the amount of freezing behaviour when placed back into the box where they 
have received shocks the day after receiving shocks. This result is different 
from that obtained with the NOL test and there are several possible reasons for 
this. 
In some instances, there are some confounding factors which prevent learning 
in contextual fear conditioning. The aversive stimuli, per se, can produce 
confounding factors such as stress (Ennaceur and Delacour, 1988) that might 
make the interpretation of the effect of VP A on memory difficult. 
This test can be performed in a variety of ways. The most common methods 
are either to lesion or drug treat the animals before training (pre-training lesion) 
(ShoTS et al., 2002, Ko et al., 2009) or after training (post-training lesion) but 
prior to re exposure to the box (Maren and Fanselow, 1997). In the present 
study, the contextual fear conditioning was done after treatment (pre training 
drug treatment). Pre-training lesions do not produce as strong a contextual 
conditioning impairment compared with post-training lesions. This is because 
in the pre training design, the contextual stimuli can be directly associated with 
foot shock in the amygdala without the processes of consolidation of the 
contextual memory in the hippocampus (Maren, 2001). In contrast, massive 
impairments are produced if hippocampal lesions are given after training 
(Maren, 2001, Anagnostaras et al., 2001). 
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Additionally, the preshock period (i.e. the time the animal spends in the foot 
shock box prior to receiving a shock) in this study was 1 minute, which is 
shorter than a typical preshock period of 2-3 minutes used in some publications 
(Fanselow, 2000, Saxe et al., 2006). The length of the preshock period, used by 
the rat to explore the context prior to a shock delivery, seems to be important 
for acquiring contextual conditioning. In addition the frequency of the shocks 
used in this study is greater than the typical shock (1:4 shocks). 
However the experimental protocol used in the present study has worked with 
other investigators in this School and the present results may indicate 
differences in the type of memory affected by VP A. 
There are several reports in the literature that contextual fear conditioning does 
not always correlate with other behavioural t e s t ~ . . For instance, animals with 
depleted hippocampal BDNF show deficits in novel object recognition (NOR) 
but do not show an impairment in contextual fear conditioning (Heldt et al., 
2007). Similarly animals with the hippocampus lesioned by ibotanic acid 
microinjection show deficits in spatial memory (Morris water maze) but not in 
contextual fear conditioning in mice (Yoon and Gaiano, 2005). This may 
indicate that the contextual fear conditioning test is measuring different aspects 
of memory from these other tests. 
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5.3 Effects of VPA on cell proliferation of adult hippocampal NSCs both in 
vivo and in vitro 
Adult neurogenesis in the dentate gyrus is required for hippocampal-dependent 
spatial memory (Dupret et al., 2008, Jmayoshi et al., 2008). Most recent papers 
show that reducing adult hippocampal neurogenesis causes deficits in spatial 
memory. This is most elearly demonstrated where conditional knock out of 
adult neural stem cells produces impaired performance in spatial tasks 
(Imayoshi et al., 2008, Jessberger et al., 2009, Dupret et al., 2008). However, a 
recent paper using mice in which the cyelin D2 gene had been knocked out, 
show no deficits in several hippocampal-dependent behavioural tests 
(Jaholkowski et al., 2009). One explanation of this contradictory result may be 
that these mice have never had any adult neurogenesis (which uses eyelin D2 
in cell division) whereas the previously described studies reduce or eliminate 
adult neurogenesis in animals which have had hippocampal neurogenesis prior 
to the conditional knock out. It is possible that animals which have never 
experienced adult neurogenesis have found other ways to process and 
consolidate spatial memories. 
Drug treatment with VP A in the present study is closer to studies usmg 
conditional knock outs where existing adult neurogenesis is reduced rather than 
where it has never occurred. 
VP A used in the present study showed similar results to other anti-mitotic 
drugs, e.g. MAM and chemotherapy (Mustafa et al., 2008, Mignone and 
Weber, 2006, Bruel-Jungerman et al., 2005). All of these drugs reduce 
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proliferation in the SGZ which then correlates with deficits in spatial memory. 
The mechanism by which proliferation is reduced is different with each drug 
and this may have differing effects on stem cell numbers and the time course of 
recovery. 
A reduction in cell proliferation will lead to a reduction in new neurons in the 
dentate gyrus (Brown et al., 2003, Imayoshi et al., 2008). Nearly all studies 
where proliferation is reduced show a cognitive effect (Raber et al., 2004, 
Drapeau et al., 2003, Seigers et al., 2008, Imayoshi et al., 2008). We can not 
prove a direct connection between a decrease in cell proliferation and a 
cognitive deficit but the impact of VPA on SGZ proliferation is a plausible 
explanation. VP A can affect other parts of the brain for example by disturbing 
the GABAergic pathways in the basal ganglia system and VP A has been found 
to accumulate in the substantia nigra, superior and inferior colliculus, and 
medulla as well as the hippocampus (Masmoudi et al., 2000). The action of 
VPA in these other brain regions may also contribute to its cognitive effects. 
Having demonstrated that VP A can reduce proliferation of hippocampal neural 
stem cells in vivo it was decided to look at the effects of VP A on these cells in 
vitro. In this way the direct effects ofVPA on these cells may be seen without 
the effects of surrounding tissues. The adult hippocampal NSC culture in this 
thesis showed that treatment with 0.3 and 1 mM VPA resulted in a significant 
inhibition of neurosphere formation and cell proliferation (Chapter 3). The 
concentration of VP A used in this experiment is similar to the human 
therapeutic serum concentration (0.35 - 1.04 mM or 50 - 150 mgll) (Hao et al., 
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2004). These indicate that the anti-mitotic effect ofVPA can act in both lower 
(0.3 mM) and upper (1 mM) levels of antiepileptic range. Thus, these 
observations warrant the anti-mitotic effect of VPA on adult hippocampal 
NSCs both in vivo and in vitro and indicate that VP A may be having a direct 
effect on the proliferation of these cells in vivo. 
Although VPA appears to have clear antiproliferative effects, through its action 
as a histone deacethylase (Bredy and Barad, 2008, Dong et al., 2007), there are 
reports of it increasing neural stem cell proliferation in vivo and in vitro. 
Feeding mice with sodium valproate-supplemented (20 mg/kg) chow for 6 
weeks induces cell proliferation in the dentate gyrus of the adult hippocampus 
(Hao et al., 2004). No behavioural tests were carried out in this study and the 
different method of dosing makes comparison with the present study difficult. 
In the same study, VPA (0.8 mM) increased the proliferation of embryonic 
cortical derived cells in culture (Hao et al., 2004). This dose is within the range 
used in the present study and is difficult to reconcile with the results presented 
here except to say that the age and brain region are different. It is possible that 
VP A might have different effects with different ways of administration, 
concentrations and cell types. 
5.4 Co"elation between VPA treatment-induced alteration in memory and 
neurogenesis 
The study of the effect ofVPA in this thesis attempted to assess the correlation 
between hippocampal memory changes and cellular effects induced by VP A 
both in vivo and in vitro. The present findings reveal that spatial memory 
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deficits corresponded with inhibition of cell proliferation in SGZ of the 
hippocampal dentate gyrus using an animal model (Chapter 2) and reduction of 
hippocampal NSCs in culture (Chapter 3). The in vitro study shows that VPA 
directly suppressed hippocampal NSC proliferation. The reduction of cell 
proliferation in this study might play a key role in memory alterations as 
previous studies have shown that over 70% of proliferating cells in the SGZ 
contributing neurons in the dentate gyrus (Zhao et al., 2006). Taken together, 
this has led to the conclusion that cellular effects relating to neurogenesis might 
be the underlying neural memory mechanism being affected by the VP A 
treatment and causing memory changes. 
Besides its antiproliferative activity, VP A has been demonstrated to be 
involved in increasing apoptosis (Blaheta et al., 2005). For example, VP A has 
been reported to increase apoptosis of hippocampal progenitor cells as 
evaluated by staining with propidium iodide (Hsieh et al., 2004). Moreover, 
apoptosis and long-term newborn neuron survival have been shown to be 
involved in hippocampal-dependent memory and learning mediated by 
neurogenesis (Dobrossy et al., 2003). In the process of neurogenesis such as 
proliferation, differentiation, survival and apoptosis of newborn neurons has 
been involved in diverse phases of hippocampal-dependent leaming and 
memory (Abrous et al., 2005). During training in the Morris water maze test, 
there is an enhancement of survival of newly generated neurons which were 
born a few weeks earlier. It is likely that these neurons are required for 
encoding, long-term storage and recall of memory as they show increased 
activity during the training period (Kee et al., 2007). In contrast, cells born 
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during the training period show an increase in apoptosis. These cells appear not 
to participate in the formation learning network connections (Dupret et al., 
2007). This process might be contributing to memory consolidation. After that, 
generation of newborn neurons is increased in the late phase of learning for 
compensating and resetting availability of the dentate gyrus to obtain novel 
memory (Abrous et al., 2005). Therefore, future studies to examine the effects 
of VP A on neurogenesis should incorporate an analysis of apoptosis and long-
term newborn neuron survival in the dentate gyrus to assess whether side 
effects of VPA might be more specific to apoptosis or survival of newly 
generated neurons or mature neurons. 
5.5 Effects of VPA on cellular changes 
The effect of VP A on neuronal differentiation was determined using DCX and 
BDNF immunoblotting in the hippocampus and frontal cortex (Chapter 2). 
Administration of VP A did not produce any alterations in levels of BDNF and 
DCX protein expression in the frontal cortex. In the frontal cortex, it might 
seem that DCX levels paralleled those of BDNF, indicating that VP A does not 
affect neuronal differentiation, survival and proliferation of newborn neurons 
in this region. Cells generated in the subventricular zone migrate forward in 
the rostral migratory stream to supply interneurons in the olfactory bulb 
(Abrous et aI., 2005). 
Conversely in the hippocampus, VP A decreased levels of BDNF protein but 
not levels of DCX. This indicates that changes of BDNF did not correspond 
with levels of DCX protein expression in the hippocampus. VP A is known to 
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accelerate neuronal differentiation in the hippocampus (Hsieh et al., 2004). It is 
possible that VP A has decreased the proliferation of dividing cells in the SGZ 
and enhanced differentiation of non-dividing precursors. This could maintain 
the levels of DCX during the period of the experiment. It would be useful for 
future studies to see if this level of DCX is maintained over longer time 
periods. Thus, BrdU and NeuN immunostaining will prove indispensible to 
confirm whether VP A induces neuronal differentiation and/or decreases 
survival of newborn neurons as well as suppressing cell proliferation of the 
adult hippocampal NSCs (Chapter 2 and 3). The role of VPA in affecting the 
various aspects ofneurogenesis may prove to be a useful field to investigate. 
5.6 Influence of VPA on cell proliferation associated with expression of 
Notchl receptor 
Notch signalling pathway has been known to have potential roles in the normal 
development of many tissue and cell types, such as effects on differentiation, 
survival, and/or proliferation. Notchl signalling is also involved in regulating 
differentiation, survival and/or proliferation of cancer cells (Allenspach et al., 
2002). Changes in Notchl signalling might be involved in the antiproliferative 
effects of VP A in different ways. In this project, changes in Notch I expression 
were observed to correlate with reductions in cell proliferation during VP A 
treatment in the animal model (Chapter 2), the adult hippocampal NSC culture 
(Chapter 3) and one of the cancer cell lines (Chapter 4). The results in the 
animal model demonstrate that VPA (300 mg/kg, two times a day), which 
inhibited cell proliferation, also reduced Notch 1 protein levels in the 
hippocampus. The in vitro studies showed that VPA reduced cell proliferation 
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in all cell types tested (cancer cell lines Epnl, Medl, SHSY5Y and primary 
hippocampal NSC), at both higher and lower doses. VP A reduced Notch 1 
expression in adult hippocampal NSC, increased Notch 1 expression in 
SHSY5Y and was undetectable in Epnl and Medl cells. These effects were 
seen only at the higher dose in the NSCs. Notch signalling is "context 
dependent" and can increase or decrease cell proliferation in different types of 
cell (Kunnimalaiyaan and Chen, 2007). Activation of the Notch signalling 
pathway is thought to mediate an increase in cell proliferation by adult neural 
progenitors (Wang et al., 2009). Reduction in the levels of Notchl may 
therefore contribute to the antiproliferative effects of VP A in adult 
hippocampal NSCs. 
In contrast some cancer cell lines have been shown to up regulate Notch 1 in 
response to VP A treatment which correlated with suppression of their 
proliferation (Stockhausen et al., 2005). Treatment of SHSY5Y cells with VPA 
in the present project reduced their proliferation and this was associated with 
an increase in Notch 1 expression. The other two cancer cell lines, Epn 1 and 
Medl, did not appear to express Notchl either before or after treatment with 
VPA (Chapter 4). 
These results clearly suggest that Notchl signalling might play a role in 
influencing cell proliferation of SHSY5Y and NSC cells. The action of 
increasing Notch appears to have opposite effects in these two types of cell. It 
is unclear whether VPA is directly affecting Notch 1 expression or whether it is 
down stream in a signalling pathway involving Sox2 as shown in possible 
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signalling cascades illustrated in Chapter 3. Notch expression however is not 
required for the antiproliferative effects of VPA, as shown by its effect on 
Epnl and Medl. It is unclear how much of the effect ofVPA on proliferation 
in NSC and SYSY5Y cells is due to its action on Notch expression. Further 
work which reduces Notch signalling in these cell types could be used to 
investigate the role of this signalling pathway in the proliferation of these cells. 
The action of VPA in reducing neural cell proliferation irrespective of their 
expression of Notch I may make it an effective drug in treating a range of 
neural tumours including neuroblastoma. It is however likely that the use of 
VP A in this way will result in cognitive effects as has been described by a 
variety of other chemotherapy agents (Mustafa et al., 2008). 
5.7 Influence of VPA on expression of stem cell markers 
Stem cell makers such as Notchl, Sox2, nestin and c-Myc have been known to 
be involved in maintaining sternness, neural stem cell proliferation, cell 
survival and neurogenesis and they also prevent cell differentiation (Breunig et 
al., 2007, Nagao et al., 2008, Cauffman et al., 2009). The effect of VPA on a 
stem cell maker, Notch 1 gene expression, was determined in vivo and in vitro 
where VP A treatment reduced levels of Notch 1 expression. The effect of VP A 
on Sox2, nestin and c-Myc expression was examined to investigate a 
correlation of these markers and Notch 1. The results showed that VP A 
treatment as well as reducing Notch 1, also reduced Sox2 and nestin expression 
however it did not change c-Myc expression. Sox2 and nestin are detected in 
NSCs and transient amplifying cells (Kempermaan, 2006, Kempermann, 
2008). These results suggest that VPA is reducing a range of stem and transit 
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amplifying cell markers as well as reducing cell proliferation. This could be 
caused by VPA pushing the cells to differentiate. These stem cell markers are 
believed to be linked in a variety of signalling pathways. There is evidence that 
nestin expression is regulated by Notchl (Mellodewet al., 2004). Moreover, it 
has been reported that both Notch 1 and Sox2 which are involved in 
maintaining neural stem and progenitor cells and inhibiting neuronal 
differentiation, are also able to control each others expression (Yan et al., 2009, 
Qu and Shi, 2009). It is not clear whether VP A is independently affecting each 
of these genes or whether the reduction in expression of one gene is causing 
effects on the expression of other stem cell genes. In conclusion, VP A reduces 
the expression of key stem cell markers which is associated with a reduction in 
the proliferation of these cells. 
5.8Summary 
In summary, the findings in this thesis provide strong evidence showing that 
administration of VP A, a widely used treatment of epilepsy and bipolar 
disorder has behavioural and cellular effects in an animal model. The 
behavioural effects are a deficit in at least one measure of spatial memory and 
confirm patient reports of the cognitive effects of this drug. Action of the drug 
on the hippocampus is strongly suggested as the behavioural test used is known 
to measure hippocampal function. This conclusion is further supported by the 
cellular and chemical changes which appear to be specific to this brain region. 
VP A treatment reduced cell proliferation in the SGZ, lowered BDNF and 
Notch 1 levels in the hippocampus but did not affect DCX. Although the lack 
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of effect on DCX is puzzling, overall VPA appears to have a significant 
detrimental effect on adult hippocampal neurogenesis. 
Further studies of adult hippocampal NSCs both in vitro show that VP A can 
reduce Notch I, Sox2 and nestin gene expression. This indicates that VP A can 
have direct affects on NSCs. 
The present study contributes to understanding the pathology and causes of 
VPA-induced cognitive deficits. In addition to the effect of VPA on NSC 
proliferation, VPA treatment potently decreased SHSY5Y tumour cell growth 
at a dose at the upper limit of the therapeutic range for epilepsy. The results 
also revealed that VP A increased expression of Notch I in these cells in 
contrast to the results from hippocampal NSCs. This present study may lay the 
groundwork for predicting drug responsiveness and guiding the development 
of future clinical epileptic and tumour therapies. 
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APPENDIX 
Al.llmmunofluoresent staining reagents 
4%PFA 
To make up 50 ml of 4% PF A, 2g of PF A powder was dissolved in 45 ml of 
dH20. To this solution, 1OJ.11 of 5M NaOH was added and then heated in a 
water bath at 55-60·C until the powder had dissolved. Once dissolved 5 ml of 
lOX PBS was added and the solution was adjusted to a pH of 7.0 using a pH 
meter. To prepare 0.5% PFA, 1.25 ml of 4% was diluted in 3.75 ml ofPBS. 
Coating of slides with APES 
The glass microscope slides were first soaked in 10% DECON overnight. 
Following overnight incubation the slides were washed in running tap water at 
60·C for 1 hour to remove the detergent and then rinsed in distilled water H20 
(dH20). To ensure the slides were cleaned, they were dried at 60·C overnight. 
Following incubations, the slides were immersed into a solution of 2% APES 
(3-Aminopropyltriethoxysilane) (Sigma-Aldrich, Inc, St.Louis, USA) in 
ethanol for 2 minutes. The slides were then washed 2X in ethanol followed by 
one wash in acetone and left to dry overnight at 3 TC. 
244 
Al.2 western blot reagents 
The fol1owing solutions were used throughout this thesis during the process of 
Western blotting. 
Lysis Buffer pH 7.6 
20 mM Tris (Invitrogen, CA, USA) 
I mM Ethylene Glycol Tetraacetic Acid (EGTA) 
(Sigma-Aldrich, Inc, St.Louis, USA) 
320 mM Sucrose (BDH Laboratory Supplies, Poole, UK) 
0.1 % Triton XI 00 (Sigma-Aldrich, Inc, St.Louis, USA) 
I mM NaF (Sigma-Aldrich, Inc, St.Louis, USA) 
10 mM Beta glycerophosphate 
(Sigma-Aldrich, Inc, St.Louis, USA) 
12.1 g 
1.9 g 
51.7 g 
500 JlI 
0.021 g 
1.08 g 
The above reagents were dissolved in 500 ml of dH20 and the solution was 
then adjusted to a pH of 7.6. When homogenizing the samples, 1 complete mini 
protease inhibitor tablet (Roche Diagnostics, Germany) was dissolved in 
1 Omlof lysis buffer. 
2X SDS-PAGE loading buffer 
0.5 M Tris (Invitrogen, CA, USA) 
Glycerol (Sigma-Aldrich, Inc, St.Louis, USA) 
10% SDS (Sigma-Aldrich, Inc, St.Louis, USA) 
dH20 
Beta mercaptoethanol (Sigma-Aldrich, Inc, St.Louis, USA) 
2.5% Bromophenol Blue (Sigma-Aldrich, Inc, St.Louis, USA) 
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2.5 ml 
2.0ml 
2.0 ml 
2.5 ml 
1.0 ml 
40JlI 
6X SDS-PAGE loading buffer 
12% SOS (Sigma-Aldrich, Inc, St.Louis, USA) 
30% Glycerol (Sigma-Aldrich, Inc, St.Louis, USA) 
603 mM 017 (Sigma-Aldrich, Inc, St.Louis, USA) 
2.5% Bromophenol Blue (Sigma-Aldrich, Inc, St.Louis, USA) 
1.5 M Tris pH 6.8 
The above components were dissolved in 10 ml of dH20. 
Lowry solution A 
100 mM NaOH 
(Fisher Chemicals UK Limited, Loughborough, UK) 
7 mM SOS (Sigma-Aldrich, Inc, St.Louis, USA) 
187 mM NaC03 
(Fisher Chemicals UK Limited, Loughborough, UK) 
The above compounds were dissolved in 500 ml of dH20 
Lowry solution B 
1.0% CUS04 (Fisons Scientific Apparatus, Loughborough, UK) 
2.0% NaK tartrate (BDH Laboratory Supplies, Poole, UK) 
1.2 g 
3 ml 
0.93 g 
80 III 
8.33 III 
2g 
I g 
10 g 
To prepare a working solution of Lowry AB, 100 III of 1.0% CUS04 and 100 III 
of 2.0% NaK tartrate was added to 20 ml of Lowry solution A. 
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lOX Electrophoresis buffer 
250 mM Tris (lnvitrogen, CA, USA) 
1.92 M Glycine 
35 M SOS (Sigma-Aldrich, Inc, St.Louis, USA) 
30.0 g 
144 g 
109 
The above components were dissolved in lItr of dH20. To prepare a working 
solution of IX Electrophoresis, 50 ml of 10X buffer was diluted in 450 ml of 
dH20 . 
Transfer buffer 
25 mM Tris (Invitrogen, CA, USA) 
192 mM Glycine (BOH Laboratory Supplies, Poole, UK) 
30.3 g 
144 g 
The above compounds were dissolved in 8ltr of dH20 and 21tr of methanol 
after which the solution was stored at 4°C. 
TBSTO.l% Tween 
25 mM Tris (Invitrogen, CA, USA) 
125 mM NaCI 
(Fisher Chemicals UK Limited, Loughborough, UK) 
30.29 g 
73.12 g 
The above compounds were dissolved in lltr of dH20 which was then adjusted 
to a pH of 7.6. After the correct pH had been obtained the solution was made 
up to lOltr to which lOml of Tween 20 (Sigma-Aldrich, Inc, St.Louis, USA) 
was added. 
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Summary of BSA dilution for constructing a standard curve during Lowry 
determination of protein concentration. 
Tube Number Sample concentration (mg/ml) BSA O.d) dH20 (Jd) 
1 0 0 200 
2 0.05 10 190 
3 0.1 20 180 
4 0.15 30 170 
5 0.2 40 160 
6 0.25 50 150 
7 0.3 60 140 
8 0.35 70 130 
9 0.4 80 120 
10 0.45 90 110 
11 0.5 100 100 
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Summary of the components for gel preparation 
Component volumes (ml) 
4% 8% 10% 12% 
Components Stacking Resolving Resolvin Resolving 
gel gel g gel gel 
Distilled H2O 2.440 3.776 4.100 3.400 
30% acrylamine 0.520 2.144 3.300 4.000 
Resolving gel buffer 1.5M 2.000 2.500 2.500 
Tris-HCL 
Stacking gel buffer 0.5M 1.000 
Tris-HCL 
10% Sodium dodecyl 0.040 0.080 0.100 0.100 
sulphate (SDS) 
10% Ammonium Per 0.020 0.040 0.050 0.050 
Sulphate (APS) 
Tetramethylethylenediamine 0.005 0.008 0.010 -- 0.010 
(TEMED) 
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Al.3 Haematocytometry 
In cell counting, the cell suspension was mixed thoroughly and then transferred 
10 III of it and mixed with 10 III trypan blue in a vial. Transfer a sample of the 
suspension immediately to the edges of both chambers of an Improved 
Neubauer Hemocytometer and let the suspension run out of the pipette and be 
drawn under the coverslip by capillary action. The fluid should run only to the 
edges of the grooves. Did not overfill or underfill the chamber, it might change 
its dimension, due to alternations in the surface tension. Cells lying within the 
central large square in both halves of the chamber were counted. Cells that lie 
on the top and left-hand lines but not including the bottom and right-hand lines 
were counted in order to avoid counting the same cell. The cell (viable cells) 
concentration per ml could be calculated by using the following formula. 
c = (n x d)/v 
c was cell concentration (cells/ml) 
n was the number of cells counted 
v was the volume counted (ml) 
d was the dilution of cell suspension 
If only the central was used, the depth of the chamber is 0.1 mm and v is 0.1 
mm2, or IxlO-4 ml. the formula becomes c = (n x d)110-4, or c = n x d x 104 . 
If only the five diagonal squares within the central 1 mm2 were counted (i.e., 
115 of the total), this equation became c = n x 5 x d X 104. 
Total cells = cells/ml x original volume of cell suspension from which the 
sample was taken. 
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Al.4 Neural stem cell medium 
Dulbecco's Modified Eagles Medium/Ham's F12 
(DMEMlFI2 1: 1, Invitrogen, CA, USA) 
Neurobasal media (Invitrogen, CA, USA) 
N2 supplement (Invitrogen, CA, USA) 
B27 (lnvitrogen, CA, USA) 
0.5% PenlStrep (Sigma-Aldrich, Inc, St.Louis, USA) 
EGF (Sigma-Aldrich, Inc, St.Louis, USA) 
FGF-2 (Invitrogen, CA, USA) 
Al.5 Quantitative peR 
50X TAE buffer, pH 8.0 
2S0 mM Tris-acetate (Invitrogen, CA, USA) 
0.5 M EDTA, pH8.0 
48 ml 
48 ml 
1 ml 
2 ml 
O.S ml 
20 ng/ml 
20 ng/ml 
121 g 
28.6 g 
Tris-acetate was dissolved in 250 ml of dH20 and then the solution was stirred 
to dissolve. EDT A was added and measure in graduated cylinder and added 
dH20 to SOO ml. To prepare a working solution of IX TAE, 10 ml of SOX 
buffer was diluted in 490 ml of dH20. 
1.4% agarosegel in TAE 
For 50 ml of 1.4% agarose gel, 0.7g agarose (Invitrogen, CA, USA) was added 
into 50mL IX TAE. The mixer was heated in a microwave 1 minute to get into 
solution, did not allow to boil over. If crystals were not dissolved, swirled and 
heated for additional 20 seconds-l minute. After microwaving, S ~ L L of 
ethidium bromide solution was added. The mixer was cooled down before 
2S1 
pouring into the gel plates, made sure the gel plates taped and contained the 
well combs prior to pouring. The gel was allowed to set about 20 minutes. 
Sequencing of primers 
Sequencing of pCS2+MTmNotchIC 
The following mouse Notchl cDNA sequence (Mus Musculus Notch gene 
homolog 1, Accession number NM_008714) was obtained from the NCBI 
Blast database, hnp:llwww.ncbi.nib.govIBLAST/Blast.cgi. The red text 
indicates homologous sequence obtained from the sequencing of 
pCS2+MTmNotchIC using SP6 and T7 primers. 
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